Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Cardiol

Retrieve available abstracts of 970 articles:
HTML format



Single Articles


    May 2024
  1. JUAREZ-OROZCO LE
    Exploring PET-derived geometric indexes in ischemic heart disease - Is more in store?
    J Nucl Cardiol. 2024 May 15:101883. doi: 10.1016/j.nuclcard.2024.101883.
    PubMed    


  2. ROQUE A, Pizzi MN
    PET/CT in aortic grafts: sufficient evidence or still leap of faith?
    J Nucl Cardiol. 2024 May 9:101882. doi: 10.1016/j.nuclcard.2024.101882.
    PubMed    


  3. MANABE O, Tamaki N
    Revealing the Hidden Depths of Takotsubo Syndrome: The Crucial Role of PET in Understanding and Managing Cardiac Microvascular Dysfunction.
    J Nucl Cardiol. 2024 May 7:101878. doi: 10.1016/j.nuclcard.2024.101878.
    PubMed    


  4. ZHANG Y, Bos E, Clarkin O, Wilson T, et al
    Interpretation of SPECT Wall Motion with Deep Learning.
    J Nucl Cardiol. 2024 May 7:101881. doi: 10.1016/j.nuclcard.2024.101881.
    PubMed     Abstract available


  5. MARK PD, Prescott E, Marner L, Hovind P, et al
    [(15)O]H(2)O myocardial perfusion PET: Added value of relative stress perfusion deficit in the prediction of significant coronary artery stenosis in a mixed population.
    J Nucl Cardiol. 2024 May 4:101880. doi: 10.1016/j.nuclcard.2024.101880.
    PubMed     Abstract available


  6. DECORADS CE, Lambert A, Roch V, Imbert L, et al
    Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
    J Nucl Cardiol. 2024;35:101849.
    PubMed     Abstract available


    April 2024
  7. SI H, He Z, Malhotra S, Zhang X, et al
    A novel method combining gated SPECT and vectorcardiography to guide left ventricular lead placement to improve response to cardiac resynchronization therapy: A Proof of Concept study.
    J Nucl Cardiol. 2024 Apr 30:101867. doi: 10.1016/j.nuclcard.2024.101867.
    PubMed     Abstract available


  8. BRORSON J, Gormsen LC, Madsen S, Tolbod LP, et al
    Splenic switch-off in [(15)O]H(2)O-PET myocardial perfusion imaging using parametric blood flow images.
    J Nucl Cardiol. 2024 Apr 27:101868. doi: 10.1016/j.nuclcard.2024.101868.
    PubMed     Abstract available


  9. KADOYA Y, Chong AY, Small GR, Chow B, et al
    Myocardial flow reserve recovery in patients with Takotsubo syndrome: insights from positron emission tomography.
    J Nucl Cardiol. 2024 Apr 27:101869. doi: 10.1016/j.nuclcard.2024.101869.
    PubMed     Abstract available


  10. HASSE B, Ledergerber B, Van Hemelrijck M, Frank M, et al
    FDG uptake patterns in PET/CT caused by inflammation and/or infection after graft surgery for thoracic aortic dissection.
    J Nucl Cardiol. 2024 Apr 26:101865. doi: 10.1016/j.nuclcard.2024.101865.
    PubMed     Abstract available


  11. MARTINEZ-LUCIO TS, Alexanderson-Rosas E, Carvajal-Juarez I, Mendoza-Ibanez AK, et al
    Left ventricular shape index and eccentricity index with ECG-gated Nitrogen-13 ammonia PET/CT in patients with myocardial infarction, ischemia and normal perfusion.
    J Nucl Cardiol. 2024 Apr 10:101862. doi: 10.1016/j.nuclcard.2024.101862.
    PubMed     Abstract available


  12. SPERRY BW, Vuppala S
    Sequential FDG PET Imaging in Cardiac Sarcoidosis.
    J Nucl Cardiol. 2024 Apr 5:101860. doi: 10.1016/j.nuclcard.2024.101860.
    PubMed    


    March 2024
  13. TAVOOSI A, Paquin A, deKemp R, Chong AY, et al
    POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF CORONARY MICROVASCULAR ANGINA IN PATIENTS WITH ANGINA AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE.
    J Nucl Cardiol. 2024 Mar 25:101853. doi: 10.1016/j.nuclcard.2024.101853.
    PubMed    


  14. ABU-QAMAR O, Biery DW, Mendonca LSM, Barrett L, et al
    Association between Abnormal Retinal Perfusion Indices by Optical Coherence Tomography Angiography and Myocardial Flow Reserve by PET/CT.
    J Nucl Cardiol. 2024 Mar 25:101852. doi: 10.1016/j.nuclcard.2024.101852.
    PubMed    


  15. BALMFORTH C, Whittington B, Tzolos E, Bing R, et al
    Translational Molecular imaging: Thrombosis Imaging with Positron Emission Tomography.
    J Nucl Cardiol. 2024 Mar 16:101848. doi: 10.1016/j.nuclcard.2024.101848.
    PubMed     Abstract available


  16. KWIECINSKI J
    Role of (18)F-sodium fluoride positron emission tomography in imaging atherosclerosis.
    J Nucl Cardiol. 2024 Mar 11:101845. doi: 10.1016/j.nuclcard.2024.101845.
    PubMed     Abstract available


  17. OKAFOR J, Khattar R, Kouranos V, Ohri S, et al
    Role of serial (18)FDG-PET in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis.
    J Nucl Cardiol. 2024 Mar 11:101842. doi: 10.1016/j.nuclcard.2024.101842.
    PubMed     Abstract available


  18. RUDDY TD, Wells RG
    Shortening the Acquisition Times of CZT SPECT Imaging for Measurement of Myocardial Blood Flow.
    J Nucl Cardiol. 2024 Mar 9:101847. doi: 10.1016/j.nuclcard.2024.101847.
    PubMed    


  19. DI CARLI MF
    How is PET/CT Imaging Revolutionizing Cardiac Care: Let me Count the Ways.
    J Nucl Cardiol. 2024 Mar 7:101844. doi: 10.1016/j.nuclcard.2024.101844.
    PubMed     Abstract available


  20. PATEL KK, Singh A, Qarajeh R, Shatla I, et al
    Prevalence of Balanced Ischemia on PET Relative Perfusion Imaging Among Patients with High-Risk Coronary Artery Disease.
    J Nucl Cardiol. 2024 Mar 2:101836. doi: 10.1016/j.nuclcard.2024.101836.
    PubMed    


  21. BOBER RM, Johnson NP
    How might coronary sinus reducer treatment change myocardial perfusion?
    J Nucl Cardiol. 2024;33:101828.
    PubMed    


  22. AL RIFAI M, Winchester D
    When should myocardial perfusion imaging be a first-test choice?
    J Nucl Cardiol. 2024;33:101824.
    PubMed    


  23. ZAMPELLA E, Assante R, Acampa W
    A good assist is followed by a goal.
    J Nucl Cardiol. 2024;33:101807.
    PubMed    


  24. AKSIT E, Kirilmaz B, Ozdemir S
    The importance of myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.
    J Nucl Cardiol. 2024;33:101791.
    PubMed    


    February 2024
  25. SOLANKI R, Singh H, Mehta V, Panda P, et al
    Potential application of (68)Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis.
    J Nucl Cardiol. 2024 Feb 23:101835. doi: 10.1016/j.nuclcard.2024.101835.
    PubMed    


  26. SEVAG PACKARD RR
    Expanding the Repertoire of (18)F-Labeled PET MPI Radiotracers.
    J Nucl Cardiol. 2024 Feb 23:101834. doi: 10.1016/j.nuclcard.2024.101834.
    PubMed    


  27. LIU A, Cain L, Munemo LT, Ahmed R, et al
    Characterisation and management of expected and unexpected urgent findings from FDG-PET-CT in cardiovascular disease.
    J Nucl Cardiol. 2024 Feb 20:101826. doi: 10.1016/j.nuclcard.2024.101826.
    PubMed     Abstract available


  28. WANG J, Chen Y, Chu H, Pang Z, et al
    Feasibility of Myocardial Blood Flow Quantification to Detect Flow-limited Coronary Artery Disease with A One-day Rest/Stress Continuous Rapid Imaging Protocol on Cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2024 Feb 20:101825. doi: 10.1016/j.nuclcard.2024.101825.
    PubMed     Abstract available


  29. REN C, Pan Q, Fu C, Wang P, et al
    Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: biodistribution, radiation dosimetry, pharmacokinetics and safety after a single injection at rest.
    J Nucl Cardiol. 2024 Feb 13:101823. doi: 10.1016/j.nuclcard.2024.101823.
    PubMed     Abstract available


  30. BOURQUE JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, et al
    (18)F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I(2)) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM
    J Nucl Cardiol. 2024 Feb 12:101786. doi: 10.1016/j.nuclcard.2023.101786.
    PubMed     Abstract available


  31. DI CARLI MF
    Navigating the positron emission tomography vs. single-photon emission computed tomography debate: A closer look at evidence and guidelines.
    J Nucl Cardiol. 2024 Feb 2:101822. doi: 10.1016/j.nuclcard.2024.101822.
    PubMed    


    January 2024
  32. BHATTARU A, Rojulpote C, Vidula M, Duda J, et al
    Deep Learning Approach for Automated Segmentation of Myocardium Using Bone Scintigraphy SPECT/CT in Patients with Suspected Cardiac Amyloidosis.
    J Nucl Cardiol. 2024 Jan 31:101809. doi: 10.1016/j.nuclcard.2024.101809.
    PubMed     Abstract available


  33. HAN Y, Ahmed AI, Saad JM, Alahdab F, et al
    Ejection Fraction And Ventricular Volumes On Rubidium Positron Emission Tomography: Prospective Validation Against Cardiovascular Magnetic Resonance.
    J Nucl Cardiol. 2024 Jan 27:101810. doi: 10.1016/j.nuclcard.2024.101810.
    PubMed     Abstract available


  34. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
    Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
    J Nucl Cardiol. 2024 Jan 19:101816. doi: 10.1016/j.nuclcard.2024.101816.
    PubMed    


  35. DIETZ M, Bochaton T, Al Mansour L, Tordo J, et al
    Identification of lipomatous metaplasia on CT images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on SPECT/CT imaging.
    J Nucl Cardiol. 2024 Jan 19:101812. doi: 10.1016/j.nuclcard.2024.101812.
    PubMed    


  36. WILLIAMS MC
    Machine learning models for PET myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Jan 18:101805. doi: 10.1016/j.nuclcard.2024.101805.
    PubMed    


  37. ROZANSKI A, Miller RJH, Han D, Gransar H, et al
    Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2024 Jan 18:101811. doi: 10.1016/j.nuclcard.2024.101811.
    PubMed     Abstract available


  38. CHENG K, Tan ST, Wechalekar K, Keramida G, et al
    Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
    J Nucl Cardiol. 2024 Jan 12:101803. doi: 10.1016/j.nuclcard.2024.101803.
    PubMed    


  39. SANGHANI R, Al-Mallah MH, Thompson R
    Challenges and Strategies to enable access to Cardiac PET in Different Parts of the World: The North American Perspective.
    J Nucl Cardiol. 2024 Jan 10:101790. doi: 10.1016/j.nuclcard.2023.101790.
    PubMed    


  40. BORGES-ROSA J, Oliveira-Santos M, Silva R, Elvas L, et al
    (18)F-FDG PET-CT FOR DIAGNOSING CUTANEOUS FISTULAS SECONDARY TO RETAINED LEAD FRAGMENTS: A RARE AND CHALLENGING COMPLICATION AFTER PACEMAKER EXTRACTION.
    J Nucl Cardiol. 2024 Jan 6:101794. doi: 10.1016/j.nuclcard.2024.101794.
    PubMed    


  41. BAILLY M, Gamet A, Metrard G
    Potential utility of myocardial blood flow quantification with SPECT in a patient undergoing treatment for breast cancer.
    J Nucl Cardiol. 2024 Jan 5:101799. doi: 10.1016/j.nuclcard.2024.101799.
    PubMed    


  42. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
    Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
    J Nucl Cardiol. 2024 Jan 5:101800. doi: 10.1016/j.nuclcard.2024.101800.
    PubMed    


  43. BERMAN D, Hunter C, Hossain A, Yao J, et al
    Machine and deep learning models for accurate detection of ischemia and scar with myocardial blood flow PET imaging.
    J Nucl Cardiol. 2024 Jan 5:101797. doi: 10.1016/j.nuclcard.2024.101797.
    PubMed     Abstract available


  44. GAEMPERLI O
    Ejection fraction and ventricular volumes on Rb PET: Validation against cardiovascular MRI.
    J Nucl Cardiol. 2024 Jan 4:101795. doi: 10.1016/j.nuclcard.2024.101795.
    PubMed    


  45. HOFF CM, Sorensen J, Kero T, Bouchelouche K, et al
    Quantitative and qualitative comparison of Rubidium-82 and Oxygen-15 water cardiac PET.
    J Nucl Cardiol. 2024 Jan 4:101796. doi: 10.1016/j.nuclcard.2024.101796.
    PubMed     Abstract available


  46. ABAZID RM, Davey RA, Romsa J, Florendo-Cumbermack A, et al
    Progressive development of cardiac amyloidosis in a hereditary transthyretin gene carrier on serial Tc-99m PYP SPECT-CT.
    J Nucl Cardiol. 2024;31:101774.
    PubMed    


  47. CROWLEY A, Gerson M
    The future of PET imaging: Looking forward to more choices and increased precision with the use of oxygen-15 water.
    J Nucl Cardiol. 2024;31:101775.
    PubMed    


  48. SUERO-ABREU GA, Lim P, Raza A, Tysarowski M, et al
    Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer.
    J Nucl Cardiol. 2024;31:101782.
    PubMed     Abstract available


  49. DI CARLI MF, Gormsen LC, Chareonthaitawee P, Johnson GB, et al
    Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
    J Nucl Cardiol. 2024;31:101779.
    PubMed     Abstract available


    December 2023
  50. ARUMUGAM P, Better N, Keng FY, Allam A, et al
    Current state and challenges of implementing a cardiac positron emission tomography program outside North America.
    J Nucl Cardiol. 2023;31:101788.
    PubMed    


  51. DANAD I, Driessen RS
    Utility of (82)Rb and [(15)O]H(2)O PET myocardial perfusion imaging in challenging (high risk) patients: "Don't throw the baby out with the bathwater".
    J Nucl Cardiol. 2023 Dec 2:101783. doi: 10.1016/j.nuclcard.2023.101783.
    PubMed    


  52. HUDSON O, Hage FG
    Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
    J Nucl Cardiol. 2023;30:2615-2617.
    PubMed    


  53. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
    Increasing frequency of dyspnea among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:2303-2313.
    PubMed     Abstract available


  54. AL-MALLAH MH
    ASNC without borders: A global effort in nuclear cardiology.
    J Nucl Cardiol. 2023;30:2972-2975.
    PubMed    


  55. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
    Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
    J Nucl Cardiol. 2023;30:2773-2789.
    PubMed     Abstract available


  56. LI L, Gao J, Chen BX, Liu X, et al
    Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
    J Nucl Cardiol. 2023;30:2712-2720.
    PubMed     Abstract available


  57. MATTHEWS B, Duddleston D, Hage FG
    Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
    J Nucl Cardiol. 2023;30:2907-2910.
    PubMed    


  58. YU W, Yang L, Zhang F, Liu B, et al
    Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
    J Nucl Cardiol. 2023;30:2593-2606.
    PubMed     Abstract available


  59. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
    Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
    J Nucl Cardiol. 2023;30:2504-2513.
    PubMed     Abstract available


  60. SCIAGRA R, Linguanti F
    The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2346-2348.
    PubMed     Abstract available


  61. REID BJ, Lindow T, Warren S, Persson E, et al
    Immediate recruitment of dormant coronary collaterals can provide more than half of normal resting perfusion during coronary occlusion in patients with coronary artery disease.
    J Nucl Cardiol. 2023;30:2338-2345.
    PubMed     Abstract available


  62. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
    Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
    J Nucl Cardiol. 2023;30:2427-2437.
    PubMed     Abstract available


  63. DAWDY J, Polina A, Abidov A
    Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
    J Nucl Cardiol. 2023;30:2837-2838.
    PubMed    


  64. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
    Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
    J Nucl Cardiol. 2023;30:2349-2360.
    PubMed     Abstract available


  65. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
    Stigmata of portal hypertension depicted on myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2813-2815.
    PubMed    


  66. RAVAL M, Siddiq S
    Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
    J Nucl Cardiol. 2023;30:2807-2808.
    PubMed    


  67. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
    Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
    J Nucl Cardiol. 2023;30:2809-2812.
    PubMed    


  68. YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
    Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
    J Nucl Cardiol. 2023;31:101777.
    PubMed     Abstract available


  69. MATTHEWS B, Duddleston D, Hage FG
    Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
    J Nucl Cardiol. 2023;30:2907-2910.
    PubMed    


  70. BUTT F, Siegel A
    Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
    J Nucl Cardiol. 2023;30:2841-2843.
    PubMed    


  71. SILLANMAKI S, Iso-Mustajarvi S
    (18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
    J Nucl Cardiol. 2023;30:2839-2840.
    PubMed    


  72. DAWDY J, Polina A, Abidov A
    Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
    J Nucl Cardiol. 2023;30:2837-2838.
    PubMed    


  73. SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
    Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2825-2827.
    PubMed    


  74. KAUR S, Bartley P, Gordon S, Higgins A, et al
    Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
    J Nucl Cardiol. 2023;30:2823-2824.
    PubMed     Abstract available


  75. YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
    Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
    J Nucl Cardiol. 2023;30:2819-2822.
    PubMed    


  76. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
    Stigmata of portal hypertension depicted on myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2813-2815.
    PubMed    


  77. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
    Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
    J Nucl Cardiol. 2023;30:2809-2812.
    PubMed    


  78. RAVAL M, Siddiq S
    Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
    J Nucl Cardiol. 2023;30:2807-2808.
    PubMed    


  79. FITCH JS, Schwartz RG
    Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
    J Nucl Cardiol. 2023;30:2803-2806.
    PubMed    


  80. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
    (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
    J Nucl Cardiol. 2023;30:2790-2802.
    PubMed     Abstract available


  81. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
    Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
    J Nucl Cardiol. 2023;30:2773-2789.
    PubMed     Abstract available


  82. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
    Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
    J Nucl Cardiol. 2023;30:2760-2772.
    PubMed     Abstract available


  83. JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
    Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
    J Nucl Cardiol. 2023;30:2750-2759.
    PubMed     Abstract available


  84. CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
    Detection and correction of patient motion in dynamic (15)O-water PET MPI.
    J Nucl Cardiol. 2023;30:2736-2749.
    PubMed     Abstract available


  85. WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
    Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
    J Nucl Cardiol. 2023;30:2721-2735.
    PubMed     Abstract available


  86. LI L, Gao J, Chen BX, Liu X, et al
    Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
    J Nucl Cardiol. 2023;30:2712-2720.
    PubMed     Abstract available


  87. DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
    Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
    J Nucl Cardiol. 2023;30:2702-2711.
    PubMed     Abstract available


  88. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023;30:2692-2701.
    PubMed     Abstract available


  89. ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
    Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    J Nucl Cardiol. 2023;30:2676-2691.
    PubMed     Abstract available


  90. SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
    A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
    J Nucl Cardiol. 2023;30:2658-2665.
    PubMed     Abstract available


  91. CAMONI L, Dondi F
    Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
    J Nucl Cardiol. 2023;30:2655-2657.
    PubMed    


  92. CASE JA, Courter SA, McGhie A, Patel KK, et al
    Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
    J Nucl Cardiol. 2023;30:2644-2654.
    PubMed     Abstract available


  93. GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
    Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
    J Nucl Cardiol. 2023;30:2633-2643.
    PubMed     Abstract available


  94. ZHANG J, Xie J, Li M, Fang W, et al
    SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2023;30:2618-2632.
    PubMed     Abstract available


  95. HUDSON O, Hage FG
    Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
    J Nucl Cardiol. 2023;30:2615-2617.
    PubMed    


  96. AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
    Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    J Nucl Cardiol. 2023;30:2607-2614.
    PubMed     Abstract available


  97. YU W, Yang L, Zhang F, Liu B, et al
    Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
    J Nucl Cardiol. 2023;30:2593-2606.
    PubMed     Abstract available


  98. LI L, Pang Z, Wang J, Chen Y, et al
    Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
    J Nucl Cardiol. 2023;30:2578-2592.
    PubMed     Abstract available


  99. CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
    Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
    J Nucl Cardiol. 2023;30:2559-2573.
    PubMed     Abstract available


  100. SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
    Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
    J Nucl Cardiol. 2023;30:2544-2555.
    PubMed     Abstract available


  101. KHOR YM, Dorbala S
    Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
    J Nucl Cardiol. 2023;30:2540-2543.
    PubMed    


  102. KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
    Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2525-2530.
    PubMed     Abstract available


  103. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    J Nucl Cardiol. 2023;30:2514-2524.
    PubMed     Abstract available


  104. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
    Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
    J Nucl Cardiol. 2023;30:2504-2513.
    PubMed     Abstract available


  105. JOHN LA, Tedrow UB, Divakaran S
    Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
    J Nucl Cardiol. 2023;30:2501-2503.
    PubMed    


  106. LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
    FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2490-2500.
    PubMed     Abstract available


  107. TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
    Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
    J Nucl Cardiol. 2023;30:2477-2489.
    PubMed     Abstract available


  108. AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
    Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
    J Nucl Cardiol. 2023;30:2464-2476.
    PubMed     Abstract available


  109. CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
    Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
    J Nucl Cardiol. 2023;30:2454-2463.
    PubMed     Abstract available


  110. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
    Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
    J Nucl Cardiol. 2023;30:2427-2437.
    PubMed     Abstract available


  111. HANSEN CL
    Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
    J Nucl Cardiol. 2023;30:2418-2426.
    PubMed     Abstract available


  112. SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
    (18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
    J Nucl Cardiol. 2023;30:2400-2414.
    PubMed     Abstract available


  113. KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
    (18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
    J Nucl Cardiol. 2023;30:2365-2378.
    PubMed     Abstract available


  114. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
    Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
    J Nucl Cardiol. 2023;30:2349-2360.
    PubMed     Abstract available


  115. SCIAGRA R, Linguanti F
    The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2346-2348.
    PubMed     Abstract available


  116. PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
    4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
    J Nucl Cardiol. 2023;30:2314-2326.
    PubMed     Abstract available


  117. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
    Increasing frequency of dyspnea among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:2303-2313.
    PubMed     Abstract available


  118. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023;30:2301-2302.
    PubMed    


  119. LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
    Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2289-2300.
    PubMed     Abstract available


  120. BATEMAN TM
    In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2273-2278.
    PubMed    


  121. JOHNSRUD DO, Port SC
    In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023;30:2269-2272.
    PubMed    


    November 2023
  122. BATEMAN TM
    In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023 Nov 10. doi: 10.1007/s12350-023-03386.
    PubMed    


  123. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    Correction to: The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023 Nov 6. doi: 10.1007/s12350-023-03389.
    PubMed    


    October 2023
  124. CHAREONTHAITAWEE P, Bateman TM, Beanlands RS, Berman DS, et al
    Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology.
    J Nucl Cardiol. 2023 Oct 27. doi: 10.1007/s12350-023-03378.
    PubMed    


  125. JOHNSRUD DO, Port SC
    In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
    J Nucl Cardiol. 2023 Oct 16. doi: 10.1007/s12350-023-03385.
    PubMed    


  126. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
    (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
    J Nucl Cardiol. 2023 Oct 3. doi: 10.1007/s12350-023-03372.
    PubMed     Abstract available


  127. LOHARKAR S, Sonavane SN, Shah H, Basu S, et al
    What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of (18)F-FDG PET/CT in monitoring response to treatment.
    J Nucl Cardiol. 2023 Oct 2. doi: 10.1007/s12350-023-03381.
    PubMed    


  128. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
    Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
    J Nucl Cardiol. 2023;30:2089-2095.
    PubMed     Abstract available


  129. BULLOCK-PALMER RP
    Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
    J Nucl Cardiol. 2023;30:2068-2072.
    PubMed    


  130. IBRAHIM J, Soman P
    The past, present, and future of attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1794-1796.
    PubMed    


  131. TOTTLEBEN J, Torres A, Doukky R
    Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
    J Nucl Cardiol. 2023;30:1897-1903.
    PubMed     Abstract available


  132. DAKIK HA, Ghazzal Z, Haidar M
    Screening asymptomatic patients post PCI with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2248-2251.
    PubMed    


  133. NAYFEH M, Ahmed AI, Al-Mallah MH
    Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1851-1855.
    PubMed    


  134. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
    Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
    J Nucl Cardiol. 2023;30:1935-1946.
    PubMed     Abstract available


  135. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
    Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
    J Nucl Cardiol. 2023;30:1922-1934.
    PubMed     Abstract available


  136. WANG Y, Yu W, Yang X, Zhang F, et al
    Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
    J Nucl Cardiol. 2023;30:1797-1809.
    PubMed     Abstract available


  137. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
    Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    J Nucl Cardiol. 2023;30:2104-2111.
    PubMed     Abstract available


  138. ANDERSSON Y, Fernandez G, Mars P, Lindow T, et al
    Significant myocardial perfusion defect during stress visible in prone but not in supine imaging.
    J Nucl Cardiol. 2023;30:2209-2212.
    PubMed    


  139. DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
    Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    J Nucl Cardiol. 2023;30:2254.
    PubMed    


  140. NIELSEN MO, Schledermann H, Jensen LT
    Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    J Nucl Cardiol. 2023;30:2252-2253.
    PubMed    


  141. DAKIK HA, Ghazzal Z, Haidar M
    Screening asymptomatic patients post PCI with myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:2248-2251.
    PubMed    


  142. CHEN LQ, Nichols KJ, Van Tosh A
    Exercise ECG must be considered in conjunction with conventional SPECT.
    J Nucl Cardiol. 2023;30:2245-2247.
    PubMed    


  143. SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
    Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
    J Nucl Cardiol. 2023;30:2242-2244.
    PubMed    


  144. AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
    Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
    J Nucl Cardiol. 2023;30:2225-2228.
    PubMed    


  145. ZMAILI M, Jaber W
    First experience of LVEF assessment with cardiac amyloid SPECT scan.
    J Nucl Cardiol. 2023;30:2222-2224.
    PubMed    


  146. TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
    Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    J Nucl Cardiol. 2023;30:2215-2221.
    PubMed    


  147. JALEEL J, Patel C, Khangembam B, Kumar S, et al
    Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:2213-2214.
    PubMed     Abstract available


  148. TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
    (99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2023;30:2198-2203.
    PubMed    


  149. QAMAR I, Grewal S, Fahed AC, Weiner R, et al
    PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
    J Nucl Cardiol. 2023;30:2187-2190.
    PubMed    


  150. DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
    Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
    J Nucl Cardiol. 2023;30:2186.
    PubMed    


  151. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
    ASNC model coverage policy: 2023 cardiac positron emission tomography.
    J Nucl Cardiol. 2023;30:2114-2185.
    PubMed    


  152. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
    Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    J Nucl Cardiol. 2023;30:2104-2111.
    PubMed     Abstract available


  153. BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
    Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
    J Nucl Cardiol. 2023;30:2096-2103.
    PubMed     Abstract available


  154. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
    Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
    J Nucl Cardiol. 2023;30:2089-2095.
    PubMed     Abstract available


  155. BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
    [(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
    J Nucl Cardiol. 2023;30:2073-2084.
    PubMed     Abstract available


  156. BULLOCK-PALMER RP
    Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
    J Nucl Cardiol. 2023;30:2068-2072.
    PubMed    


  157. XU R, Yang H, Zhang J, Chen S, et al
    Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
    J Nucl Cardiol. 2023;30:2058-2067.
    PubMed     Abstract available


  158. PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
    Including myocardial flow reserve by PET in prediction models: Ready to fly?
    J Nucl Cardiol. 2023;30:2054-2057.
    PubMed    


  159. MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
    Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
    J Nucl Cardiol. 2023;30:2043-2053.
    PubMed     Abstract available


  160. HULTEN E, Keating FK
    Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
    J Nucl Cardiol. 2023;30:2039-2042.
    PubMed    


  161. KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
    Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
    J Nucl Cardiol. 2023;30:2018-2028.
    PubMed     Abstract available


  162. MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
    Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
    J Nucl Cardiol. 2023;30:2006-2017.
    PubMed     Abstract available


  163. DAI N, Zhang B, Gong Z, Dong Z, et al
    Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
    J Nucl Cardiol. 2023;30:1992-2002.
    PubMed     Abstract available


  164. WANG A, Mahmood U, Tang X, Jain D, et al
    A case of disappearing amyloid on technetium pyrophosphate scan.
    J Nucl Cardiol. 2023;30:1986-1991.
    PubMed     Abstract available


  165. TANG X, Dai N, Zhang B, Cai H, et al
    Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
    J Nucl Cardiol. 2023;30:1973-1982.
    PubMed     Abstract available


  166. NAKAJIMA K, Shibutani T
    Are nuclear medicine images quantified in 2D and 3D equally functional?
    J Nucl Cardiol. 2023;30:1968-1972.
    PubMed    


  167. IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
    Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
    J Nucl Cardiol. 2023;30:1959-1967.
    PubMed     Abstract available


  168. FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
    Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
    J Nucl Cardiol. 2023;30:1947-1958.
    PubMed     Abstract available


  169. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
    Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
    J Nucl Cardiol. 2023;30:1935-1946.
    PubMed     Abstract available


  170. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
    Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
    J Nucl Cardiol. 2023;30:1922-1934.
    PubMed     Abstract available


  171. QUTBI M
    Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
    J Nucl Cardiol. 2023;30:1910-1921.
    PubMed     Abstract available


  172. TOTTLEBEN J, Torres A, Doukky R
    Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
    J Nucl Cardiol. 2023;30:1897-1903.
    PubMed     Abstract available


  173. KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
    Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
    J Nucl Cardiol. 2023;30:1890-1896.
    PubMed     Abstract available


  174. HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
    Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1879-1885.
    PubMed     Abstract available


  175. CHEN X, Liu C
    Deep-learning-based methods of attenuation correction for SPECT and PET.
    J Nucl Cardiol. 2023;30:1859-1878.
    PubMed     Abstract available


  176. NAYFEH M, Ahmed AI, Al-Mallah MH
    Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1851-1855.
    PubMed    


  177. HIJAZI W, Miller RJH
    Deep learning to automate SPECT MPI myocardial reorientation.
    J Nucl Cardiol. 2023;30:1836-1837.
    PubMed    


  178. ZHU F, Wang G, Zhao C, Malhotra S, et al
    Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
    J Nucl Cardiol. 2023;30:1825-1835.
    PubMed     Abstract available


  179. GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
    Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
    J Nucl Cardiol. 2023;30:1810-1821.
    PubMed     Abstract available


  180. WANG Y, Yu W, Yang X, Zhang F, et al
    Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
    J Nucl Cardiol. 2023;30:1797-1809.
    PubMed     Abstract available


  181. IBRAHIM J, Soman P
    The past, present, and future of attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1794-1796.
    PubMed    


  182. CHOPRA S, Singh SS, Sood A, Parmar M, et al
    Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
    J Nucl Cardiol. 2023;30:1782-1793.
    PubMed     Abstract available


  183. SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
    Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1773-1781.
    PubMed     Abstract available


  184. KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
    PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
    J Nucl Cardiol. 2023;30:1761-1772.
    PubMed     Abstract available


  185. BERMAN DS
    Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
    J Nucl Cardiol. 2023;30:1751-1755.
    PubMed    


  186. BERMAN DS
    Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
    J Nucl Cardiol. 2023;30:1751-1755.
    PubMed    


    September 2023
  187. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
    Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
    J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03371.
    PubMed     Abstract available


  188. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03377.
    PubMed     Abstract available


  189. LIMA BB, Benz DC
    Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
    J Nucl Cardiol. 2023 Sep 20. doi: 10.1007/s12350-023-03376.
    PubMed    


  190. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
    ASNC model coverage policy: 2023 cardiac positron emission tomography.
    J Nucl Cardiol. 2023 Sep 5. doi: 10.1007/s12350-023-03355.
    PubMed    


  191. JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
    Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
    J Nucl Cardiol. 2023 Sep 1. doi: 10.1007/s12350-023-03359.
    PubMed     Abstract available


    August 2023
  192. CAMONI L, Dondi F
    Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
    J Nucl Cardiol. 2023 Aug 31. doi: 10.1007/s12350-023-03369.
    PubMed    


  193. CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
    Detection and correction of patient motion in dynamic (15)O-water PET MPI.
    J Nucl Cardiol. 2023 Aug 28. doi: 10.1007/s12350-023-03358.
    PubMed     Abstract available


  194. LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
    Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
    J Nucl Cardiol. 2023 Aug 25. doi: 10.1007/s12350-023-03360.
    PubMed     Abstract available


  195. DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
    Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
    J Nucl Cardiol. 2023 Aug 21. doi: 10.1007/s12350-023-03350.
    PubMed     Abstract available


  196. WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
    Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
    J Nucl Cardiol. 2023 Aug 21. doi: 10.1007/s12350-023-03353.
    PubMed     Abstract available


  197. PARIZHER G, Dugan E, Jaber WA
    What is this image? 2023 image 2 results: In vivo demonstration of regadenoson-induced severe ischemia on PET myocardial perfusion imaging in a patient with hypertrophic obstructive cardiomyopathy and nonobstructive coronary artery disease.
    J Nucl Cardiol. 2023 Aug 21. doi: 10.1007/s12350-023-03366.
    PubMed    


  198. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
    The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    J Nucl Cardiol. 2023 Aug 17. doi: 10.1007/s12350-023-03349.
    PubMed     Abstract available


  199. KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
    PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
    J Nucl Cardiol. 2023 Aug 17. doi: 10.1007/s12350-023-03248.
    PubMed     Abstract available


  200. ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
    Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    J Nucl Cardiol. 2023 Aug 16. doi: 10.1007/s12350-023-03345.
    PubMed     Abstract available


  201. DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
    Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
    J Nucl Cardiol. 2023 Aug 10. doi: 10.1007/s12350-023-03357.
    PubMed    


  202. ROZANSKI A, Han D, Miller RJH, Gransar H, et al
    Decline in typical angina among patients referred for cardiac stress testing.
    J Nucl Cardiol. 2023;30:1309-1320.
    PubMed     Abstract available


  203. ZAMPELLA E, Assante R, Acampa W
    Myocardial perfusion reserve by CZT cameras: A journey inside coronary microvascular circulation. Is it time to leave yet?
    J Nucl Cardiol. 2023;30:1668-1670.
    PubMed    


  204. HATIPOGLU S, Wechalekar AD, Wechalekar K
    Extensive cardiac FDG uptake in a patient with AL amyloidosis.
    J Nucl Cardiol. 2023;30:1497-1503.
    PubMed     Abstract available


  205. DEPUEY EG
    Incidental scan findings in cardiac amyloid scintigraphy.
    J Nucl Cardiol. 2023;30:1671-1687.
    PubMed     Abstract available


  206. DJAILEB L, De Leiris N, Canu M, Sy OP, et al
    Regional CZT myocardial perfusion reserve for the detection of territories with simultaneously impaired CFR and IMR in patients without obstructive coronary artery disease: a pilot study.
    J Nucl Cardiol. 2023;30:1656-1667.
    PubMed     Abstract available


  207. LASSEN ML, Wissenberg M, Byrne C, Kjaer A, et al
    Performance of 8- vs 16 ECG-gated reconstructions in assessing myocardial function using Rubidium-82 myocardial perfusion imaging: Findings in a young, healthy population.
    J Nucl Cardiol. 2023;30:1406-1413.
    PubMed     Abstract available


  208. SIEKKINEN R, Han C, Maaniitty T, Teras M, et al
    A retrospective evaluation of Bayesian-penalized likelihood reconstruction for [(15)O]H(2)O myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1602-1612.
    PubMed     Abstract available


  209. VIS R, Mathijssen H, Keijsers RGM, van de Garde EMW, et al
    Prednisone vs methotrexate in treatment naive cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1543-1553.
    PubMed     Abstract available


  210. KITKUNGVAN D, Johnson NP, Bui L, Patel MB, et al
    Does financial hardship associate with abnormal quantitative myocardial perfusion and major adverse cardiovascular event?
    J Nucl Cardiol. 2023;30:1528-1539.
    PubMed     Abstract available


  211. PETRETTA M, Megna R, Assante R, Zampella E, et al
    External validation and update of the J-ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:1443-1453.
    PubMed     Abstract available


  212. SARASTE A, Knuuti J, Bax JJ
    More evidence for prognostic value of quantification of myocardial perfusion.
    J Nucl Cardiol. 2023;30:1396-1398.
    PubMed    


  213. LADRIERE T, Desmonts C, Zimmermann PA, Peyronnet D, et al
    Impact of disposable syringes type choice on myocardial perfusion imaging procedures with [(99m)Tc]Tc-tetrofosmin.
    J Nucl Cardiol. 2023;30:1399-1405.
    PubMed     Abstract available


  214. RUDDY TD, Tavoosi A, Taqueti VR
    Role of nuclear cardiology in diagnosis and risk stratification of coronary microvascular disease.
    J Nucl Cardiol. 2023;30:1327-1340.
    PubMed     Abstract available


  215. DAWDY J, Akins X, Shafi I, Kottam A, et al
    Myocardial perfusion imaging in patients with subcutaneous implantable cardioverter defibrillators: Is this the correct test?
    J Nucl Cardiol. 2023;30:1713-1716.
    PubMed    


  216. MUT F, Carvajal I, Camilletti J, Erriest J, et al
    Cardiac amyloidosis in Latin America: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group.
    J Nucl Cardiol. 2023;30:1592-1601.
    PubMed     Abstract available


  217. MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
    LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
    J Nucl Cardiol. 2023;30:1693-1696.
    PubMed    


    July 2023
  218. KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
    Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    J Nucl Cardiol. 2023 Jul 31. doi: 10.1007/s12350-023-03346.
    PubMed     Abstract available


  219. BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
    Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
    J Nucl Cardiol. 2023 Jul 31. doi: 10.1007/s12350-023-03339.
    PubMed     Abstract available


  220. SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
    A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
    J Nucl Cardiol. 2023 Jul 25. doi: 10.1007/s12350-023-03340.
    PubMed     Abstract available


  221. ZHANG J, Xie J, Li M, Fang W, et al
    SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
    J Nucl Cardiol. 2023 Jul 25. doi: 10.1007/s12350-023-03334.
    PubMed     Abstract available


  222. JOHN LA, Tedrow UB, Divakaran S
    Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
    J Nucl Cardiol. 2023 Jul 20. doi: 10.1007/s12350-023-03342.
    PubMed    


  223. KHOR YM, Dorbala S
    Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
    J Nucl Cardiol. 2023 Jul 19. doi: 10.1007/s12350-023-03341.
    PubMed    


  224. QAMAR I, Grewal S, Fahed AC, Weiner R, et al
    PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
    J Nucl Cardiol. 2023 Jul 19. doi: 10.1007/s12350-023-03337.
    PubMed    


  225. CASE JA, Courter SA, McGhie A, Patel KK, et al
    Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
    J Nucl Cardiol. 2023 Jul 18. doi: 10.1007/s12350-023-03336.
    PubMed     Abstract available


  226. LI L, Pang Z, Wang J, Chen Y, et al
    Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
    J Nucl Cardiol. 2023 Jul 11. doi: 10.1007/s12350-023-03332.
    PubMed     Abstract available


  227. GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
    Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
    J Nucl Cardiol. 2023 Jul 10. doi: 10.1007/s12350-023-03335.
    PubMed     Abstract available


  228. CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
    Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
    J Nucl Cardiol. 2023 Jul 6. doi: 10.1007/s12350-023-03322.
    PubMed     Abstract available


  229. DEKEMP RA
    Toward improved standardization of PET myocardial blood flow.
    J Nucl Cardiol. 2023 Jul 5. doi: 10.1007/s12350-023-03324.
    PubMed    


    June 2023
  230. HIJAZI W, Miller RJH
    In the thick of it: highlighting the importance of SPECT imaging.
    J Nucl Cardiol. 2023 Jun 29. doi: 10.1007/s12350-023-03326.
    PubMed    


  231. SMILEY DA, Maurer MS, Einstein AJ
    Reply to the letter: In the thick of it: highlighting the importance of SPECT imaging.
    J Nucl Cardiol. 2023 Jun 29. doi: 10.1007/s12350-023-03328.
    PubMed    


  232. DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
    Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    J Nucl Cardiol. 2023 Jun 29. doi: 10.1007/s12350-023-03329.
    PubMed    


  233. WANG A, Mahmood U, Tang X, Jain D, et al
    A case of disappearing amyloid on technetium pyrophosphate scan.
    J Nucl Cardiol. 2023 Jun 20. doi: 10.1007/s12350-023-03316.
    PubMed     Abstract available


  234. BUTT F, Siegel A
    Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
    J Nucl Cardiol. 2023 Jun 14. doi: 10.1007/s12350-023-03315.
    PubMed    


  235. SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
    Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
    J Nucl Cardiol. 2023 Jun 14. doi: 10.1007/s12350-023-03312.
    PubMed     Abstract available


  236. SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
    (18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
    J Nucl Cardiol. 2023 Jun 1. doi: 10.1007/s12350-023-03285.
    PubMed     Abstract available



  237. CME INSTRUCTIONS: The current status of CZT SPECT myocardial blood flow and reserve assessment: Tips and tricks.
    J Nucl Cardiol. 2023;30:1040-1042.
    PubMed    


  238. ZAMPELLA E, Assante R, Acampa W
    The addition of coronary artery calcium to myocardial perfusion: Double or nothing?
    J Nucl Cardiol. 2023;30:1019-1021.
    PubMed    


  239. KAUSHIK P, Patel C, Chandra KB, Kumar S, et al
    Semiquantitative evaluation of (68)Ga-DOTANOC uptake in the normal myocardium: establishment of reference values.
    J Nucl Cardiol. 2023;30:1121-1128.
    PubMed     Abstract available


  240. GARCIA-CARDENAS M, Espejel-Guzman A, Antonio-Villa NE, Michel-Vasquez A, et al
    Diagnosis, performance and added value of assessing ventricular dyssynchrony by phase analysis in patients with three-vessel disease: A single-center cross-sectional study in Mexico.
    J Nucl Cardiol. 2023;30:1219-1229.
    PubMed     Abstract available


  241. DECORADS CE, Lambert A, Roch V, Imbert L, et al
    Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.
    J Nucl Cardiol. 2023;30:1202-1209.
    PubMed     Abstract available


  242. NYE JA
    Applying deep learning attenuation correction in the presence of motion.
    J Nucl Cardiol. 2023;30:1038-1039.
    PubMed    


  243. GIRARD AA, Elrod J, Bhambhvani P, Hage FG, et al
    Cases from a busy nuclear cardiology laboratory.
    J Nucl Cardiol. 2023;30:1103-1109.
    PubMed    


  244. KANEKO K, Nagao M, Yamamoto A, Sakai A, et al
    FDG uptake patterns in isolated and systemic cardiac sarcoidosis.
    J Nucl Cardiol. 2023;30:1065-1074.
    PubMed     Abstract available


  245. JAYADEVA PS, Stowers S, Tang EW, Vitola J, et al
    The impact of coronary calcium score as an addition to myocardial perfusion imaging in altering clinical management (ICCAMPA trial).
    J Nucl Cardiol. 2023;30:1004-1018.
    PubMed     Abstract available


  246. KITAGAWA T, Sasaki K, Fujii Y, Tatsugami F, et al
    A longitudinal pilot study to assess temporal changes in coronary arterial (18)F-sodium fluoride uptake.
    J Nucl Cardiol. 2023;30:1158-1165.
    PubMed     Abstract available


    May 2023
  247. TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
    Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
    J Nucl Cardiol. 2023 May 31. doi: 10.1007/s12350-023-03303.
    PubMed     Abstract available


  248. CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
    Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
    J Nucl Cardiol. 2023 May 31. doi: 10.1007/s12350-023-03296.
    PubMed     Abstract available


  249. ARMENIA EM, Mackin ML, Karmilowicz P, Jawaid A, et al
    What is this image? 2023 image 1 results: Precision high-resolution CZT SPECT imaging to evaluate cardiac aTTR amyloidosis.
    J Nucl Cardiol. 2023 May 31. doi: 10.1007/s12350-023-03279.
    PubMed    


  250. LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
    FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    J Nucl Cardiol. 2023 May 31. doi: 10.1007/s12350-023-03306.
    PubMed     Abstract available


  251. SILLANMAKI S, Iso-Mustajarvi S
    (18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
    J Nucl Cardiol. 2023 May 30:1-2. doi: 10.1007/s12350-023-03302.
    PubMed    


  252. AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
    Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
    J Nucl Cardiol. 2023 May 24. doi: 10.1007/s12350-023-03297.
    PubMed     Abstract available


  253. MURPHY J, AlJaroudi WA, Hage FG
    Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2022: positron emission tomography, computed tomography, and magnetic resonance.
    J Nucl Cardiol. 2023 May 19. doi: 10.1007/s12350-023-03283.
    PubMed     Abstract available


  254. LAUZIER PT, Boczar KE, Caires MC, Alshaheen M, et al
    What is this image? 2023 Image 6 result: (18)F-FDG PET in a patient with cardiac sarcoidosis and hibernating myocardium: A case report.
    J Nucl Cardiol. 2023 May 19. doi: 10.1007/s12350-023-03292.
    PubMed    


  255. DOUKKY R
    ASNC SPECT-MPI quality metrics: a race to the top.
    J Nucl Cardiol. 2023 May 16. doi: 10.1007/s12350-023-03284.
    PubMed    


  256. HULTEN E, Keating FK
    Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
    J Nucl Cardiol. 2023 May 16. doi: 10.1007/s12350-023-03286.
    PubMed    


  257. HANSEN CL
    Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
    J Nucl Cardiol. 2023 May 12. doi: 10.1007/s12350-023-03291.
    PubMed     Abstract available


  258. VAN TOSH A, Nichols KJ
    SPECT measurements of myocardial blood flow and flow reserve: from development to implementation.
    J Nucl Cardiol. 2023 May 9. doi: 10.1007/s12350-023-03273.
    PubMed    


  259. NAKAJIMA K, Shibutani T
    Are nuclear medicine images quantified in 2D and 3D equally functional?
    J Nucl Cardiol. 2023 May 8. doi: 10.1007/s12350-023-03290.
    PubMed    


  260. QUTBI M
    Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
    J Nucl Cardiol. 2023 May 4. doi: 10.1007/s12350-023-03266.
    PubMed     Abstract available


  261. AUER B, Kijewski MF, Dorbala S
    Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now!
    J Nucl Cardiol. 2023 May 3. doi: 10.1007/s12350-023-03278.
    PubMed    


  262. SMILEY D, Einstein AJ, Chan N, Mintz A, et al
    In the thick of it: hereditary cardiac amyloidosis identified by (124)I-AT-01 PET imaging but not cardiac MRI or SPECT (99m)Tc pyrophosphate scintigraphy.
    J Nucl Cardiol. 2023 May 3. doi: 10.1007/s12350-023-03267.
    PubMed    


  263. PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
    4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
    J Nucl Cardiol. 2023 May 2. doi: 10.1007/s12350-023-03269.
    PubMed     Abstract available


  264. KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
    (18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
    J Nucl Cardiol. 2023 May 1. doi: 10.1007/s12350-023-03277.
    PubMed     Abstract available


  265. BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
    [(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
    J Nucl Cardiol. 2023 May 1. doi: 10.1007/s12350-023-03265.
    PubMed     Abstract available


  266. YARAHMADI P, Nguyen PK
    PET-FDG for vascular imaging: a "visual barometer" for inflammatory risk?
    J Nucl Cardiol. 2023 May 1. doi: 10.1007/s12350-023-03250.
    PubMed    


    April 2023
  267. HIJAZI W, Miller RJH
    Deep learning to automate SPECT MPI myocardial reorientation.
    J Nucl Cardiol. 2023 Apr 26. doi: 10.1007/s12350-023-03260.
    PubMed    


  268. KAUR S, Bartley P, Gordon S, Higgins A, et al
    Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
    J Nucl Cardiol. 2023 Apr 25. doi: 10.1007/s12350-023-03258.
    PubMed     Abstract available


  269. XU R, Yang H, Zhang J, Chen S, et al
    Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
    J Nucl Cardiol. 2023 Apr 24. doi: 10.1007/s12350-023-03241.
    PubMed     Abstract available


  270. KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
    Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
    J Nucl Cardiol. 2023 Apr 19. doi: 10.1007/s12350-023-03237.
    PubMed     Abstract available


  271. PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
    Including myocardial flow reserve by PET in prediction models: Ready to fly?
    J Nucl Cardiol. 2023 Apr 18. doi: 10.1007/s12350-023-03259.
    PubMed    


  272. SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
    Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2023 Apr 13. doi: 10.1007/s12350-023-03263.
    PubMed    


  273. AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
    Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    J Nucl Cardiol. 2023 Apr 3. doi: 10.1007/s12350-023-03256.
    PubMed     Abstract available


  274. DAVID S, Packard RRS
    Prevalence and nature of extracardiac findings in PET/CT myocardial perfusion imaging.
    J Nucl Cardiol. 2023 Apr 3. doi: 10.1007/s12350-023-03239.
    PubMed    


  275. MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
    Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
    J Nucl Cardiol. 2023 Apr 3. doi: 10.1007/s12350-023-03255.
    PubMed     Abstract available


  276. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2023;30:441-443.
    PubMed     Abstract available


  277. ALJAROUDI WA, Hage FG
    Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2022: single photon emission computed tomography.
    J Nucl Cardiol. 2023;30:452-478.
    PubMed     Abstract available


  278. HAGE FG, Einstein AJ, Ananthasubramaniam K, Bourque JM, et al
    Quality metrics for single-photon emission computed tomography myocardial perfusion imaging: an ASNC information statement.
    J Nucl Cardiol. 2023;30:864-907.
    PubMed    


  279. LIMA BB, Cuddy SAM
    Myocardial perfusion imaging in anomalous coronary arteries: do we know who to refer for cardiac surgery?
    J Nucl Cardiol. 2023;30:790-791.
    PubMed    


  280. OSBORNE MT, Abohashem S, Naddaf N, Abbasi T, et al
    The combined effect of air and transportation noise pollution on atherosclerotic inflammation and risk of cardiovascular disease events.
    J Nucl Cardiol. 2023;30:665-679.
    PubMed     Abstract available


  281. SPERRY BW, Bateman TM, Akin EA, Bravo PE, et al
    Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.
    J Nucl Cardiol. 2023;30:626-652.
    PubMed     Abstract available


  282. HIGAKI A, Kawaguchi N, Kurokawa T, Okabe H, et al
    Content-based image retrieval for the diagnosis of myocardial perfusion imaging using a deep convolutional autoencoder.
    J Nucl Cardiol. 2023;30:540-549.
    PubMed     Abstract available


  283. ELSADANY M, Stringer B, Bote J, Abdulla KH, et al
    Buccal caffeine strips for reversal of adverse symptoms of vasodilator stress.
    J Nucl Cardiol. 2023;30:574-580.
    PubMed     Abstract available


  284. ASIF T, Gupta A, Murthi M, Soman P, et al
    Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.
    J Nucl Cardiol. 2023;30:708-715.
    PubMed     Abstract available


  285. HIJAZI W, Leslie W, Filipchuk N, Choo R, et al
    External validation of the CRAX2MACE model.
    J Nucl Cardiol. 2023;30:702-707.
    PubMed     Abstract available


    March 2023
  286. YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
    Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
    J Nucl Cardiol. 2023 Mar 28. doi: 10.1007/s12350-023-03254.
    PubMed    


  287. PAVON AG, Ceriani L, Raditchkova M, Leo LA, et al
    What is this image? 2023 image 5 result: Role of 18-Fluorodeoxyglucose positron emission tomography and computed tomography in cardiac implanted electronic device infection.
    J Nucl Cardiol. 2023 Mar 27. doi: 10.1007/s12350-023-03228.
    PubMed    


  288. KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
    Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
    J Nucl Cardiol. 2023 Mar 21. doi: 10.1007/s12350-023-03220.
    PubMed     Abstract available


  289. TANG X, Dai N, Zhang B, Cai H, et al
    Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
    J Nucl Cardiol. 2023 Mar 16. doi: 10.1007/s12350-023-03240.
    PubMed     Abstract available


  290. DAI N, Zhang B, Gong Z, Dong Z, et al
    Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
    J Nucl Cardiol. 2023 Mar 16. doi: 10.1007/s12350-023-03245.
    PubMed     Abstract available


  291. HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
    Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
    J Nucl Cardiol. 2023 Mar 14. doi: 10.1007/s12350-023-03236.
    PubMed     Abstract available


  292. IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
    Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
    J Nucl Cardiol. 2023 Mar 14. doi: 10.1007/s12350-023-03233.
    PubMed     Abstract available


  293. FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
    Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
    J Nucl Cardiol. 2023 Mar 14. doi: 10.1007/s12350-023-03225.
    PubMed     Abstract available


  294. ZHU F, Wang G, Zhao C, Malhotra S, et al
    Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
    J Nucl Cardiol. 2023 Mar 1. doi: 10.1007/s12350-023-03226.
    PubMed     Abstract available


    February 2023
  295. GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
    Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
    J Nucl Cardiol. 2023 Feb 28. doi: 10.1007/s12350-023-03205.
    PubMed     Abstract available


  296. CHOPRA S, Singh SS, Sood A, Parmar M, et al
    Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
    J Nucl Cardiol. 2023 Feb 27. doi: 10.1007/s12350-023-03210.
    PubMed     Abstract available


  297. SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
    Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
    J Nucl Cardiol. 2023 Feb 24. doi: 10.1007/s12350-023-03222.
    PubMed     Abstract available


  298. LEE H, Bravo PE
    Reference myocardial uptake values on somatostatin receptor-targeted PET: not yet in preference to visual assessment.
    J Nucl Cardiol. 2023 Feb 23. doi: 10.1007/s12350-023-03219.
    PubMed    


  299. MADAMANCHI C, Weinberg RL, Murthy VL
    Utility of serum ketone levels for assessment of myocardial glucose suppression for (18)F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis.
    J Nucl Cardiol. 2023 Feb 23. doi: 10.1007/s12350-023-03209.
    PubMed     Abstract available


  300. NIELSEN MO, Schledermann H, Jensen LT
    Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    J Nucl Cardiol. 2023 Feb 16. doi: 10.1007/s12350-023-03207.
    PubMed    


  301. BOCZAR KE, Beanlands RS, Glassman SJ, Wang J, et al
    Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study.
    J Nucl Cardiol. 2023 Feb 8. doi: 10.1007/s12350-023-03204.
    PubMed     Abstract available


  302. ALAHDAB F, Ahmed AI, Al-Mallah M
    Coronary computed tomography angiography and single-photon emission computerized tomography in chronic total occlusions: the Rosetta Stone for PCI planning?
    J Nucl Cardiol. 2023;30:399-402.
    PubMed    


  303. JONES KA, Paterson CA, Ray S, Motherwell DW, et al
    Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography.
    J Nucl Cardiol. 2023;30:193-200.
    PubMed     Abstract available


  304. KAGNA O, Keidar Z, Ben-Haim S
    Negative influence of antimicrobial therapy on radiolabeled white blood cells scintigraphy performance in infective endocarditis: myth or fact?
    J Nucl Cardiol. 2023;30:354-356.
    PubMed    


  305. TRAVIN MI
    The challenges of using radionuclide imaging to guide cardiac device implantation in patients with heart failure.
    J Nucl Cardiol. 2023;30:383-387.
    PubMed    


  306. HE Z, Zhang X, Zhao C, Ling X, et al
    A method using deep learning to discover new predictors from left-ventricular mechanical dyssynchrony for CRT response.
    J Nucl Cardiol. 2023;30:201-213.
    PubMed     Abstract available


  307. HOLCMAN K, Rubis P, Cmiel B, Zabek A, et al
    To what extent does prior antimicrobial therapy affect the diagnostic performance of radiolabeled leukocyte scintigraphy in infective endocarditis?
    J Nucl Cardiol. 2023;30:343-353.
    PubMed     Abstract available


  308. STASSEN J, van der Bijl P, Bax JJ
    Using a deep learning algorithm to score coronary artery calcium in myocardial perfusion imaging: A real opportunity or just a new hype?
    J Nucl Cardiol. 2023;30:251-253.
    PubMed    


  309. TOTTLEBEN J, Howland J, Rofael M, Co MLF, et al
    The prognostic and diagnostic implications of surveillance serial myocardial perfusion imaging in asymptomatic renal transplant candidates.
    J Nucl Cardiol. 2023;30:152-163.
    PubMed     Abstract available


  310. AVALON JC, Fuqua J, Deskins S, Miller T, et al
    Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.
    J Nucl Cardiol. 2023;30:127-139.
    PubMed     Abstract available


  311. ARVIDSSON I, Davidsson A, Overgaard NC, Pagonis C, et al
    Deep learning prediction of quantitative coronary angiography values using myocardial perfusion images with a CZT camera.
    J Nucl Cardiol. 2023;30:116-126.
    PubMed     Abstract available


  312. MILLER RJH, Rozanski A, Slomka PJ, Han D, et al
    Development and validation of ischemia risk scores.
    J Nucl Cardiol. 2023;30:324-334.
    PubMed     Abstract available


  313. VAN DER BIJL P, Stassen J, Bax JJ
    Application of a deep learning algorithm to calcium scoring in myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:321-323.
    PubMed    


  314. SARTORETTI T, Gennari AG, Sartoretti E, Skawran S, et al
    Fully automated deep learning powered calcium scoring in patients undergoing myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:313-320.
    PubMed     Abstract available


  315. MARKETOU ME, Kapsoritakis N, Bourogianni O, Patrianakos A, et al
    Hybrid imaging of neuroendocrine tumors in the heart: Union is strength.
    J Nucl Cardiol. 2023;30:298-312.
    PubMed     Abstract available


  316. ZHANG X, Chen J, Zhang Q, Tang G, et al
    Tc-99m PYP scintigraphy identified multi-organ disease associated with transthyretin Phe64Ser mutation.
    J Nucl Cardiol. 2023;30:411-412.
    PubMed    


  317. JOSEPH L, Clarkson S, Heindl B, Iskandrian AE, et al
    Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging.
    J Nucl Cardiol. 2023;30:144-151.
    PubMed    


    January 2023
  318. OSBORNE MT, Qamar I, Selvaraj S
    A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on (18)F-FDG PET imaging.
    J Nucl Cardiol. 2023 Jan 24. doi: 10.1007/s12350-023-03199.
    PubMed    


  319. FITCH JS, Schwartz RG
    Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
    J Nucl Cardiol. 2023 Jan 22. doi: 10.1007/s12350-023-03197.
    PubMed    


  320. CHEN LQ, Nichols KJ, Van Tosh A
    Exercise ECG must be considered in conjunction with conventional SPECT.
    J Nucl Cardiol. 2023 Jan 17. doi: 10.1007/s12350-022-03181.
    PubMed    


  321. KURONUMA K, van Diemen PA, Han D, Lin A, et al
    Relationship between impaired myocardial blood flow by positron emission tomography and low-attenuation plaque burden and pericoronary adipose tissue attenuation from coronary computed tomography: From the prospective PACIFIC trial.
    J Nucl Cardiol. 2023 Jan 16. doi: 10.1007/s12350-022-03194.
    PubMed     Abstract available


  322. HUCK DM, Weber B
    The "power of zero" CAC validated for absence of ischemia on PET?
    J Nucl Cardiol. 2023 Jan 10. doi: 10.1007/s12350-022-03192.
    PubMed    


  323. FREY SM, Clerc OF, Honegger U, Amrein M, et al
    The power of zero calcium in 82-Rubidium PET irrespective of sex and age.
    J Nucl Cardiol. 2023 Jan 9. doi: 10.1007/s12350-022-03174.
    PubMed     Abstract available


  324. VAN DALEN JA, Koenders SS, Metselaar RJ, Vendel BN, et al
    Machine learning based model to diagnose obstructive coronary artery disease using calcium scoring, PET imaging, and clinical data.
    J Nucl Cardiol. 2023 Jan 9. doi: 10.1007/s12350-022-03166.
    PubMed     Abstract available


  325. SAAD JM, Ahmed AI, Han Y, El Nihum LI, et al
    Splenic switch-off in regadenoson (82)Rb-PET myocardial perfusion imaging: assessment of clinical utility.
    J Nucl Cardiol. 2023 Jan 6. doi: 10.1007/s12350-022-03158.
    PubMed     Abstract available


  326. SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
    Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
    J Nucl Cardiol. 2023 Jan 6. doi: 10.1007/s12350-022-03163.
    PubMed    


  327. DEGTIAROVA G, Garefa C, Boehm R, Ciancone D, et al
    Radiomics for the detection of diffusely impaired myocardial perfusion: A proof-of-concept study using 13N-ammonia positron emission tomography.
    J Nucl Cardiol. 2023 Jan 5. doi: 10.1007/s12350-022-03179.
    PubMed     Abstract available


  328. JOCHUMSEN MR, Overgaard DL, Vendelbo MH, Madsen MA, et al
    Extracardiac findings with increased perfusion during clinical O-15-H(2)O PET/CT myocardial perfusion imaging: A case series.
    J Nucl Cardiol. 2023 Jan 5:1-11. doi: 10.1007/s12350-022-03156.
    PubMed     Abstract available


  329. FEHER A, Pieszko K, Miller R, Lemley M, et al
    Correction to: Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging.
    J Nucl Cardiol. 2023 Jan 4. doi: 10.1007/s12350-022-03196.
    PubMed    


  330. MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
    Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
    J Nucl Cardiol. 2023 Jan 4. doi: 10.1007/s12350-022-03165.
    PubMed     Abstract available


  331. SUN R, Ma R, Wang M, Han K, et al
    Prognostic value of myocardial flow reserve derived by quantitative SPECT for patients with intermediate coronary stenoses.
    J Nucl Cardiol. 2023 Jan 2. doi: 10.1007/s12350-022-03186.
    PubMed     Abstract available


    December 2022
  332. RASUL S, Calabretta R
    Impact of ECG gating methods on the assessment of left ventricular cardiac function using PET/MRI.
    J Nucl Cardiol. 2022 Dec 29. doi: 10.1007/s12350-022-03177.
    PubMed    


  333. PETERS M, Port S
    What is this image? 2022 Image 4 result: Massive right ventricular hypertrophy detected by Tc-99m sestamibi SPECT MPI study.
    J Nucl Cardiol. 2022 Dec 27. doi: 10.1007/s12350-022-03189.
    PubMed    


  334. DIETZ M, Kamani CH, Allenbach G, Rubimbura V, et al
    Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-82 SiPM PET/CT.
    J Nucl Cardiol. 2022 Dec 27. doi: 10.1007/s12350-022-03155.
    PubMed     Abstract available


  335. MONROY-GONZALEZ AG, Erba PA, Slart RHJA
    (68)Ga-DOTATATE PET/CT for assessment of cardiac sarcoidosis: hidden opportunities?
    J Nucl Cardiol. 2022 Dec 24. doi: 10.1007/s12350-022-03168.
    PubMed    


  336. IKOMA T, Ohtani H, Ohno K, Iguchi K, et al
    Diagnostic value of heart-to-mediastinum ratio in (99m)Tc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2022 Dec 22. doi: 10.1007/s12350-022-03180.
    PubMed     Abstract available


  337. LIGA R, Gimelli A
    Risk stratification of patients with INOCA: is perfusion PET imaging the game winner?
    J Nucl Cardiol. 2022 Dec 21. doi: 10.1007/s12350-022-03169.
    PubMed    


  338. MCCUBREY RO, Mason SM, Le VT, Bride DL, et al
    A highly predictive cardiac positron emission tomography (PET) risk score for 90-day and one-year major adverse cardiac events and revascularization.
    J Nucl Cardiol. 2022 Dec 19. doi: 10.1007/s12350-022-03028.
    PubMed     Abstract available


  339. WOLLENWEBER T, Rettl R, Kretschmer-Chott E, Rasul S, et al
    Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters.
    J Nucl Cardiol. 2022 Dec 13. doi: 10.1007/s12350-022-03149.
    PubMed     Abstract available


  340. NORDSTROM J, Kvernby S, Kero T, Sorensen J, et al
    Left-ventricular volumes and ejection fraction from cardiac ECG-gated (15)O-water positron emission tomography compared to cardiac magnetic resonance imaging using simultaneous hybrid PET/MR.
    J Nucl Cardiol. 2022 Dec 8. doi: 10.1007/s12350-022-03154.
    PubMed     Abstract available


  341. KRAKOVICH A, Gelbart E, Moalem I, Naimushin A, et al
    Dose-consistent dynamic SPECT.
    J Nucl Cardiol. 2022 Dec 8. doi: 10.1007/s12350-022-03160.
    PubMed     Abstract available


  342. THANIGAINATHAN T, Sharma A, Patel C, Seth S, et al
    Imaging of cardiac sympathetic dysfunction with 18F-FDOPA PET/CT in patients with heart failure: a pilot study.
    J Nucl Cardiol. 2022 Dec 6. doi: 10.1007/s12350-022-03150.
    PubMed     Abstract available


  343. CHOUEIRY J, Mistry NP, Beanlands RSB, deKemp RA, et al
    Automated dynamic motion correction improves repeatability and reproducibility of myocardial blood flow quantification with rubidium-82 PET imaging.
    J Nucl Cardiol. 2022 Dec 2. doi: 10.1007/s12350-022-03134.
    PubMed     Abstract available


  344. KWIECINSKI J
    Imaging coronary and aortic microcalcification activity with (18)F-sodium fluoride.
    J Nucl Cardiol. 2022;29:3366-3368.
    PubMed    


  345. HAGIO T, Murthy VL
    Deep learning: Opening a third eye to myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:3311-3314.
    PubMed    


  346. WEN W, Gao M, Yun M, Meng J, et al
    Associations between coronary/aortic (18)F-sodium fluoride uptake and pro-atherosclerosis factors in patients with multivessel coronary artery disease.
    J Nucl Cardiol. 2022;29:3352-3365.
    PubMed     Abstract available


  347. IBRAHIM J, Nieves RA, Barakat AF, Hynal K, et al
    DSPECT-specific normative limits for left ventricular size and function.
    J Nucl Cardiol. 2022;29:3293-3299.
    PubMed     Abstract available


  348. SHAUKAT ALI A, Finnerty V, Harel F, Marquis-Gravel G, et al
    Impact of rubidium imaging availability on management of patients with acute chest pain.
    J Nucl Cardiol. 2022;29:3281-3290.
    PubMed     Abstract available


  349. HAN D, Rozanski A, Miller RJH, Sharir T, et al
    Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry.
    J Nucl Cardiol. 2022;29:3221-3232.
    PubMed     Abstract available


  350. LASSEN ML, Wissenberg M, Byrne C, Sheykhzade M, et al
    Image-derived and physiological markers to predict adequate adenosine-induced hyperemic response in Rubidium-82 myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:3207-3217.
    PubMed     Abstract available


  351. REGIS C, Rouzet F
    A new perspective for phase analysis of radionuclide angiocardiography.
    J Nucl Cardiol. 2022;29:3099-3101.
    PubMed    


  352. GOEL A, Bandyopadhyay D, He ZX, Yang MF, et al
    Cardiac (18)F-FDG imaging for direct myocardial ischemia imaging.
    J Nucl Cardiol. 2022;29:3039-3043.
    PubMed    


  353. VIJ A, Doukky R
    Stress myocardial perfusion imaging vs. stress echocardiography for risk stratification of kidney transplant candidates: Does it even matter?
    J Nucl Cardiol. 2022;29:3000-3002.
    PubMed    


  354. SINGH A, Miller RJH
    Deep learning-based attenuation map generation and correction; could it be useful clinically?
    J Nucl Cardiol. 2022;29:2893-2895.
    PubMed    


  355. HASNIE AA, Patel N, Bhambhvani P, Iskandrian AE, et al
    Cases from a busy nuclear cardiology laboratory.
    J Nucl Cardiol. 2022;29:3482-3490.
    PubMed    


  356. DIVAKARAN S, Caron JP, Zhou W, Hainer J, et al
    Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer.
    J Nucl Cardiol. 2022;29:3072-3081.
    PubMed     Abstract available


  357. BAUTZ J, Stypmann J, Reiermann S, Pavenstadt HJ, et al
    Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography.
    J Nucl Cardiol. 2022;29:2988-2999.
    PubMed     Abstract available


  358. MEGNA R, Petretta M, Assante R, Zampella E, et al
    External validation of the CRAX2MACE model in an Italian cohort of patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:2967-2973.
    PubMed     Abstract available


  359. IMAI S, Tahara N, Igata S, Tahara A, et al
    Vascular/perivascular inflammation in IgG4-related disease.
    J Nucl Cardiol. 2022;29:2920-2933.
    PubMed     Abstract available


  360. MORGAN WS, Ives CW, Farag AA, Kumar V, et al
    Effect of left ventricular mechanical dyssynchrony assessed pre-renal transplantation on cardiovascular death post transplantation.
    J Nucl Cardiol. 2022;29:2896-2905.
    PubMed     Abstract available


  361. ROZANSKI A, Miller RJH, Han D, Gransar H, et al
    The prevalence and predictors of inducible myocardial ischemia among patients referred for radionuclide stress testing.
    J Nucl Cardiol. 2022;29:2839-2849.
    PubMed     Abstract available


  362. WANG R, Wang Y, Wang H
    Cardiac involvement in polymyositis: Role of myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:3629-3631.
    PubMed    


  363. ELSADANY M, McMahon SR, Mehla S, Duvall WL, et al
    Hemiplegic migraine episode triggered by regadenoson.
    J Nucl Cardiol. 2022;29:3469-3473.
    PubMed     Abstract available


  364. FORSBERG L, Soares M, Gonon A
    Myocardial perfusion imaging performed by dedicated cardiac cadmium-zinc-telluride camera in dextrocardia with situs inversus: A case report.
    J Nucl Cardiol. 2022;29:3599-3603.
    PubMed    


  365. KELDERMAN JR, Jolink FEJ, Benjamens S, Monroy-Gonzalez AG, et al
    Diagnostic accuracy of myocardial perfusion imaging in patients evaluated for kidney transplantation: A systematic review and meta-analysis.
    J Nucl Cardiol. 2022;29:3405-3415.
    PubMed     Abstract available


  366. TANI Y, Norikane T, Takami Y, Mitamura K, et al
    Potential utility of (18)F-NaF PET/CT in cardiac amyloidosis.
    J Nucl Cardiol. 2022;29:3557-3561.
    PubMed    


  367. MAYURASAKORN S, Kiatkittikul P, Chotipanich C, Promteangtrong C, et al
    Imaging an ATTR cardiac amyloidosis patient using fluorine-18 sodium fluoride PET/CT: A case report.
    J Nucl Cardiol. 2022;29:3554-3556.
    PubMed    


  368. YANG Y, Chen P, Liu L, Lin J, et al
    The value of 18F-FDG PET/CT in evaluating the efficacy of chemotherapy for diffuse large B-cell lymphoma with cardiac involvement.
    J Nucl Cardiol. 2022;29:3548-3553.
    PubMed    


  369. SATAPATHY S, Kumar R, Kavanal AJ, Krishnaraju VS, et al
    COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of (18)F-FDG PET/CT to assess myocardial involvement.
    J Nucl Cardiol. 2022;29:3546-3547.
    PubMed    


  370. BAGHDADI Y, Di Dea MT, Moadel RM, Travin MI, et al
    A potential artifact to consider when performing (99m)Tc-sestamibi myocardial perfusion SPECT imaging in patients with multiple myeloma.
    J Nucl Cardiol. 2022;29:3543-3545.
    PubMed    


  371. BERNHARD B, Grani C
    18F-FDG PET/CT imaging in the workup of cardiac and pericardial masses.
    J Nucl Cardiol. 2022;29:3466-3468.
    PubMed    


  372. MARIE PY, Visvikis-Siest S
    Integrating polymorphism signatures with myocardial perfusion imaging data to improve the prevention of coronary artery disease: Science or science-fiction?
    J Nucl Cardiol. 2022;29:2917-2919.
    PubMed    


  373. HAIDER A, Bengs S, Gebhard C, Fiechter M, et al
    Hybrid positron emission tomography and magnetic resonance imaging in carotid atherosclerosis: Not ready for prime time?
    J Nucl Cardiol. 2022;29:3458-3460.
    PubMed    


  374. ANGELIDIS G, Valotassiou V, Satra M, Psimadas D, et al
    Investigating the genetic characteristics of CAD: Is there a role for myocardial perfusion imaging techniques?
    J Nucl Cardiol. 2022;29:2909-2916.
    PubMed     Abstract available


  375. AGHAYEV A
    Utilization of FDG-PET/CT in the diagnosis of native valve endocarditis: There is a hope, but we need more data!
    J Nucl Cardiol. 2022;29:3455-3457.
    PubMed    


    November 2022
  376. AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
    Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
    J Nucl Cardiol. 2022 Nov 28. doi: 10.1007/s12350-022-03151.
    PubMed    


  377. ADHADUK M, Paudel B, Khalid MU, Ashwath M, et al
    Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    J Nucl Cardiol. 2022 Nov 28. doi: 10.1007/s12350-022-03129.
    PubMed     Abstract available


  378. CALABRETTA R, Hacker M
    A PET-derived tumor expansion pattern to differentiate between primary cardiac lymphoma from primary cardiac sarcoma.
    J Nucl Cardiol. 2022 Nov 22. doi: 10.1007/s12350-022-03097.
    PubMed    


  379. VAN DEN HOOGEN IJ, Wang X, Butcher SC, Maaniitty T, et al
    Incorporating coronary artery calcium scoring in the prediction of obstructive coronary artery disease with myocardial ischemia: a study with sequential use of coronary computed tomography angiography and positron emission tomography imaging.
    J Nucl Cardiol. 2022 Nov 15. pii: 10.1007/s12350-022-03132.
    PubMed     Abstract available


  380. ZMAILI M, Jaber W
    First experience of LVEF assessment with cardiac amyloid SPECT scan.
    J Nucl Cardiol. 2022 Nov 15. pii: 10.1007/s12350-022-03112.
    PubMed    


  381. TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
    Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    J Nucl Cardiol. 2022 Nov 9. pii: 10.1007/s12350-022-03128.
    PubMed    


  382. NICHOLS KJ, Yoon SY, Van Tosh A, Palestro CJ, et al
    (99m)Tc-PYP SPECT and SPECT/CT quantitation for diagnosing cardiac transthyretin amyloidosis.
    J Nucl Cardiol. 2022 Nov 9. pii: 10.1007/s12350-022-03133.
    PubMed     Abstract available


  383. ZAMPELLA E, Mannarino T, D'Antonio A, Assante R, et al
    Prediction of outcome by (82)Rb PET/CT in patients with ischemia and nonobstructive coronary arteries.
    J Nucl Cardiol. 2022 Nov 9. pii: 10.1007/s12350-022-03144.
    PubMed     Abstract available


  384. BLOMJOUS MSH, Mulders TA, Wahadat AR, Tanis W, et al
    (18)F-FDG/PET-CT imaging findings after sternotomy.
    J Nucl Cardiol. 2022 Nov 8. pii: 10.1007/s12350-022-03126.
    PubMed     Abstract available


  385. MAEDA-OGATA S, Tahara N, Tahara A, Bekki M, et al
    Treatment response to Tafamidis quantitatively assessed by serial bone scintigraphy in transthyretin amyloid cardiomyopathy.
    J Nucl Cardiol. 2022 Nov 8. pii: 10.1007/s12350-022-03137.
    PubMed    


  386. YOUSEFI H, Shi L, Soufer A, Tsatkin V, et al
    Quantification of intramyocardial blood volume using (99m)Tc-RBC SPECT/CT: a pilot human study.
    J Nucl Cardiol. 2022 Nov 1. pii: 10.1007/s12350-022-03123.
    PubMed     Abstract available


    October 2022
  387. KARTHIKEYAN G, Peix A, Devasenapathy N, Jimenez-Heffernan A, et al
    Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial.
    J Nucl Cardiol. 2022 Oct 25. pii: 10.1007/s12350-022-03108.
    PubMed     Abstract available


  388. LEE H, Schubert EK, Vidula MK, Pryma DA, et al
    Potential clinical utility of (68)Ga-DOTATATE PET/CT for detection and response assessment in cardiac sarcoidosis.
    J Nucl Cardiol. 2022 Oct 20. pii: 10.1007/s12350-022-03111.
    PubMed     Abstract available


  389. FEHER A, Pieszko K, Miller R, Lemley M, et al
    Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging.
    J Nucl Cardiol. 2022 Oct 4. pii: 10.1007/s12350-022-03099.
    PubMed     Abstract available


  390. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2022;29:2061-2063.
    PubMed     Abstract available


  391. WEINBERG RL, Malhotra S
    Nuclear cardiology in the literature: A selection of recent, original research papers.
    J Nucl Cardiol. 2022;29:2067-2069.
    PubMed    


  392. THOMPSON RC
    Response to: The practicalities of COVID's impact on nuclear cardiology.
    J Nucl Cardiol. 2022;29:2741.
    PubMed    


  393. LEE JC, Baer RA
    The practicalities of COVID's impact on nuclear cardiology.
    J Nucl Cardiol. 2022;29:2739-2740.
    PubMed    


  394. MILLER RJH, Hauser MT, Sharir T, Einstein AJ, et al
    Machine learning to predict abnormal myocardial perfusion from pre-test features.
    J Nucl Cardiol. 2022;29:2393-2403.
    PubMed     Abstract available


  395. ZAMPELLA E, Assante R, Acampa W
    Myocardial perfusion imaging and CAC score: Not only a brick in the wall.
    J Nucl Cardiol. 2022;29:2457-2459.
    PubMed    


  396. PARK J, Young BD, Miller EJ
    Potential novel imaging targets of inflammation in cardiac sarcoidosis.
    J Nucl Cardiol. 2022;29:2171-2187.
    PubMed     Abstract available


  397. TAVOOSI AN, Kadoya Y, Ruddy TD
    Added value to stress myocardial perfusion imaging studies with measurement of left ventricular mass.
    J Nucl Cardiol. 2022;29:2374-2377.
    PubMed    


  398. BOURQUE JM, Einstein AJ, Dorbala S
    ASNC Imaging Indications (ASNC-I(2)): Multisocietal indications for radionuclide imaging in the multimodality context-Series rationale and methodology.
    J Nucl Cardiol. 2022;29:2667-2678.
    PubMed     Abstract available


  399. ZAMPELLA E, Mannarino T, Gaudieri V, D'Antonio A, et al
    Effect of changes in perfusion defect size during serial stress myocardial perfusion imaging on cardiovascular outcomes in patients treated with primary percutaneous coronary intervention after myocardial infarction.
    J Nucl Cardiol. 2022;29:2624-2632.
    PubMed     Abstract available


  400. WANG R, Li X, Huangfu S, Yao Q, et al
    Combining body mass index with waist circumference to assess coronary microvascular function in patients with non-obstructive coronary artery disease.
    J Nucl Cardiol. 2022;29:2434-2445.
    PubMed     Abstract available


  401. JIA N, Zhang R, Liu B, Liu B, et al
    Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study.
    J Nucl Cardiol. 2022;29:2404-2419.
    PubMed     Abstract available


  402. MIYAJIMA K, Tawarahara K, Saito N
    Serial changes of myocardial perfusion imaging in takotsubo and reverse takotsubo cardiomyopathy.
    J Nucl Cardiol. 2022;29:2599-2611.
    PubMed     Abstract available


  403. D'ANTONIO A, Assante R, Zampella E, Acampa W, et al
    High technology by CZT cameras: It is time to join forces.
    J Nucl Cardiol. 2022;29:2322-2324.
    PubMed    


  404. NAPPI C, Petretta M, Assante R, Zampella E, et al
    Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:2521-2530.
    PubMed     Abstract available


  405. SHARAIN K, Homb A, Chareonthaitawee P, AbouEzzeddine OF, et al
    (99m)Technetium-pyrophosphate cardiac scintigraphy cases from a busy nuclear cardiology laboratory.
    J Nucl Cardiol. 2022;29:2157-2167.
    PubMed    


  406. BEKKI M, Tahara N, Tahara A, Sugiyama Y, et al
    Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naive cardiac sarcoidosis.
    J Nucl Cardiol. 2022;29:2132-2144.
    PubMed     Abstract available


  407. BENTSEN S, Sams A, Hasbak P, Edvinsson L, et al
    Myocardial perfusion recovery induced by an alpha-calcitonin gene-related peptide analogue.
    J Nucl Cardiol. 2022;29:2090-2099.
    PubMed     Abstract available


  408. SAZONOVA SI, Varlamova JV, Nikitin NA, Minin SM, et al
    Cardiac (123)I-mIBG scintigraphy for prediction of catheter ablation outcome in patients with atrial fibrillation.
    J Nucl Cardiol. 2022;29:2220-2231.
    PubMed     Abstract available


  409. NOTOHAMIPRODJO S, Nekolla SG, Robu S, Villagran Asiares A, et al
    Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using (68)Ga-FAPI-04.
    J Nucl Cardiol. 2022;29:2254-2261.
    PubMed     Abstract available


  410. MALEK H, Yaghoobi N
    Transient multifocal pulmonary uptake of 99mTc-sestamibi in myocardial perfusion imaging: Iatrogenic clot artifact.
    J Nucl Cardiol. 2022;29:2724-2727.
    PubMed    


  411. ABAZID RM, Romsa JG, Warrington JC, Akincioglu C, et al
    Complementary role of hybrid imaging with SPECT myocardial perfusion and coronary CT angiography in hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2022;29:2716-2720.
    PubMed    


  412. VIDULA MK, Han Y, Litt H, Bravo PE, et al
    Left ventricular mural thrombus appearing as a photopenic defect on myocardial viability PET imaging.
    J Nucl Cardiol. 2022;29:2713-2715.
    PubMed    


  413. JIANG M, Chen P, Zheng J
    Primary cardiac angiosarcoma with thrombosis and multiple bone marrow metastases mimicking lymphoma on (18)F-FDG PET/CT.
    J Nucl Cardiol. 2022;29:2709-2712.
    PubMed    


    September 2022
  414. DESHAYES S, Manrique A
    (64)Cu-DOTATATE, the growing signal for PET imaging of vascular inflammation?
    J Nucl Cardiol. 2022 Sep 30. pii: 10.1007/s12350-022-03110.
    PubMed    


  415. VILLAGRAN ASIARES A, Vitadello T, Bogdanovic B, Solari EL, et al
    Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging.
    J Nucl Cardiol. 2022 Sep 30. pii: 10.1007/s12350-022-03105.
    PubMed     Abstract available


  416. BOURSIER C, Chevalier E, Varlot J, Filippetti L, et al
    Detection of acute myocarditis by ECG-triggered PET imaging of somatostatin receptors compared to cardiac magnetic resonance: preliminary results.
    J Nucl Cardiol. 2022 Sep 19. pii: 10.1007/s12350-022-03090.
    PubMed     Abstract available


  417. DU Y, Shang J, Sun J, Wang L, et al
    Deep-learning-based estimation of attenuation map improves attenuation correction performance over direct attenuation estimation for myocardial perfusion SPECT.
    J Nucl Cardiol. 2022 Sep 12. pii: 10.1007/s12350-022-03092.
    PubMed     Abstract available


  418. LIANG HX, Yang YL, Ren JY, Xie Z, et al
    What is this image? 2022 image 2 result: Right atrial angiosarcoma detected with (13)N-NH3 myocardial PET/CT and (18)F-FDG PET/CT.
    J Nucl Cardiol. 2022 Sep 6. pii: 10.1007/s12350-022-03098.
    PubMed    


    August 2022
  419. PACELLA S
    Amyloid PET/CT imaging really improved diagnostic accuracy of cardiac amyloidosis? An open discussion.
    J Nucl Cardiol. 2022 Aug 31. pii: 10.1007/s12350-022-03096.
    PubMed    


  420. JALEEL J, Patel C, Khangembam B, Kumar S, et al
    Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
    J Nucl Cardiol. 2022 Aug 31. pii: 10.1007/s12350-022-03087.
    PubMed     Abstract available


  421. JENSEN JK, Madsen JS, Jensen MEK, Kjaer A, et al
    [(64)Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans.
    J Nucl Cardiol. 2022 Aug 31. pii: 10.1007/s12350-022-03084.
    PubMed     Abstract available


  422. SUN J, Jiang H, Du Y, Li CY, et al
    Deep learning-based denoising in projection-domain and reconstruction-domain for low-dose myocardial perfusion SPECT.
    J Nucl Cardiol. 2022 Aug 18. pii: 10.1007/s12350-022-03045.
    PubMed     Abstract available


  423. WANG TKM, Dong T, Cremer PC, Najm H, et al
    Utility of positron emission tomography myocardial perfusion imaging for identifying ischemia and guiding treatment in patients with anomalous coronary arteries.
    J Nucl Cardiol. 2022 Aug 17. pii: 10.1007/s12350-022-03071.
    PubMed     Abstract available


  424. WANG L, Zheng Y, Zhang J, Wang M, et al
    Diagnostic value of quantitative myocardial blood flow assessment by NaI(Tl) SPECT in detecting significant stenosis: a prospective, multi-center study.
    J Nucl Cardiol. 2022 Aug 15. pii: 10.1007/s12350-022-03085.
    PubMed     Abstract available


  425. TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
    (99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2022 Aug 15. pii: 10.1007/s12350-022-03082.
    PubMed    


  426. NORDSTROM J, Lindstrom E, Kero T, Sorensen J, et al
    Influence of image reconstruction on quantitative cardiac (15)O-water positron emission tomography.
    J Nucl Cardiol. 2022 Aug 4. pii: 10.1007/s12350-022-03075.
    PubMed     Abstract available


  427. GONG JN, Chen BX, Xing HQ, Huo L, et al
    Pulmonary artery imaging with (68) Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2022 Aug 4. pii: 10.1007/s12350-022-03069.
    PubMed     Abstract available


  428. LIU L, Dai N, Yin G, Zhang W, et al
    Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA.
    J Nucl Cardiol. 2022 Aug 2. pii: 10.1007/s12350-022-03038.
    PubMed     Abstract available



  429. CME INSTRUCTIONS: Diagnostic accuracy of dynamic CZT-SPECT in coronary artery disease: A systematic review and meta-analysis.
    J Nucl Cardiol. 2022;29:1683-1685.
    PubMed    


  430. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2022;29:1487-1489.
    PubMed     Abstract available


  431. SADEGHI MM
    Beyond perfusion imaging.
    J Nucl Cardiol. 2022;29:1485-1486.
    PubMed    


  432. WEINBERG RL, Malhotra S
    Nuclear cardiology in the literature: A selection of recent, original research papers.
    J Nucl Cardiol. 2022;29:1494-1496.
    PubMed    


  433. LIN H, Zhang X, Einstein AJ, Tang G, et al
    Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis.
    J Nucl Cardiol. 2022;29:2024-2028.
    PubMed    


  434. BENZ DC, Kaufmann PA, Dorbala S
    Transmural perfusion: A new direction for myocardial blood flow.
    J Nucl Cardiol. 2022;29:1952-1955.
    PubMed    


  435. KWIECINSKI J
    (18)F-fluorodeoxyglucose and (18)F-sodium fluoride for imaging atherosclerotic plaque activity.
    J Nucl Cardiol. 2022;29:1710-1712.
    PubMed    


  436. CALABRETTA R, Kokomani A, Fumagalli C, Olivotto I, et al
    Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2022;29:1946-1951.
    PubMed     Abstract available


  437. AGHAYEV A, Cheezum MK, Steigner ML, Mousavi N, et al
    Multimodality imaging to distinguish between benign and malignant cardiac masses.
    J Nucl Cardiol. 2022;29:1504-1517.
    PubMed     Abstract available


  438. TAILLEFER R
    Scintillation cameras: A new clinical era has come.
    J Nucl Cardiol. 2022;29:1942-1945.
    PubMed    


  439. LAMMERTSMA AA
    Accurate quantification of myocardial perfusion.
    J Nucl Cardiol. 2022;29:1973-1975.
    PubMed    


  440. MAANIITTY T, Knuuti J, Saraste A
    Stress myocardial blood flow and revascularization in chronic coronary artery disease.
    J Nucl Cardiol. 2022;29:1900-1902.
    PubMed    


  441. FERENCZI P, Couffinhal T, Mamou A, Mamou Y, et al
    Myocardial blood flows and reserves on solid state camera: Correlations with coronary history and cardiovascular risk factors.
    J Nucl Cardiol. 2022;29:1671-1678.
    PubMed     Abstract available


  442. SHAREDALAL P, Gerard P, Jain D
    Pharmacological stress myocardial perfusion imaging after an inadequate exercise stress test.
    J Nucl Cardiol. 2022;29:1796-1798.
    PubMed    


  443. PLATA-CORONA JC, Carvajal-Juarez I, Espinola-Zavaleta N, Damas-De Los Santos F, et al
    (13)N-Ammonia myocardial blood flow quantitation in patient with aneurismal coronary artery disease.
    J Nucl Cardiol. 2022;29:1826-1831.
    PubMed     Abstract available


  444. CHEN YC, Pan MJ, Wang QQ, Wang YH, et al
    Intravenous insulin injection supplemented with subsequent milk consumption is a safer formulation for cardiac viability (18)F-FDG imaging.
    J Nucl Cardiol. 2022;29:1985-1991.
    PubMed     Abstract available


  445. WAQAR F, Athar MW, Dwivedi AK, Ahmad S, et al
    Visual patterns of breast attenuation artifacts in women and men with an upright and supine cadmiun-zinc-telluride camera.
    J Nucl Cardiol. 2022;29:1976-1984.
    PubMed     Abstract available


  446. KAISER Y, Verberne HJ
    Arterial (18)F-NaF-uptake as a marker for vascular calcification activity. Can a little salt cut the sweet: a golden bullet to evaluate vascular mineralization?
    J Nucl Cardiol. 2022;29:1867-1869.
    PubMed    


  447. LESLIE WD, Bryanton M, Goertzen A, Slomka P, et al
    Prediction of 2-year major adverse cardiac events from myocardial perfusion scintigraphy and clinical risk factors.
    J Nucl Cardiol. 2022;29:1956-1963.
    PubMed     Abstract available


  448. BELLINGE JW, Francis RJ, Lee SC, Vickery A, et al
    The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trial.
    J Nucl Cardiol. 2022;29:1855-1866.
    PubMed     Abstract available


  449. SINGHVI A, Suacier S, Verma I, Felpel K, et al
    Impact of Gd-153 scanning line source attenuation correction on downstream invasive testing.
    J Nucl Cardiol. 2022;29:1832-1842.
    PubMed     Abstract available


  450. LEE JC, Delaney FT
    Prevalence and clinical significance of incidental findings on CT attenuation correction for myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:1813-1822.
    PubMed     Abstract available


  451. YANG H, Faust E, Gao E, Sethi S, et al
    Evaluating the use of pharmacological stress agents during single-photon emission computed tomography myocardial perfusion imaging tests after inadequate exercise stress test.
    J Nucl Cardiol. 2022;29:1788-1795.
    PubMed     Abstract available


  452. ANANTHASUBRAMANIAM K, Kitt TM, Saxena A, Feng Q, et al
    Healthcare resource utilization among patients receiving non-invasive testing for coronary artery disease in an outpatient setting: A cohort study reflecting daily practice trends.
    J Nucl Cardiol. 2022;29:1776-1787.
    PubMed     Abstract available


  453. YU W, Zhang F, Liu B, Wang J, et al
    Incremental value of epicardial fat volume to coronary artery calcium score and traditional risk factors for predicting myocardial ischemia in patients with suspected coronary artery disease.
    J Nucl Cardiol. 2022;29:1583-1592.
    PubMed     Abstract available


  454. TAGLIERI N, Bonfiglioli R, Bon I, Malosso P, et al
    Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people.
    J Nucl Cardiol. 2022;29:1566-1575.
    PubMed     Abstract available


  455. VILLAGRAN ASIARES A, Yakushev I, Nekolla SG
    Gating failure can result in underestimation of cardiac function in myocardial perfusion scintigraphy.
    J Nucl Cardiol. 2022;29:2038-2041.
    PubMed     Abstract available


  456. KANZAKI Y, Watanabe T, Sohmiya K, Hoshiga M, et al
    Aneurysmal formation from silent myocardial infarction mimics increased (18)F-FDG uptake pattern.
    J Nucl Cardiol. 2022;29:2031-2034.
    PubMed    


    July 2022
  457. DURAN JM, Borges-Neto S
    Bone scintigraphy imaging and transthyretin-related (ATTR) cardiac amyloidosis: New tricks from an old tool?
    J Nucl Cardiol. 2022 Jul 22. pii: 10.1007/s12350-022-03032.
    PubMed    


  458. GUPTA K, Ananthasubramaniam K
    If you don't kill pollution it could kill you: pathophysiologic insights into pollution mediated cardiovascular risk through FDG PET imaging.
    J Nucl Cardiol. 2022 Jul 20. pii: 10.1007/s12350-022-03022.
    PubMed    


  459. DONG T, Wang TKM, Cremer P, Najm HK, et al
    A story of resolved ischemia from anomalous coronary arteries as told by PET/CT.
    J Nucl Cardiol. 2022 Jul 18. pii: 10.1007/s12350-022-03055.
    PubMed    


  460. VAN VELZEN SGM, Dobrolinska MM, Knaapen P, van Herten RLM, et al
    Automated cardiovascular risk categorization through AI-driven coronary calcium quantification in cardiac PET acquired attenuation correction CT.
    J Nucl Cardiol. 2022 Jul 18. pii: 10.1007/s12350-022-03047.
    PubMed     Abstract available


  461. MILLER EJ, Campisi R, Shah NR, McMahon S, et al
    Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.
    J Nucl Cardiol. 2022 Jul 15. pii: 10.1007/s12350-022-03059.
    PubMed    


  462. MAURER A, Sustar A, Giannopoulos AA, Grunig H, et al
    Left ventricular function and volumes from gated [(13)N]-ammonia positron emission tomography myocardial perfusion imaging: A prospective head-to-head comparison against CMR using a hybrid PET/MR device.
    J Nucl Cardiol. 2022 Jul 11. pii: 10.1007/s12350-022-03029.
    PubMed     Abstract available


  463. OKADA T, Kawaguchi N, Miyagawa M, Matsuoka M, et al
    Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
    J Nucl Cardiol. 2022 Jul 8. pii: 10.1007/s12350-022-03034.
    PubMed     Abstract available


  464. MANSOUR N, Nekolla SG, Reyes E, Angelidis G, et al
    Multi-center study of inter-rater reproducibility, image quality, and diagnostic accuracy of CZT versus conventional SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2022 Jul 7. pii: 10.1007/s12350-022-03054.
    PubMed     Abstract available


  465. SUDA K, Tahara N, Bekki M, Nakamura T, et al
    Ongoing vascular inflammation evaluated by (18)F-fluorodeoxyglucose positron emission tomography in patients long after Kawasaki disease.
    J Nucl Cardiol. 2022 Jul 7. pii: 10.1007/s12350-022-03041.
    PubMed     Abstract available


  466. AHMED AI, Saad JM, Han Y, Malahfji M, et al
    Incremental prognostic value of positron emission tomography derived left ventricular mass.
    J Nucl Cardiol. 2022 Jul 6. pii: 10.1007/s12350-022-03035.
    PubMed     Abstract available


  467. YUAN H, Qiu J, Chiu KWH, Chan LWC, et al
    PET/CT morphology and cardiac conduction disorders help discriminate primary cardiac lymphoma from primary cardiac sarcoma.
    J Nucl Cardiol. 2022 Jul 5. pii: 10.1007/s12350-022-03042.
    PubMed     Abstract available


    June 2022
  468. PACELLA S
    18F-FMISO PET/CT: a new promising radiotracer for cardiac sarcoidosis and extracardiac involvement?
    J Nucl Cardiol. 2022 Jun 29. pii: 10.1007/s12350-022-03052.
    PubMed    


  469. MEZUE K, Chow D, Tawakol A, Fakhri GE, et al
    PET myocardial perfusion imaging in superior vena cava syndrome.
    J Nucl Cardiol. 2022 Jun 28. pii: 10.1007/s12350-022-03033.
    PubMed    


  470. KRAKOVICH A, Zaretsky U, Gelbart E, Moalem I, et al
    Anthropomorphic cardiac phantom for dynamic SPECT.
    J Nucl Cardiol. 2022 Jun 27. pii: 10.1007/s12350-022-03024.
    PubMed     Abstract available


  471. MANAPRAGADA PP, Bhambhvani PG
    'Do No Harm': optimizing protocol for FDG PET cardiac viability assessment.
    J Nucl Cardiol. 2022 Jun 23. pii: 10.1007/s12350-022-03043.
    PubMed    


  472. DOBROLINSKA MM, Lazarenko SV, van der Zant FM, Does L, et al
    Performance of visual, manual, and automatic coronary calcium scoring of cardiac (13)N-ammonia PET/low dose CT.
    J Nucl Cardiol. 2022 Jun 16. pii: 10.1007/s12350-022-03018.
    PubMed     Abstract available


  473. NORIKANE T, Yamamoto Y, Dobashi H, Noma T, et al
    (11)C-MET PET for diagnosis and therapeutic monitoring in a patient with IgG4-related periaortitis/periarteritis concomitant with atherosclerosis.
    J Nucl Cardiol. 2022 Jun 14. pii: 10.1007/s12350-022-03023.
    PubMed    


  474. SINGH A, Kwiecinski J, Cadet S, Killekar A, et al
    Automated nonlinear registration of coronary PET to CT angiography using pseudo-CT generated from PET with generative adversarial networks.
    J Nucl Cardiol. 2022 Jun 14. pii: 10.1007/s12350-022-03010.
    PubMed     Abstract available


  475. CHEN X, Liu C
    Deep-learning-based methods of attenuation correction for SPECT and PET.
    J Nucl Cardiol. 2022 Jun 9. pii: 10.1007/s12350-022-03007.
    PubMed     Abstract available


  476. WANG C, Ma Y, Liu Y, Li L, et al
    Texture analysis of SPECT myocardial perfusion provides prognostic value for dilated cardiomyopathy.
    J Nucl Cardiol. 2022 Jun 8. pii: 10.1007/s12350-022-03006.
    PubMed     Abstract available


  477. MALHOTRA S, Singh V, Pilati S, Trepashko D, et al
    Comparable image interpretation of 1- and 3-hour technetium-99m HDP scintigraphy for transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2022 Jun 8. pii: 10.1007/s12350-022-03021.
    PubMed    


  478. CREAN AM, Small GS, Chow BJW, Ruddy TD, et al
    High-resolution PET demonstrates extensive ischemia/fibrosis mismatch in a patient with hypertrophic cardiomyopathy: the power of multimodality image fusion.
    J Nucl Cardiol. 2022 Jun 7. pii: 10.1007/s12350-022-02993.
    PubMed    


  479. HERRERA-MARTINEZ Y, Vercher-Conejero JL, Martin-Marcuartu JJ, Telue Vega A, et al
    [(68)Ga]-DOTATOC PET/CT in myocardial metastases of neuroendocrine neoplasms.
    J Nucl Cardiol. 2022 Jun 2. pii: 10.1007/s12350-022-03014.
    PubMed    



  480. ASNC Begins Search for New Editor-in-Chief of the Journal of Nuclear Cardiology.
    J Nucl Cardiol. 2022;29:1484.
    PubMed    


  481. MALIK A, Sharain K, Foley T, Chareonthaitawee P, et al
    What is this image? 2022 image 6 result : Characteristic findings of apical hypertrophic cardiomyopathy on single photon emission computed tomography.
    J Nucl Cardiol. 2022;29:910-915.
    PubMed    


  482. CALNON DA
    Nuclear cardiology technologists: the MVPs of our nuclear cardiology programs.
    J Nucl Cardiol. 2022;29:1481-1483.
    PubMed    


  483. LEE JC, Baer RA
    The complementary roles of MPS and CAC in renal patients.
    J Nucl Cardiol. 2022;29:1446.
    PubMed    


  484. WACKERS FJT
    What happened to ASNC's founding members? The 2021 survey.
    J Nucl Cardiol. 2022;29:917-918.
    PubMed    


  485. HUNG GU
    Optimizing diagnosis and risk stratification of ischemic heart disease by myocardial perfusion imaging: The incremental values of non-perfusion variables during vasodilator stress.
    J Nucl Cardiol. 2022;29:934-937.
    PubMed    


  486. AL-MALLAH MH, Ahmed AI, Nabi F, Chang SM, et al
    Outcomes of patients with moderate-to-severe Ischemia excluded from the ischemia trial.
    J Nucl Cardiol. 2022;29:1100-1105.
    PubMed     Abstract available


  487. KHOURY AE, Nasr S, Chehade F
    (99m)Tc-PYP scintigraphic diagnosis of cardiac amyloidosis in a patient with new onset heart failure.
    J Nucl Cardiol. 2022;29:1434-1438.
    PubMed    


  488. TOUTOUZAS K, Antonopoulos AS, Koutagiar I, Skoumas I, et al
    Visceral adipose tissue phenotype and hypoadiponectinemia are associated with aortic Fluorine-18 fluorodeoxyglucose uptake in patients with familial dyslipidemias.
    J Nucl Cardiol. 2022;29:1405-1414.
    PubMed     Abstract available


  489. SHAREDALAL P, Singh A, Shah N, Jain D, et al
    Automated abstraction of myocardial perfusion imaging reports using natural language processing.
    J Nucl Cardiol. 2022;29:1188-1190.
    PubMed    


  490. FLETCHER AJ, Lembo M, Kwiecinski J, Syed MBJ, et al
    Quantifying microcalcification activity in the thoracic aorta.
    J Nucl Cardiol. 2022;29:1372-1385.
    PubMed     Abstract available


  491. MOODY WE, Arumugam P
    Assessment of stress adequacy with adenosine: Does the answer lie in the spleen?
    J Nucl Cardiol. 2022;29:1215-1218.
    PubMed    


  492. TAKEHANA K
    Takotsubo cardiomyopathy: What should myocardial perfusion imaging reveal.
    J Nucl Cardiol. 2022;29:1047-1050.
    PubMed    


  493. KASSAB K, Al-Ogaili A, Malhotra S
    Abnormal vasodilator stress electrocardiogram with normal myocardial perfusion: Clinical decision-making and review of literature.
    J Nucl Cardiol. 2022;29:1257-1265.
    PubMed     Abstract available


  494. ZHENG C, Sun BC, Wu YL, Ferencik M, et al
    Automated abstraction of myocardial perfusion imaging reports using natural language processing.
    J Nucl Cardiol. 2022;29:1178-1187.
    PubMed     Abstract available


  495. SAKATANI T, Kasahara T, Irie D, Tsubakimoto Y, et al
    Prognostic value of left ventricular mechanical dyssynchrony induced by exercise stress in patients with normal myocardial perfusion single-photon emission computed tomography.
    J Nucl Cardiol. 2022;29:1-10.
    PubMed     Abstract available


  496. MALEK H, Maghsudi M, Yaghoobi N
    Extra-cardiac multifocal lung uptake of (99m)Tc-sestamibi in myocardial perfusion imaging: An asymptomatic case with coronavirus infection features.
    J Nucl Cardiol. 2022;29:1471-1474.
    PubMed    


  497. ROZANSKI A, Berman DS, Iskandrian AE
    The imperative to assess physical function among all patients undergoing stress myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:946-951.
    PubMed    


  498. CASTRO-VILLACORTA H, Ortiz-Velazquez JF, Preciado-Gutierrez OU, Paz-Gomez R, et al
    Normal myocardial perfusion despite a very high coronary calcium score.
    J Nucl Cardiol. 2022;29:1460-1467.
    PubMed     Abstract available


  499. MIRSHAHVALAD SA, Chavoshi M, Hekmat S
    Diagnostic performance of prone-only myocardial perfusion imaging versus coronary angiography in the detection of coronary artery disease: A systematic review and meta-analysis.
    J Nucl Cardiol. 2022;29:1339-1351.
    PubMed     Abstract available


    May 2022
  500. HALBONI A, Dawdy J, Mishra T, Dayco J, et al
    18F-FDG PET/CT assisted exclusion of cardiac device-related infective endocarditis.
    J Nucl Cardiol. 2022 May 26. pii: 10.1007/s12350-022-03008.
    PubMed    


  501. KESSLER L, Fragoso Costa P, Kersting D, Jentzen W, et al
    Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis.
    J Nucl Cardiol. 2022 May 13. pii: 10.1007/s12350-022-02960.
    PubMed     Abstract available


  502. VAN DER BIJL P, Stassen J, Bax JJ
    (18)F-FDG PET/CT for the diagnosis of aortic inflammation in COVID-19.
    J Nucl Cardiol. 2022 May 10. pii: 10.1007/s12350-022-02950.
    PubMed    


  503. XIE H, Thorn S, Chen X, Zhou B, et al
    Increasing angular sampling through deep learning for stationary cardiac SPECT image reconstruction.
    J Nucl Cardiol. 2022 May 4. pii: 10.1007/s12350-022-02972.
    PubMed     Abstract available


  504. VLACHOPOULOS C, Terentes-Printzios D, Katsaounou P, Solomou E, et al
    Time-related aortic inflammatory response, as assessed with (18)F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study.
    J Nucl Cardiol. 2022 May 2. pii: 10.1007/s12350-022-02962.
    PubMed     Abstract available


    April 2022
  505. CERQUEIRA MD
    Cardiac SPECT or PET?: Is there still a debate?
    J Nucl Cardiol. 2022 Apr 29. pii: 10.1007/s12350-022-02982.
    PubMed    


  506. BENGS S, Warnock GI, Portmann A, Mikail N, et al
    Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice.
    J Nucl Cardiol. 2022 Apr 28. pii: 10.1007/s12350-022-02968.
    PubMed     Abstract available


  507. CHEN X, Hendrik Pretorius P, Zhou B, Liu H, et al
    Cross-vender, cross-tracer, and cross-protocol deep transfer learning for attenuation map generation of cardiac SPECT.
    J Nucl Cardiol. 2022 Apr 26. pii: 10.1007/s12350-022-02978.
    PubMed     Abstract available


  508. HASHIMOTO H, Oka T, Nakanishi R, Mizumura S, et al
    Evaluation of balloon pulmonary angioplasty using lung perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2022 Apr 26. pii: 10.1007/s12350-022-02971.
    PubMed     Abstract available


  509. SALVALAGGIO A, Cipriani A, Righetto S, Artioli P, et al
    Incidental cardiac uptake of (99m)Tc-diphosphonates is predictive of poor outcome: data from 9616 bone scintigraphies.
    J Nucl Cardiol. 2022 Apr 18. pii: 10.1007/s12350-022-02961.
    PubMed     Abstract available


  510. LASSEN ML, Wissenberg M, Byrne C, Kjaer A, et al
    Optimization of the left ventricle ejection fraction estimate obtained during cardiac adenosine stress (82)Rubidium-PET scanning: impact of different reconstruction protocols.
    J Nucl Cardiol. 2022 Apr 12. pii: 10.1007/s12350-022-02946.
    PubMed     Abstract available


  511. MSHELBWALA FS, Ananthasubramaniam K
    All that glitters is not sarcoidosis: Importance of systematic review of (18)F-FDG-PET data and integration of clinical information.
    J Nucl Cardiol. 2022 Apr 11. pii: 10.1007/s12350-022-02956.
    PubMed    


  512. MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
    LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
    J Nucl Cardiol. 2022 Apr 11. pii: 10.1007/s12350-022-02966.
    PubMed    


  513. SMITH MF
    Assessing if adequate hyperemic response to pharmacologic stress in Rb-82 PET myocardial perfusion imaging is achieved: are biomarkers helpful?
    J Nucl Cardiol. 2022 Apr 8. pii: 10.1007/s12350-022-02954.
    PubMed    


  514. WERNER RA, Martinez RB, Marcus C, Kruse MJ, et al
    Diagnostic performance of IQ.SPECT with high-speed scanning: A preliminary quality control study in obese patients.
    J Nucl Cardiol. 2022 Apr 6. pii: 10.1007/s12350-022-02928.
    PubMed     Abstract available


  515. ASSANTE R, D'Antonio A, Mannarino T, Nappi C, et al
    Simultaneous assessment of myocardial perfusion and adrenergic innervation in patients with heart failure by low-dose dual-isotope CZT SPECT imaging.
    J Nucl Cardiol. 2022 Apr 4. pii: 10.1007/s12350-022-02951.
    PubMed     Abstract available


  516. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2022;29:392-394.
    PubMed     Abstract available


  517. CALNON DA
    Combining myocardial perfusion imaging with coronary artery calcium scoring: The time is NOW!
    J Nucl Cardiol. 2022;29:898-900.
    PubMed    


  518. WANG JZ, Zelt JGE, Kaps N, Lavallee A, et al
    Does quantification of [(11)C]meta-hydroxyephedrine and [(13)N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy.
    J Nucl Cardiol. 2022;29:413-425.
    PubMed     Abstract available


  519. MILLER TD
    Drawing the line between a normal and mildly abnormal nuclear cardiology scan.
    J Nucl Cardiol. 2022;29:836-839.
    PubMed    


  520. THOMAS GS, Taghav A
    Integrating baseline electrocardiography and myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:822-825.
    PubMed    


  521. VALZANIA C, Bonfiglioli R, Fallani F, Martignani C, et al
    Single-photon cardiac imaging in patients with cardiac implantable electrical devices.
    J Nucl Cardiol. 2022;29:633-641.
    PubMed     Abstract available


  522. ALJIZEERI A, Badarin FA, Al-Mallah MH
    Automation in Nuclear Cardiology: Time for Flurpiridaz to Join the Club.
    J Nucl Cardiol. 2022;29:709-711.
    PubMed    


  523. HENZLOVA MJ, Duvall L
    Is the CZT technology the future of nuclear cardiology?
    J Nucl Cardiol. 2022;29:737-740.
    PubMed    


  524. ROZANSKI A, Gransar H, Hayes SW, Friedman JD, et al
    Mortality risk among patients undergoing exercise versus pharmacologic myocardial perfusion imaging: A propensity-based comparison.
    J Nucl Cardiol. 2022;29:840-852.
    PubMed     Abstract available


  525. KASSAB K, Hussain K, Torres A, Iskander F, et al
    The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:826-835.
    PubMed     Abstract available


  526. AVENDANO R, Hashemi-Zonouz T, Sandoval V, Liu C, et al
    Anger recall mental stress decreases (123)I-metaiodobenzylguanidine ((123)I-MIBG) uptake and increases heterogeneity of cardiac sympathetic activity in the myocardium in patients with ischemic cardiomyopathy.
    J Nucl Cardiol. 2022;29:798-809.
    PubMed     Abstract available


  527. BELLINI P, Albano D, Bertoli M, Peli A, et al
    Incidental thymoma detection during myocardial perfusion imaging by CZT camera.
    J Nucl Cardiol. 2022;29:866-870.
    PubMed    


  528. KUDO T, Imakhanova A
    Quantification of amyloid deposition using bone scan agents.
    J Nucl Cardiol. 2022;29:515-518.
    PubMed    


  529. LU X, Zhao M, Tian C, Wei H, et al
    Prognostic value of ventricular mechanical dyssynchrony in patients with left ventricular aneurysm: A comparative study of medical and surgical treatment.
    J Nucl Cardiol. 2022;29:652-660.
    PubMed     Abstract available


  530. SAZONOVA SI, Atabekov TA, Batalov RE, Mishkina AI, et al
    Prediction of appropriate ICD therapy in patients with ischemic heart failure.
    J Nucl Cardiol. 2022;29:680-691.
    PubMed     Abstract available


  531. STENDAHL JC, Liu Z, Boutagy NE, Nataneli E, et al
    Prototype device for endoventricular beta-emitting radiotracer detection and molecularly-guided intervention.
    J Nucl Cardiol. 2022;29:663-676.
    PubMed     Abstract available


  532. ASSANTE R, Salvatore E, Nappi C, Peluso S, et al
    Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease.
    J Nucl Cardiol. 2022;29:642-648.
    PubMed     Abstract available


  533. MCREE CW, Brice LR, Farag AA, Iskandrian AE, et al
    Evolution of symptoms in patients with stable angina after normal regadenoson myocardial perfusion imaging: The Radionuclide Imaging and Symptomatic Evolution study (RISE).
    J Nucl Cardiol. 2022;29:612-621.
    PubMed     Abstract available


  534. JONES KA, Small AD, Ray S, Hamilton DJ, et al
    Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy.
    J Nucl Cardiol. 2022;29:581-589.
    PubMed     Abstract available


    March 2022
  535. GU Y, Han K, Zhang Z, Zhao Z, et al
    (68)Ga-FAPI PET/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study.
    J Nucl Cardiol. 2022 Mar 23. pii: 10.1007/s12350-022-02952.
    PubMed     Abstract available


  536. DUFF L, Scarsbrook AF, Mackie SL, Frood R, et al
    A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis.
    J Nucl Cardiol. 2022 Mar 23. pii: 10.1007/s12350-022-02927.
    PubMed     Abstract available


  537. YANG S, Ma J, Li T, Wang P, et al
    Radioiodinated hypericin as a tracer for detection of acute myocardial infarction: SPECT-CT imaging in a swine model.
    J Nucl Cardiol. 2022 Mar 16. pii: 10.1007/s12350-022-02933.
    PubMed     Abstract available


  538. HAN Y, Ahmed AI, Hayden C, Jung AK, et al
    Change in positron emission tomography perfusion imaging quality with a data-driven motion correction algorithm.
    J Nucl Cardiol. 2022 Mar 11. pii: 10.1007/s12350-021-02902.
    PubMed     Abstract available


  539. RISCHPLER C, Kersting D, Nekolla SG
    To quantify or not to quantify, that is the question: Semi-quantitative vs. visual analysis of Rb-82 myocardial perfusion imaging PET.
    J Nucl Cardiol. 2022 Mar 10. pii: 10.1007/s12350-022-02935.
    PubMed    


  540. YEUNG MW, Benjamins JW, Knol RJJ, van der Zant FM, et al
    Multi-task Deep Learning of Myocardial Blood Flow and Cardiovascular Risk Traits from PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2022 Mar 10. pii: 10.1007/s12350-022-02920.
    PubMed     Abstract available


  541. AIKAWA T, Kamada R, Ogino J, Saitou T, et al
    Cardiac resynchronization therapy through a subcutaneous tunnel assessed by phase analysis of gated myocardial perfusion SPECT imaging.
    J Nucl Cardiol. 2022 Mar 8. pii: 10.1007/s12350-022-02916.
    PubMed    


  542. SLOMKA P
    Future of nuclear cardiology is bright: Promise of cardiac PET/CT and artificial intelligence.
    J Nucl Cardiol. 2022 Mar 4. pii: 10.1007/s12350-022-02942.
    PubMed    


  543. SANTOYO-SAAVEDRA AH, Espinola-Zavaleta N, Bermudez-Gonzalez JL, Gonzalez-Hernandez MA, et al
    The importance of time for the evaluation of viability by SPECT.
    J Nucl Cardiol. 2022 Mar 1. pii: 10.1007/s12350-022-02934.
    PubMed    


    February 2022
  544. GERMAINI M, Boursier C, Goehringer F, Selton-Suty C, et al
    The detection of infectious endocarditis may be enhanced by a repeat FDG-PET while maintaining patients on a ketogenic diet.
    J Nucl Cardiol. 2022 Feb 22. pii: 10.1007/s12350-022-02921.
    PubMed     Abstract available


  545. XU Z, Tang H, Malhotra S, Dong M, et al
    Three-dimensional Fusion of Myocardial Perfusion SPECT and Invasive Coronary Angiography Guides Coronary Revascularization.
    J Nucl Cardiol. 2022 Feb 22. pii: 10.1007/s12350-022-02907.
    PubMed     Abstract available


  546. MIYAMOTO K, Norikane T, Ihara-Nishishita A, Takami Y, et al
    What is this image? 2022 image 5 result : Apical ring uptake on 18F-FDG PET/CT indicating apical hypertrophic cardiomyopathy with apical aneurysm.
    J Nucl Cardiol. 2022 Feb 22. pii: 10.1007/s12350-022-02931.
    PubMed    


  547. GENNARI AG, Grunig H, Benz DC, Skawran S, et al
    Low-dose CT from myocardial perfusion SPECT/CT allows the detection of anemia in preoperative patients.
    J Nucl Cardiol. 2022 Feb 17. pii: 10.1007/s12350-021-02899.
    PubMed     Abstract available


  548. GAZZILLI M, Albano D, Lucchini S, Peli A, et al
    Correction to: New criteria for the diagnosis of infective endocarditis using 18F-FDG PET/CT imaging.
    J Nucl Cardiol. 2022 Feb 11. pii: 10.1007/s12350-022-02919.
    PubMed    


  549. ITAYA N, Tahara N, Bekki M, Fukumoto Y, et al
    The role of coronary angioscopy and FDG-PET/CTA in interventional therapy.
    J Nucl Cardiol. 2022 Feb 8. pii: 10.1007/s12350-022-02915.
    PubMed    


  550. CALNON DA
    Ensuring patient access to modern myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:387-388.
    PubMed    


  551. THOMPSON RC, Al-Mallah MH, Beanlands RSB, Calnon DA, et al
    ASNC's thoughts on the AHA/ACC chest pain guidelines.
    J Nucl Cardiol. 2022;29:19-23.
    PubMed    


  552. KERO T, Saraste A, Lagerqvist B, Sorensen J, et al
    Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease.
    J Nucl Cardiol. 2022;29:24-36.
    PubMed     Abstract available


  553. VIJ A, Doukky R
    The Prognostic Value of MPI in CKD: Can we do better?
    J Nucl Cardiol. 2022;29:155-157.
    PubMed    


  554. CANTONI V, Green R, Acampa W, Assante R, et al
    Prognostic value of myocardial perfusion imaging in patients with chronic kidney disease: A systematic review and meta-analysis.
    J Nucl Cardiol. 2022;29:141-154.
    PubMed     Abstract available


  555. MANNARINO T, Gaudieri V, Acampa W
    Vasodilators and myocardial blood flow by CZT cameras: Make us see further.
    J Nucl Cardiol. 2022;29:123-125.
    PubMed    


  556. WEILER-SAGIE M, Ben-Haim S
    Variability in bone-seeking tracers and imaging protocols for the diagnosis of cardiac amyloidosis: The more the merrier?
    J Nucl Cardiol. 2022;29:319-322.
    PubMed    


  557. BOLLAMPALLY N, Barwad P, Sood A, Parmar M, et al
    Serendipitous detection of hiatus hernia due to stomach wall tracer uptake on (99m)Tc-MIBI myocardial perfusion imaging.
    J Nucl Cardiol. 2022;29:372-375.
    PubMed    


  558. MEGNA R, Nappi C, Gaudieri V, Mannarino T, et al
    Diagnostic value of clinical risk scores for predicting normal stress myocardial perfusion imaging in subjects without coronary artery calcium.
    J Nucl Cardiol. 2022;29:323-333.
    PubMed     Abstract available


  559. SANTARELLI MF, Genovesi D, Positano V, Di Sarlo R, et al
    Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy.
    J Nucl Cardiol. 2022;29:307-318.
    PubMed     Abstract available


  560. TZOLOS E, Kwiecinski J, Lassen ML, Cadet S, et al
    Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.
    J Nucl Cardiol. 2022;29:126-135.
    PubMed     Abstract available


  561. MILLER RJH, Cadet S, Pournazari P, Pope A, et al
    Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis.
    J Nucl Cardiol. 2022;29:86-96.
    PubMed     Abstract available


  562. ROMERO-FARINA G, Aguade-Bruix S, Cuellar-Calabria H, Pizzi MN, et al
    Gender differences in outcome in patients with diabetes mellitus.
    J Nucl Cardiol. 2022;29:72-82.
    PubMed     Abstract available


  563. WEBER B, Perez-Chada LM, Divakaran S, Brown JM, et al
    Coronary microvascular dysfunction in patients with psoriasis.
    J Nucl Cardiol. 2022;29:37-42.
    PubMed     Abstract available


  564. ANANTHASUBRAMANIAM K
    ASNC Image Guide Registry: Leading the way toward improving quality and patient care in nuclear cardiology.
    J Nucl Cardiol. 2022;29:177-180.
    PubMed    


  565. ABIKHZER G, Martineau P, Gregoire J, Finnerty V, et al
    [(18)F]FDG-PET CT for the evaluation of native valve endocarditis.
    J Nucl Cardiol. 2022;29:158-165.
    PubMed     Abstract available


    January 2022
  566. YOUNG KA, Lyle M, Rosenbaum AN, Chang IC, et al
    (18)F-FDG/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.
    J Nucl Cardiol. 2022 Jan 27. pii: 10.1007/s12350-021-02886.
    PubMed     Abstract available


  567. GRKOVSKI M, Zanzonico PB, Modak S, Humm JL, et al
    F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation.
    J Nucl Cardiol. 2022 Jan 6. pii: 10.1007/s12350-021-02813.
    PubMed     Abstract available


    December 2021
  568. BORREN NM, Gerritse TJ, Ottervanger JP, Mouden M, et al
    Semi-quantitative assessment of ischemia with rubidium-82 PET myocardial perfusion imaging.
    J Nucl Cardiol. 2021 Dec 30. pii: 10.1007/s12350-021-02884.
    PubMed     Abstract available


  569. TAKAHASHI K, Sasaki D, Yamashita M, Sakaue T, et al
    Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2021 Dec 28. pii: 10.1007/s12350-021-02890.
    PubMed     Abstract available


  570. PUCAR D, Hinchcliff M
    FDG PET vascular imaging in IgG4-RD: Potential and challenges.
    J Nucl Cardiol. 2021 Dec 28. pii: 10.1007/s12350-021-02887.
    PubMed    


  571. RISCHPLER C, Seifert R
    Combined PET and MRI for the masses! : At least for the cardiac ones.
    J Nucl Cardiol. 2021 Dec 21. pii: 10.1007/s12350-021-02881.
    PubMed    


  572. ROQUE A, Pizzi MN
    (18)F-FDG PET/CT: Not only a promise for complex scenarios-let's talk about aortic grafts.
    J Nucl Cardiol. 2021 Dec 21. pii: 10.1007/s12350-021-02888.
    PubMed    


  573. TAVOOSI A, deKemp RA, Dennie C, Glineur D, et al
    Diagnosis of unrecognized aortic dissection by hybrid PET/CT rubidium-82 imaging.
    J Nucl Cardiol. 2021 Dec 21. pii: 10.1007/s12350-021-02871.
    PubMed    


  574. NYE JA, Cooke CD
    Accounting for residual activity in the estimate of myocardial blood flow with PET.
    J Nucl Cardiol. 2021 Dec 16. pii: 10.1007/s12350-021-02873.
    PubMed    


  575. CALABRETTA R, Castello A, Giglioli C, Cecchi E, et al
    Prognostic value of divergent pattern detection by 99mTc-sestamibi gated SPECT in patients with anterior acute myocardial infarction.
    J Nucl Cardiol. 2021 Dec 16. pii: 10.1007/s12350-021-02874.
    PubMed     Abstract available


  576. WATANABE S, Nakajima K, Wakabayashi H, Yoneyama H, et al
    Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.
    J Nucl Cardiol. 2021 Dec 14. pii: 10.1007/s12350-021-02857.
    PubMed     Abstract available


  577. PANDEY S
    Quantitative SPECT in PYP imaging: Ready for prime time or too early to tell?
    J Nucl Cardiol. 2021 Dec 10. pii: 10.1007/s12350-021-02882.
    PubMed    


  578. NAHASS M, Kempf J
    Severe myocardial stunning after myocardial perfusion on gated SPECT exercise stress test.
    J Nucl Cardiol. 2021 Dec 10. pii: 10.1007/s12350-021-02819.
    PubMed    


  579. LI GY, Hong JL, Wang SY, Xie Z, et al
    Pericardial paraganglioma detected with contrast-enhanced CT, MRI, and (18)F-FDG PET/CT findings.
    J Nucl Cardiol. 2021 Dec 7. pii: 10.1007/s12350-021-02872.
    PubMed    


  580. ANANTHASUBRAMANIAM K, Arumugam P
    Can we "REFINE" the art of predicting ischemia on SPECT myocardial perfusion imaging?
    J Nucl Cardiol. 2021 Dec 6. pii: 10.1007/s12350-021-02867.
    PubMed    



  581. CME INSTRUCTIONS: Evaluation of cardiac allograft vasculopathy by positron emission tomography.
    J Nucl Cardiol. 2021;28:2613-2615.
    PubMed    


  582. SCHELBERT HR
    Daniel S. Berman, MD, born on July 15, 1944.
    J Nucl Cardiol. 2021;28:2479-2482.
    PubMed    


  583. STASSEN J, van der Bijl P, Bax JJ
    Optimizing (99m)Tc-DPD scintigraphy: Adding value to the diagnosis and treatment of cardiac transthyretin amyloidosis.
    J Nucl Cardiol. 2021;28:2497-2499.
    PubMed    


  584. SHARIR T, Brodkin B
    Can myocardial perfusion imaging predict outcome in patients with angina and ischemia but no obstructive coronary artery disease (INOCA)?
    J Nucl Cardiol. 2021;28:3038-3043.
    PubMed    


  585. ALJAROUDI W
    Left ventricular mechanical dyssynchrony in patient with CAD: The Saga continues.
    J Nucl Cardiol. 2021;28:3021-3024.
    PubMed    


  586. GROARKE JD, Divakaran S, Nohria A, Killoran JH, et al
    Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation.
    J Nucl Cardiol. 2021;28:2976-2987.
    PubMed     Abstract available


  587. SHAH JN, Murray KM, Lucas FL, Fairfield KM, et al
    Variation in additional testing and patient outcomes after stress echocardiography or myocardial perfusion imaging, according to accreditation status of testing site.
    J Nucl Cardiol. 2021;28:2952-2961.
    PubMed     Abstract available


  588. HAYRAPETIAN A, Berenji GR, Nguyen KL, Li Y, et al
    (18)F-Sodium fluoride uptake is associated with severity of atherosclerotic stenosis in stable ischemic heart disease.
    J Nucl Cardiol. 2021;28:3058-3066.
    PubMed     Abstract available


  589. KAVANAL AJ, Singh H, Panda P, Vijay J, et al
    Prominent aortic radiotracer activity on equilibrium radionuclide ventriculography (ERNV) due to anterior transposition of aorta: A clue to diagnosing levo-transposition of great arteries (L-TGA) ?
    J Nucl Cardiol. 2021;28:3096-3099.
    PubMed     Abstract available


  590. OTAKI Y, Miller RJH, Slomka PJ
    Elucidating the pathophysiology of left bundle branch block related perfusion defects.
    J Nucl Cardiol. 2021;28:2923-2926.
    PubMed    


  591. KHAN A, Engineer R, Wang S, Jaber WA, et al
    Initial experience regarding the safety and yield of rest-stress myocardial perfusion imaging in emergency department patients with mildly abnormal high-sensitivity cardiac troponins.
    J Nucl Cardiol. 2021;28:2941-2948.
    PubMed     Abstract available


  592. MILLER RJH, Han D, Rozanski A, Gransar H, et al
    CZT camera systems may provide better risk stratification for low-risk patients.
    J Nucl Cardiol. 2021;28:2927-2936.
    PubMed     Abstract available


  593. NAKAJIMA K, Wakabayashi H
    Value of combined perfusion and metabolic tracers versus stress-rest perfusion imaging for coronary heart disease.
    J Nucl Cardiol. 2021;28:3081-3084.
    PubMed    


  594. MOODY WE, Holloway B, Arumugam P, Gill S, et al
    Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study.
    J Nucl Cardiol. 2021;28:2876-2891.
    PubMed     Abstract available


  595. SCHUMANN CL, Bourque JM
    Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter.
    J Nucl Cardiol. 2021;28:2684-2686.
    PubMed    


  596. SUN XX, Li S, Fang W, Tian YQ, et al
    Preserved myocardial viability in patients with chronic total occlusion of a single coronary artery.
    J Nucl Cardiol. 2021;28:2812-2822.
    PubMed     Abstract available


  597. MATSUNARI I
    Microvascular function measurement in mice: From large to small.
    J Nucl Cardiol. 2021;28:2657-2659.
    PubMed     Abstract available


  598. RENAUD JM, Premaratne M, Villeneuve MC, Finnerty V, et al
    Site qualification and clinical interpretation standards for (99m)Tc-SPECT perfusion imaging in a multi-center study of MITNEC (Medical Imaging Trials Network of Canada).
    J Nucl Cardiol. 2021;28:2712-2725.
    PubMed     Abstract available


  599. XI XY, Wang L, Hsu B, Zhao ZQ, et al
    (99m)Tc-3SPboroxime: A neutral (99m)Tc(III) radiotracer with high heart uptake and long myocardial retention.
    J Nucl Cardiol. 2021;28:2687-2696.
    PubMed     Abstract available


  600. SCHOLTENS AM, Verberne HJ
    FDG uptake in marrow and spleen: What does it mean? : Importance of clinical context in the interpretation of FDG uptake in marrow and spleen in infective endocarditis.
    J Nucl Cardiol. 2021;28:2543-2544.
    PubMed    


  601. JAYADEVA PS, Better N
    How viable is SPECT for viability assessment in the PET era?
    J Nucl Cardiol. 2021;28:2557-2559.
    PubMed    


  602. WENNING C, Vrachimis A, Pavenstadt HJ, Reuter S, et al
    Coronary artery calcium burden, carotid atherosclerotic plaque burden, and myocardial blood flow in patients with end-stage renal disease: A non-invasive imaging study combining PET/CT and 3D ultrasound.
    J Nucl Cardiol. 2021;28:2660-2670.
    PubMed     Abstract available


  603. GUERRATY MA, Johnson LC, Blankemeyer E, Rader DJ, et al
    Development and feasibility of quantitative dynamic cardiac imaging for mice using muSPECT.
    J Nucl Cardiol. 2021;28:2647-2656.
    PubMed     Abstract available


  604. SHIBUTANI T, Nakajima K, Yoneyama H, Konishi T, et al
    The utility of heart-to-mediastinum ratio using a planar image created from IQ-SPECT with Iodine-123 meta-iodobenzylguanidine.
    J Nucl Cardiol. 2021;28:2569-2577.
    PubMed     Abstract available


  605. BAILLY M, Thibault F, Courtehoux M, Metrard G, et al
    Impact of attenuation correction for CZT-SPECT measurement of myocardial blood flow.
    J Nucl Cardiol. 2021;28:2560-2568.
    PubMed     Abstract available


  606. ZHANG F, Wang J, Shao X, Yang M, et al
    Incremental value of myocardial wall motion and thickening to perfusion alone by gated SPECT myocardial perfusion imaging for viability assessment in patients with ischemic heart failure.
    J Nucl Cardiol. 2021;28:2545-2556.
    PubMed     Abstract available


  607. BOURSIER C, Duval X, Mahida B, Hoen B, et al
    Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET.
    J Nucl Cardiol. 2021;28:2533-2542.
    PubMed     Abstract available


  608. DO J, Ruddy TD, Wells RG
    Reduced acquisition times for measurement of myocardial blood flow with (99m)Tc-tetrofosmin and solid-state detector SPECT.
    J Nucl Cardiol. 2021;28:2518-2529.
    PubMed     Abstract available


  609. LIGA R, Gimelli A
    Dynamic ultrafast CZT imaging: Time for a paradigm change in myocardial perfusion imaging.
    J Nucl Cardiol. 2021;28:2530-2532.
    PubMed    


  610. CASE JA
    3D iterative reconstruction can do so much more than reduce dose.
    J Nucl Cardiol. 2021;28:2633-2637.
    PubMed     Abstract available


  611. PREVOST S
    Beware! Some crucial information is left unattended on our myocardial perfusion scans!
    J Nucl Cardiol. 2021;28:2642-2643.
    PubMed    


  612. DIVAKARAN S, Osborne MT
    Preparation is everything: The impact of a structured preparation protocol on cardiac (18)F-FDG PET imaging for cardiac sarcoidosis.
    J Nucl Cardiol. 2021;28:2638-2641.
    PubMed    


    November 2021
  613. CUOCOLO A, Petretta M
    Ventilation/perfusion SPECT: One more promising resource to fight the medical Hydra.
    J Nucl Cardiol. 2021 Nov 24. pii: 10.1007/s12350-021-02846.
    PubMed    


  614. BOCZAR KE, Faller E, Zeng W, Wang J, et al
    Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study.
    J Nucl Cardiol. 2021 Nov 24. pii: 10.1007/s12350-021-02830.
    PubMed     Abstract available


  615. ZAMPELLA E, Assante R, Acampa W, Gaudieri V, et al
    Incremental value of (18)F-FDG cardiac PET imaging over dobutamine stress echocardiography in predicting myocardial ischemia in patients with suspected coronary artery disease.
    J Nucl Cardiol. 2021 Nov 17. pii: 10.1007/s12350-021-02852.
    PubMed     Abstract available


  616. CORBY-ZAUNER C, Monney P, Papadimitriou-Olivgeris M, Prior JO, et al
    (18)F-FDG-PET/CT as part of the diagnostic workup of native valve endocarditis: A case report.
    J Nucl Cardiol. 2021 Nov 17. pii: 10.1007/s12350-021-02849.
    PubMed    


  617. POITRASSON-RIVIERE A, Moody JB, Renaud JM, Hagio T, et al
    Impact of residual subtraction on myocardial blood flow and reserve estimates from rapid dynamic PET protocols.
    J Nucl Cardiol. 2021 Nov 15. pii: 10.1007/s12350-021-02837.
    PubMed     Abstract available


  618. GAO D, Tavoosi A, Wiefels C, Merani A, et al
    Data-driven motion correction rescues interpretation of rubidium PET scan with extreme breathing artifacts.
    J Nucl Cardiol. 2021 Nov 12. pii: 10.1007/s12350-021-02814.
    PubMed    


  619. XI XY, Liu Z, Wang LF, Yang MF, et al
    Prognostic value of cardiac inflammation in ST-segment elevation myocardial infarction: A (18)F-fluorodeoxyglucose PET/CT study.
    J Nucl Cardiol. 2021 Nov 12. pii: 10.1007/s12350-021-02858.
    PubMed     Abstract available


  620. HAN D, Rozanski A, Gransar H, Tzolos E, et al
    Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry.
    J Nucl Cardiol. 2021 Nov 10. pii: 10.1007/s12350-021-02810.
    PubMed     Abstract available


  621. LIANG HX, Yang YL, Ren JY, Xie Z, et al
    Right atrial angiosarcoma detected with (13)N-NH3 myocardial PET/CT and (18)F-FDG PET/CT.
    J Nucl Cardiol. 2021 Nov 8. pii: 10.1007/s12350-021-02850.
    PubMed    


  622. PUDIS M, Gracia-Sanchez L, Munoz-Palomar A, Sanchez-Rodriguez IE, et al
    Richter's transformation with isolated cardiac involvement diagnosed by 2-[(18)F]FDG PET/CT scan.
    J Nucl Cardiol. 2021 Nov 8. pii: 10.1007/s12350-021-02845.
    PubMed    


    October 2021
  623. WAHADAT AR, Tanis W, Mulders TA, Graven LH, et al
    Normal imaging findings after ascending aorta prosthesis implantation on (18)F-Fluorodeoxyglucose Positron Emission Tomography with computed tomography.
    J Nucl Cardiol. 2021 Oct 27. pii: 10.1007/s12350-021-02826.
    PubMed     Abstract available


  624. LIU H, Wu J, Shi L, Liu Y, et al
    Post-reconstruction attenuation correction for SPECT myocardium perfusion imaging facilitated by deep learning-based attenuation map generation.
    J Nucl Cardiol. 2021 Oct 20. pii: 10.1007/s12350-021-02817.
    PubMed     Abstract available


  625. MISTRY NP, AlShaheen M, Leung E, Chow B, et al
    Previous BioGlue repair mimicking cardiac infection with (18)F-FDG PET imaging.
    J Nucl Cardiol. 2021 Oct 19. pii: 10.1007/s12350-021-02807.
    PubMed    


  626. ELWAZIR MY, Chareonthaitawee P
    Can we REFINE stress-only SPECT MPI protocols using machine learning?
    J Nucl Cardiol. 2021 Oct 19. pii: 10.1007/s12350-021-02822.
    PubMed    


  627. KATO S, Aikawa T, Ibe T, Manabe O, et al
    Delayed (18)F-fluorodeoxyglucose PET/CT imaging improves detection of cardiac involvement in sarcoidosis.
    J Nucl Cardiol. 2021 Oct 17. pii: 10.1007/s12350-021-02815.
    PubMed    


  628. WERNER RA, Rowe SP, Higuchi T
    No major impact of prescribed CAD drugs on myocardial perfusion uptake derived by [(82)]rubidium PET.
    J Nucl Cardiol. 2021 Oct 5. pii: 10.1007/s12350-021-02786.
    PubMed    


  629. BENTSEN S, Bang LE, Hasbak P, Kjaer A, et al
    Amiodarone attenuates cardiac Rubidium-82 in consecutive PET/CT scans in a rodent model.
    J Nucl Cardiol. 2021 Oct 5. pii: 10.1007/s12350-021-02785.
    PubMed     Abstract available


  630. DIVAKARAN S, Blankstein R
    FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis.
    J Nucl Cardiol. 2021 Oct 4. pii: 10.1007/s12350-021-02809.
    PubMed    


  631. ROSHANKAR G, White GC, Cadet S, Fine NM, et al
    Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.
    J Nucl Cardiol. 2021 Oct 3. pii: 10.1007/s12350-021-02806.
    PubMed     Abstract available


  632. HASNIE UA, Hawi R, Andrikopoulou E, Iskandrian AE, et al
    Stress testing and myocardial perfusion imaging for patients after recovery from severe COVID-19 infection requiring hospitalization: A single-center experience.
    J Nucl Cardiol. 2021;28:2167-2173.
    PubMed     Abstract available


  633. DELABIE P, Hyafil F
    Increased lung signal as a hint of COVID-19 infection on Tc-99m-sestamibi myocardial perfusion scintigraphy.
    J Nucl Cardiol. 2021;28:2384-2385.
    PubMed    


  634. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2021;28:1817-1819.
    PubMed     Abstract available


  635. RUIZ N, Bhambhvani P, Iskandrian AE, Hage FG, et al
    Cases from a busy nuclear cardiology laboratory.
    J Nucl Cardiol. 2021;28:2362-2369.
    PubMed    


  636. NIEVES RA, Bukhari S, Harinstein ME
    Adding value to myocardial perfusion scintigraphy: A prediction tool to predict adverse cardiac outcomes and risk stratify.
    J Nucl Cardiol. 2021;28:2283-2285.
    PubMed    


  637. PRISTERA N, Bhargava A
    Tricked by transient ischemic dilation: A case of hypertrophic cardiomyopathy.
    J Nucl Cardiol. 2021;28:2415-2418.
    PubMed    


  638. THAKKAR HV, Cheng M, Better N
    "False-positive" Myocardial Perfusion Scan in a patient presenting with sickle cell crisis.
    J Nucl Cardiol. 2021;28:2412-2414.
    PubMed    


  639. MEDEPALLI LC, Medepalli VM, Scully TA
    The complementary nature of multimodal imaging in the management of an anomalous aortic origin of the right coronary artery from the left coronary cusp.
    J Nucl Cardiol. 2021;28:2399-2402.
    PubMed     Abstract available


  640. ASIF T, Lee Chuy K, Malhotra S
    Asystole following Regadenoson administration: Review of literature, risk factors and management.
    J Nucl Cardiol. 2021;28:2046-2055.
    PubMed     Abstract available


  641. MURRAY CSG, Moadel RM, Tauras JM, Zamora E, et al
    A potential pitfall in the use of (99m)Tc-PYP imaging for diagnosing cardiac ATTR amyloidosis.
    J Nucl Cardiol. 2021;28:2395-2398.
    PubMed    


  642. EL-TALLAWI KC, Parikh R, Nabi F, Maclayton PI, et al
    A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis.
    J Nucl Cardiol. 2021;28:2390-2394.
    PubMed    


  643. NORIKANE T, Yamamoto Y, Kengo F, Takami Y, et al
    Hypertrophic cardiomyopathy incidentally detected by 99mTc-HAS-D scintigraphy.
    J Nucl Cardiol. 2021;28:2374-2378.
    PubMed    


  644. SUCCAR C, Zgheib A, Dakik HA
    Coronary microvascular dysfunction post acute myocardial infarction.
    J Nucl Cardiol. 2021;28:2370-2373.
    PubMed    


  645. DUNN TS 2ND, Hage FG
    Stress myocardial perfusion imaging: Can we tell the results without doing the test?
    J Nucl Cardiol. 2021;28:1903-1905.
    PubMed    


  646. HUANG X, D'Addabbo J, Nguyen PK
    Coronary artery calcification: More than meets the eye.
    J Nucl Cardiol. 2021;28:2215-2219.
    PubMed    


  647. TAWAKOL A, Fakhri GE, Catana C, Sosnovik DE, et al
    Advances in cardiac PET/MR imaging: Facilitating cutting-edge structural and biological phenotyping of the cardiovascular system.
    J Nucl Cardiol. 2021;28:2026-2029.
    PubMed    


  648. WELLS RG, Klein R
    Dynamic phantoms: Making the right tool for the job.
    J Nucl Cardiol. 2021;28:2310-2312.
    PubMed    


  649. JUNEAU D, Pelletier-Galarneau M
    Revisiting the relevance of the 3-month safety period in the evaluation of prosthetic valve endocarditis with FDG-PET/CT.
    J Nucl Cardiol. 2021;28:2269-2271.
    PubMed    


  650. SCHWARTZ RG, Vidula H
    2020 vision: New insights on hypoxia imaging to assess cardiac and extra-cardiac active inflammatory sarcoidosis.
    J Nucl Cardiol. 2021;28:2149-2150.
    PubMed    


  651. LASSEN ML, Slomka PJ
    Cardiac PET/MR: Are sophisticated attenuation correction techniques necessary for clinical routine assessments?
    J Nucl Cardiol. 2021;28:2205-2206.
    PubMed    


  652. GEWIRTZ H
    PET (18)F-flurpridaz quantitative measurements of myocardial blood flow: Added value for diagnosis of coronary artery disease? Of course!
    J Nucl Cardiol. 2021;28:2330-2334.
    PubMed    


  653. LI X, Yang W, Ma W, Zhou X, et al
    (18)F-FDG PET imaging-monitored anti-inflammatory therapy for acute myocardial infarction: Exploring the role of MCC950 in murine model.
    J Nucl Cardiol. 2021;28:2346-2357.
    PubMed     Abstract available


  654. MOODY JB, Poitrasson-Riviere A, Hagio T, Buckley C, et al
    Added value of myocardial blood flow using (18)F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial.
    J Nucl Cardiol. 2021;28:2313-2329.
    PubMed     Abstract available


  655. KIKO T, Yokokawa T, Misaka T, Masuda A, et al
    Myocardial viability with chronic total occlusion assessed by hybrid positron emission tomography/magnetic resonance imaging.
    J Nucl Cardiol. 2021;28:2335-2342.
    PubMed     Abstract available


  656. KRAKOVICH A, Zaretsky U, Moalem I, Naimushin A, et al
    A new cardiac phantom for dynamic SPECT.
    J Nucl Cardiol. 2021;28:2299-2309.
    PubMed     Abstract available


  657. CHIH S, Chong AY, Bernick J, Wells GA, et al
    Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance.
    J Nucl Cardiol. 2021;28:2286-2298.
    PubMed     Abstract available


  658. DEN HARDER AM, Wolterink JM, Bartstra JW, Spiering W, et al
    Vascular uptake on (18)F-sodium fluoride positron emission tomography: precursor of vascular calcification?
    J Nucl Cardiol. 2021;28:2244-2254.
    PubMed     Abstract available


  659. ROQUE A, Pizzi MN
    18F-FDG PET/CT and cardiac CTA in transcatheter aortic valve implanted endocarditis: Still at the beginning of a long road.
    J Nucl Cardiol. 2021;28:2083-2085.
    PubMed    


  660. WAHADAT AR, Tanis W, Scholtens AM, Bekker M, et al
    Normal imaging findings after aortic valve implantation on (18)F-Fluorodeoxyglucose positron emission tomography with computed tomography.
    J Nucl Cardiol. 2021;28:2258-2268.
    PubMed     Abstract available


  661. TREGLIA G, Slart RHJA, Glaudemans AWJM
    Diagnostic performance and image interpretation of (18)F-FDG PET/CT in aortic graft infection: Two sides of the same coin.
    J Nucl Cardiol. 2021;28:2229-2232.
    PubMed    


  662. MENG J, Zhao H, Liu Y, Chen D, et al
    Assessment of cardiac tumors by (18)F-FDG PET/CT imaging: Histological correlation and clinical outcomes.
    J Nucl Cardiol. 2021;28:2233-2243.
    PubMed     Abstract available


  663. EINSPIELER I, Mergen V, Wendorff H, Haller B, et al
    Diagnostic performance of quantitative and qualitative parameters for the diagnosis of aortic graft infection using [(18)F]-FDG PET/CT.
    J Nucl Cardiol. 2021;28:2220-2228.
    PubMed     Abstract available


  664. ROBSON PM, Vergani V, Benkert T, Trivieri MG, et al
    Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR.
    J Nucl Cardiol. 2021;28:2194-2204.
    PubMed     Abstract available


  665. HSU JJ, Fong F, Patel R, Qiao R, et al
    Changes in microarchitecture of atherosclerotic calcification assessed by (18)F-NaF PET and CT after a progressive exercise regimen in hyperlipidemic mice.
    J Nucl Cardiol. 2021;28:2207-2214.
    PubMed     Abstract available


  666. BLOOM SA, Thompson RC
    The way to the heart is through the stomach; PPI's, aspirin, and gastric radiotracer activity.
    J Nucl Cardiol. 2021;28:1986-1987.
    PubMed    


  667. BELLINGE JW, Schultz CJ
    Optimizing arterial (18)F-sodium fluoride positron emission tomography analysis.
    J Nucl Cardiol. 2021;28:1887-1890.
    PubMed    


  668. MOTWANI M
    Hiding beyond plain sight: Textural analysis of positron emission tomography to identify high-risk plaques in carotid atherosclerosis.
    J Nucl Cardiol. 2021;28:1872-1874.
    PubMed    


  669. SYED MBJ, Fletcher AJ, Dweck MR
    Imaging cellular activity and proliferation in the aortic wall.
    J Nucl Cardiol. 2021;28:1972-1975.
    PubMed    


  670. KAFOURIS PP, Koutagiar IP, Georgakopoulos AT, Spyrou GM, et al
    Fluorine-18 fluorodeoxyglucose positron emission tomography-based textural features for prediction of event prone carotid atherosclerotic plaques.
    J Nucl Cardiol. 2021;28:1861-1871.
    PubMed     Abstract available


  671. MEGNA R, Assante R, Zampella E, Gaudieri V, et al
    Pretest models for predicting abnormal stress single-photon emission computed tomography myocardial perfusion imaging.
    J Nucl Cardiol. 2021;28:1891-1902.
    PubMed     Abstract available


  672. MA Q, Sridhar G, Power T, Agiro A, et al
    Assessing the downstream value of first-line cardiac positron emission tomography (PET) imaging using real world Medicare fee-for-service claims data.
    J Nucl Cardiol. 2021;28:2126-2137.
    PubMed     Abstract available


  673. ROBERTS G, Lloyd JJ, Jefferson E, Kane JPM, et al
    Uniformity of cardiac (123)I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia.
    J Nucl Cardiol. 2021;28:2151-2163.
    PubMed     Abstract available


  674. FURUYA S, Naya M, Manabe O, Hirata K, et al
    (18)F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.
    J Nucl Cardiol. 2021;28:2141-2148.
    PubMed     Abstract available


  675. BAJAJ NS, Bhambhvani P
    SPECT-derived absolute myocardial perfusion measures: A step in the right direction.
    J Nucl Cardiol. 2021;28:1919-1922.
    PubMed    


  676. SHARMA V, Mughal L, Dimitropoulos G, Sheikh A, et al
    The additive prognostic value of coronary calcium score (CCS) to single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI)-real world data from a single center.
    J Nucl Cardiol. 2021;28:2086-2096.
    PubMed     Abstract available


  677. PYSLAR N, Doukky R
    Myocardial perfusion imaging and coronary calcium score: A marriage made in heaven.
    J Nucl Cardiol. 2021;28:2097-2099.
    PubMed    


  678. PRATO FS, Wisenberg G
    Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using (18)F-florbetapir PET/CT.
    J Nucl Cardiol. 2021;28:2011-2013.
    PubMed    


  679. TOCZEK J
    Evolution of arterial [(18)F]-sodium fluoride uptake and calcification.
    J Nucl Cardiol. 2021;28:1946-1948.
    PubMed    


  680. WAHADAT AR, Tanis W, Swart LE, Scholtens A, et al
    Added value of (18)F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis.
    J Nucl Cardiol. 2021;28:2072-2082.
    PubMed     Abstract available


  681. PECLAT TR, de Souza ACDAH, Souza VF, Nakamoto AMK, et al
    The additional prognostic value of myocardial perfusion SPECT in patients with known coronary artery disease with high exercise capacity.
    J Nucl Cardiol. 2021;28:2056-2066.
    PubMed     Abstract available


  682. ANDREWS JPM, MacNaught G, Moss AJ, Doris MK, et al
    Cardiovascular (18)F-fluoride positron emission tomography-magnetic resonance imaging: A comparison study.
    J Nucl Cardiol. 2021;28:1-12.
    PubMed     Abstract available


  683. CHO SG, Kim HY, Bom HS
    What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?
    J Nucl Cardiol. 2021;28:1958-1960.
    PubMed    


  684. NODOUSHANI A, El-Sady MS, Park MA, Castilloveitia GL, et al
    Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using (18)F-Florbetapir PET/CT.
    J Nucl Cardiol. 2021;28:2004-2010.
    PubMed     Abstract available


  685. AIMO A, Gimelli A
    Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question.
    J Nucl Cardiol. 2021;28:1933-1935.
    PubMed    


  686. NAKAHARA T, Narula J, Fox JJ, Jinzaki M, et al
    Temporal relationship between (18)F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification.
    J Nucl Cardiol. 2021;28:1936-1945.
    PubMed     Abstract available


  687. MINUTOLI F, Di Bella G, Mazzeo A, Laudicella R, et al
    Serial scanning with (99m)Tc-3, 3-diphosphono-1, 2-propanodicarboxylic acid ((99m)Tc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation.
    J Nucl Cardiol. 2021;28:1949-1957.
    PubMed     Abstract available


  688. RASMUSSEN T, Kjaer A, Lassen ML, Pedersen AN, et al
    No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study.
    J Nucl Cardiol. 2021;28:1923-1932.
    PubMed     Abstract available


  689. GANDHI R, Cawthorne C, Craggs LJL, Wright JD, et al
    Cell proliferation detected using [(18)F]FLT PET/CT as an early marker of abdominal aortic aneurysm.
    J Nucl Cardiol. 2021;28:1961-1971.
    PubMed     Abstract available


  690. ROSE DS, Robinson B, Kannan S, Lee JC, et al
    Interaction between the effects of proton pump inhibitors and aspirin on gastric wall sestamibi uptake on myocardial perfusion imaging.
    J Nucl Cardiol. 2021;28:1976-1985.
    PubMed     Abstract available


  691. GIUBBINI R, Bertoli M, Durmo R, Bonacina M, et al
    Comparison between N(13)NH3-PET and (99m)Tc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve.
    J Nucl Cardiol. 2021;28:1906-1918.
    PubMed     Abstract available


  692. AKERELE MI, Karakatsanis NA, Forsythe RO, Dweck MR, et al
    Iterative reconstruction incorporating background correction improves quantification of [(18)F]-NaF PET/CT images of patients with abdominal aortic aneurysm.
    J Nucl Cardiol. 2021;28:1875-1886.
    PubMed     Abstract available


  693. KAWAGUCHI N, Okayama H, Kido T, Fukuyama N, et al
    Clinical significance of corrected relative flow reserve derived from (13)N-ammonia positron emission tomography combined with coronary computed tomography angiography.
    J Nucl Cardiol. 2021;28:1851-1860.
    PubMed     Abstract available


    September 2021
  694. JOHNSON NP, Gould KL
    How shall we judge a PET flow model?
    J Nucl Cardiol. 2021 Sep 24. pii: 10.1007/s12350-021-02805.
    PubMed    


  695. SPERRY BW
    Opportunities to improve image quality in PET myocardial viability imaging in diabetics.
    J Nucl Cardiol. 2021 Sep 13. pii: 10.1007/s12350-021-02792.
    PubMed    


  696. CALNON DA
    Noninvasive surveillance for cardiac allograft vasculopathy following heart transplantation: One of several emerging clinical applications for cardiac positron emission tomography with assessment of myocardial blood flow reserve.
    J Nucl Cardiol. 2021 Sep 13. pii: 10.1007/s12350-021-02776.
    PubMed    


  697. REIJRINK M, de Boer SA, Te Velde-Keyzer CA, Sluiter JKE, et al
    [(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus.
    J Nucl Cardiol. 2021 Sep 13. pii: 10.1007/s12350-021-02781.
    PubMed     Abstract available


  698. IUCCI G, Bullock-Palmer RP
    What is this image? 2021 image 2 result : The use of 99m technetium-pyrophosphate planar imaging to guide the diagnosis of cardiac amyloidosis.
    J Nucl Cardiol. 2021 Sep 9. pii: 10.1007/s12350-021-02783.
    PubMed    


  699. HAGE FG
    Is SPECT myocardial perfusion imaging on its dying bed?
    J Nucl Cardiol. 2021 Sep 9. pii: 10.1007/s12350-021-02803.
    PubMed    


  700. PATEL VN, Pieper JA, Poitrasson-Riviere A, Kopin D, et al
    The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
    J Nucl Cardiol. 2021 Sep 9. pii: 10.1007/s12350-021-02780.
    PubMed     Abstract available


  701. SCHULTZ J, Siekkinen R, Tadi MJ, Teras M, et al
    Effect of respiratory motion correction and CT-based attenuation correction on dual-gated cardiac PET image quality and quantification.
    J Nucl Cardiol. 2021 Sep 3. pii: 10.1007/s12350-021-02769.
    PubMed     Abstract available


  702. MOUDEN M, Jager PL, van Dalen JA, van Dijk JD, et al
    Added value of coronary artery calcium score in the reporting of SPECT versus PET myocardial perfusion imaging.
    J Nucl Cardiol. 2021 Sep 3. pii: 10.1007/s12350-021-02789.
    PubMed     Abstract available


  703. AHPIN C, de Oliveira Brito JB, Chow B, Leung E, et al
    Aortitis and coronary artery vasculitis of unusual etiology: IgG4-related disease defined by (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET).
    J Nucl Cardiol. 2021 Sep 2. pii: 10.1007/s12350-021-02771.
    PubMed    


    August 2021
  704. POITRASSON-RIVIERE A, Moody JB, Renaud JM, Hagio T, et al
    Effect of iterations and time of flight on normal distributions of (82)Rb PET relative perfusion and myocardial blood flow.
    J Nucl Cardiol. 2021 Aug 26. pii: 10.1007/s12350-021-02775.
    PubMed     Abstract available


  705. MATSUMOTO N, Suzuki Y, Okumura Y
    Myocardial scar reduction after cardiac resynchronization therapy assessed by gated myocardial perfusion SPECT.
    J Nucl Cardiol. 2021 Aug 24. pii: 10.1007/s12350-021-02787.
    PubMed    


  706. RENAUD JM, Poitrasson-Riviere A, Hagio T, Moody JB, et al
    Myocardial flow reserve estimation with contemporary CZT-SPECT and (99m)Tc-tracers lacks precision for routine clinical application.
    J Nucl Cardiol. 2021 Aug 23. pii: 10.1007/s12350-021-02761.
    PubMed     Abstract available


  707. VAN TOSH A, Cao JJ, Votaw JR, Cooke CD, et al
    Clinical implications of compromised (82)Rb PET data acquisition.
    J Nucl Cardiol. 2021 Aug 20. pii: 10.1007/s12350-021-02774.
    PubMed     Abstract available


  708. NELSON LM, Christensen TE, Rossing K, Hasbak P, et al
    Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantation.
    J Nucl Cardiol. 2021 Aug 19. pii: 10.1007/s12350-021-02742.
    PubMed     Abstract available


  709. CAMONI L, Albano D
    Contrast-enhanced (18)F-FDG PET/CT to differentiate primary cardiac lymphoma from primary cardiac angiosarcoma.
    J Nucl Cardiol. 2021 Aug 19. pii: 10.1007/s12350-021-02767.
    PubMed    


  710. WANG CY, Hung GU, Lo HC, Tsai SC, et al
    Clinical impacts of scar reduction on gated myocardial perfusion SPECT after cardiac resynchronization therapy.
    J Nucl Cardiol. 2021 Aug 19. pii: 10.1007/s12350-021-02722.
    PubMed     Abstract available


  711. NESTEROV SV, Sciagra R, Orozco LEJ, Prior JO, et al
    One-tissue compartment model for myocardial perfusion quantification with N-13 ammonia PET provides matching results: A cross-comparison between Carimas, FlowQuant, and PMOD.
    J Nucl Cardiol. 2021 Aug 18. pii: 10.1007/s12350-021-02741.
    PubMed     Abstract available


  712. FREY SM, Honegger U, Clerc OF, Caobelli F, et al
    Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
    J Nucl Cardiol. 2021 Aug 13. pii: 10.1007/s12350-021-02729.
    PubMed     Abstract available


  713. ZOGALA D
    FDG PET in infective endocarditis: There are still horizons to conquer.
    J Nucl Cardiol. 2021 Aug 12. pii: 10.1007/s12350-021-02756.
    PubMed    


  714. HUSSAIN M, Wolinsky D, Collier P, Jaber W, et al
    Exclusive gastric uptake on 99m-Technetium pyrophosphate scanning.
    J Nucl Cardiol. 2021 Aug 12. pii: 10.1007/s12350-021-02762.
    PubMed    


  715. PIRI R, Edenbrandt L, Larsson M, Enqvist O, et al
    "Global" cardiac atherosclerotic burden assessed by artificial intelligence-based versus manual segmentation in (18)F-sodium fluoride PET/CT scans: Head-to-head comparison.
    J Nucl Cardiol. 2021 Aug 12. pii: 10.1007/s12350-021-02758.
    PubMed     Abstract available


  716. ABADIE B, Jaber W
    Dobutamine stress PET/CT for assessment of hemodynamic significance of coronary myocardial bridges.
    J Nucl Cardiol. 2021 Aug 5. pii: 10.1007/s12350-021-02759.
    PubMed     Abstract available


  717. PANJER M, Dobrolinska M, Wagenaar NRL, Slart RHJA, et al
    Diagnostic accuracy of dynamic CZT-SPECT in coronary artery disease. A systematic review and meta-analysis.
    J Nucl Cardiol. 2021 Aug 4. pii: 10.1007/s12350-021-02721.
    PubMed     Abstract available


  718. CANTONI V, Green R, D'Antonio A, Cuocolo A, et al
    Dynamic CZT-SPECT in coronary artery disease: Where are we now?
    J Nucl Cardiol. 2021 Aug 4. pii: 10.1007/s12350-021-02752.
    PubMed    


  719. LEHNER S, Nowak I, Zacherl M, Brosch-Lenz J, et al
    Quantitative myocardial perfusion SPECT/CT for the assessment of myocardial tracer uptake in patients with three-vessel coronary artery disease: Initial experiences and results.
    J Nucl Cardiol. 2021 Aug 2. pii: 10.1007/s12350-021-02735.
    PubMed     Abstract available


  720. GARCIA EV
    Artificial intelligence in nuclear cardiology: Preparing for the fifth industrial revolution.
    J Nucl Cardiol. 2021;28:1199-1202.
    PubMed    


  721. BHAMBHVANI P, Hage FG, Iskandrian AE
    A quick glance at selected topics in this issue.
    J Nucl Cardiol. 2021;28:1204-1206.
    PubMed     Abstract available


  722. THOMPSON RC
    ASNC and the new world of medical education: A glimpse of the future.
    J Nucl Cardiol. 2021;28:1809-1811.
    PubMed    


  723. ISKANDRIAN AE
    Changes in the Journal.
    J Nucl Cardiol. 2021;28:1203.
    PubMed    


  724. SHARAIN K, AbouEzzeddine OF, Homb A, Chareonthaitawee P, et al
    Cardiac sarcoidosis cases from a busy nuclear cardiology laboratory.
    J Nucl Cardiol. 2021;28:1553-1568.
    PubMed    


  725. ASSANTE R, Mainolfi CG, Zampella E, Gaudieri V, et al
    Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging.
    J Nucl Cardiol. 2021;28:1222-1233.
    PubMed     Abstract available


  726. LIU H, Thorn S, Wu J, Fazzone-Chettiar R, et al
    Quantification of myocardial blood flow (MBF) and reserve (MFR) incorporated with a novel segmentation approach: Assessments of quantitative precision and the lower limit of normal MBF and MFR in patients.
    J Nucl Cardiol. 2021;28:1236-1248.
    PubMed     Abstract available


  727. SIOKA C, Nikas D, Tsoumani A, Kiortsis DN, et al
    Transient myocardial ischemia due to corticosteroid use in a patient with multiple sclerosis diagnosed with myocardial perfusion imaging.
    J Nucl Cardiol. 2021;28:1805-1808.
    PubMed    


  728. HUTT E, Hachamovitch R, Jaber WA
    The Mediastinum is LIT.
    J Nucl Cardiol. 2021;28:1802-1804.
    PubMed    


  729. KHALAF S, Khan N, Al-Mallah M, Kassi M, et al
    A positive PYP scan: Thinking beyond amyloid.
    J Nucl Cardiol. 2021;28:1796-1797.
    PubMed    


  730. IMBERT L, Perrin M, Claudin M, Boursier C, et al
    High quality attenuation-corrected myocardial perfusion images may be achieved in patients with morbid obesity using a whole-body CZT camera and a low-dose injection protocol.
    J Nucl Cardiol. 2021;28:1791-1792.
    PubMed    


  731. MARINHO AV, Ferreira MJ, Silva R, Elvas L, et al
    The culprit was inside myocardium.
    J Nucl Cardiol. 2021;28:1785-1787.
    PubMed    


  732. YANDRAPALLI S, Malik A, Jain D
    SPECT myocardial perfusion imaging-based ischemia-guided early coronary revascularization improves survival: More fuel to the fire.
    J Nucl Cardiol. 2021;28:1688-1691.
    PubMed    


  733. GOMEZ J
    Left ventricular myocardial volume in CZT SPECT: Expanding the horizon?
    J Nucl Cardiol. 2021;28:1634-1635.
    PubMed    


  734. MARIE PY, Manrique A
    Myocardial revascularization driven by functional testing and PET imaging.
    J Nucl Cardiol. 2021;28:1673-1675.
    PubMed    


  735. SHARIR T, Hollander I, Hemo B, Tsamir J, et al
    Survival benefit of coronary revascularization after myocardial perfusion SPECT: The role of ischemia.
    J Nucl Cardiol. 2021;28:1676-1687.
    PubMed     Abstract available


  736. BENETOS G, Giannopoulos AA
    Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
    J Nucl Cardiol. 2021;28:1757-1759.
    PubMed    


  737. JOHNSON NP, Gould KL
    Potential errors in interpreting hibernation due to FDG scaling?
    J Nucl Cardiol. 2021;28:1740-1744.
    PubMed    


  738. CADE WT, Laforest R, Bohnert KL, Reeds DN, et al
    Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome.
    J Nucl Cardiol. 2021;28:1649-1659.
    PubMed     Abstract available


  739. AKIL S, Hedeer F, Oddstig J, Olsson T, et al
    Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decision.
    J Nucl Cardiol. 2021;28:1664-1672.
    PubMed     Abstract available


  740. BORCHERT T, Beitar L, Langer LBN, Polyak A, et al
    Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals.
    J Nucl Cardiol. 2021;28:1636-1645.
    PubMed     Abstract available


  741. GIMELLI A, Pugliese NR, Buechel RR, Bertasi M, et al
    Changes in left ventricle myocardial volume during stress test using cadmium-zinc-telluride cardiac imaging: Implications in coronary artery disease.
    J Nucl Cardiol. 2021;28:1623-1633.
    PubMed     Abstract available


  742. POITRASSON-RIVIERE A, Murthy VL
    Optimizing accuracy and precision with motion correction of PET myocardial blood flow measurements.
    J Nucl Cardiol. 2021;28:1726-1729.
    PubMed    


  743. NAPPI C, Gaudieri V, Cuocolo A
    Computed tomography calls out nuclear imaging in its field: It doesn't matter how you are searching but what you are looking for.
    J Nucl Cardiol. 2021;28:1715-1717.
    PubMed    


  744. GROSSMAN GB, Baptista IS
    Quantitative analysis: Specific normal database for the best practice.
    J Nucl Cardiol. 2021;28:1294-1297.
    PubMed    


  745. COLON CM, Marshell RL, Roth CP, Farag AA, et al
    The prognostic value of myocardial perfusion imaging in patients with type 2 myocardial infarction.
    J Nucl Cardiol. 2021;28:1611-1620.
    PubMed     Abstract available


  746. KOYANAGAWA K, Naya M, Aikawa T, Manabe O, et al
    The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.
    J Nucl Cardiol. 2021;28:1745-1756.
    PubMed     Abstract available


  747. DEGTIAROVA G, Claus P, Duchenne J, Schramm G, et al
    Impact of left bundle branch block on myocardial perfusion and metabolism: A positron emission tomography study.
    J Nucl Cardiol. 2021;28:1730-1739.
    PubMed     Abstract available


  748. BING R, Dweck MR
    Aortic valve and coronary 18F-sodium fluoride activity: a common cause?
    J Nucl Cardiol. 2021;28:1532-1535.
    PubMed    


  749. OTAKI Y, Lassen ML, Manabe O, Eisenberg E, et al
    Short-term repeatability of myocardial blood flow using (82)Rb PET/CT: The effect of arterial input function position and motion correction.
    J Nucl Cardiol. 2021;28:1718-1725.
    PubMed     Abstract available


  750. PUGLIESE NR, Gimelli A
    Men are from Mars and women are from Venus: The nuclear cardiology point of view.
    J Nucl Cardiol. 2021;28:1583-1585.
    PubMed    


  751. EL MAHDIUI M, Smit JM, van Rosendael AR, Jukema JW, et al
    Relationship between coronary artery calcification and myocardial ischemia on computed tomography myocardial perfusion in patients with stable chest pain.
    J Nucl Cardiol. 2021;28:1707-1714.
    PubMed     Abstract available


  752. BOKHARI S, Schneider RH, Salerno JW, Rainforth MV, et al
    Effects of cardiac rehabilitation with and without meditation on myocardial blood flow using quantitative positron emission tomography: A pilot study.
    J Nucl Cardiol. 2021;28:1596-1607.
    PubMed     Abstract available


  753. ABULIZI M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, et al
    (18)F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis.
    J Nucl Cardiol. 2021;28:1586-1595.
    PubMed     Abstract available


  754. ATHAR MW, Waqar F, Dwivedi AK, Ahmad S, et al
    Effects of gender and defect reversibility on detection of coronary disease with an upright and supine cadmium-zinc-telluride camera.
    J Nucl Cardiol. 2021;28:1569-1582.
    PubMed     Abstract available


  755. VAN DIJK JD, Dotinga M, Jager PL, Slump CH, et al
    Body weight-dependent Rubidium-82 activity results in constant image quality in myocardial perfusion imaging with PET.
    J Nucl Cardiol. 2021;28:1536-1544.
    PubMed     Abstract available


  756. KAMANI CH, Prior JO
    Assessment of myocardial viability using a [(15)O]-water perfusion PET: Towards a one-stop shop?
    J Nucl Cardiol. 2021;28:1281-1283.
    PubMed    


  757. CUDDY-WALSH SG, Wells RG
    Noise heterogeneity in attenuation-corrected cardiac SPECT images increases perfusion value uncertainty near the base of the heart.
    J Nucl Cardiol. 2021;28:1284-1293.
    PubMed     Abstract available


  758. GRONMAN M, Tarkia M, Stark C, Vahasilta T, et al
    Assessment of myocardial viability with [(15)O]water PET: A validation study in experimental myocardial infarction.
    J Nucl Cardiol. 2021;28:1271-1280.
    PubMed     Abstract available


  759. GEWIRTZ H
    CMR quantitative measurements of myocardial blood flow: Not ready for routine clinical application.
    J Nucl Cardiol. 2021;28:1267-1270.
    PubMed    


  760. KERO T, Johansson E, Engstrom M, Eggers KM, et al
    Evaluation of quantitative CMR perfusion imaging by comparison with simultaneous (15)O-water-PET.
    J Nucl Cardiol. 2021;28:1252-1266.
    PubMed     Abstract available


  761. DUVALL WL, Case J, Lundbye J, Cerqueira M, et al
    Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature.
    J Nucl Cardiol. 2021;28:1381-1394.
    PubMed     Abstract available


  762. SLOMKA P
    Do we need dedicated cardiac SPECT systems?
    J Nucl Cardiol. 2021;28:1331-1333.
    PubMed    


  763. WINCHESTER DE, Shaw LJ
    The importance of the patient's voice in nuclear cardiology.
    J Nucl Cardiol. 2021;28:1519-1521.
    PubMed    


  764. PUCAR D, Liu C
    Standardization and quantification is a key to the future of atherosclerosis FDG PET/CT imaging.
    J Nucl Cardiol. 2021;28:1360-1363.
    PubMed    


  765. GAUDIERI V, Nappi C, Petretta M
    Radionuclide imaging of jeopardized myocardium: From the beginning of the race to the finish line.
    J Nucl Cardiol. 2021;28:1435-1437.
    PubMed    


  766. LASSEN ML, Slomka PJ
    Myocardial blood flow: Is motion correction necessary?
    J Nucl Cardiol. 2021;28:1347-1348.
    PubMed    


  767. VERBERNE HJ, Verschure DO
    How to best appreciate the possible clinical role of cardiac (123)I-mIBG scintigraphy in heart failure patients: Trying not to get lost while going in the right direction!
    J Nucl Cardiol. 2021;28:1504-1506.
    PubMed    


  768. PELLETIER-GALARNEAU M, Ruddy TD
    A big step towards clinical implementation of myocardial blood flow quantification with CZT SPECT.
    J Nucl Cardiol. 2021;28:1487-1489.
    PubMed    


  769. CANTONI V, Assante R, Cuocolo A
    (18)F-sodium fluoride: An old tracer with a new promising clinical application.
    J Nucl Cardiol. 2021;28:1474-1476.
    PubMed    


  770. ROMERO-FARINA G, Aguade-Bruix S
    Equilibrium radionuclide angiography: Present and future.
    J Nucl Cardiol. 2021;28:1315-1322.
    PubMed    


  771. NAKAMOTO Y, Kitagawa T, Sasaki K, Tatsugami F, et al
    Clinical implications of (18)F-sodium fluoride uptake in subclinical aortic valve calcification: Its relation to coronary atherosclerosis and its predictive value.
    J Nucl Cardiol. 2021;28:1522-1531.
    PubMed     Abstract available


  772. VERSCHURE DO, Verberne HJ
    Gated SPECT MPI and CT venography fusion: A new approach for appropriate CRT-pacemaker lead placement?
    J Nucl Cardiol. 2021;28:1446-1448.
    PubMed    


  773. LI J, Walker DR, Biesbrock G, Kristy RM, et al
    Factors that impact a patient's experience when undergoing single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in the US: A survey of patients, imaging center staff, and physicians.
    J Nucl Cardiol. 2021;28:1507-1518.
    PubMed     Abstract available


  774. AGOSTINI D, Ananthasubramaniam K, Chandna H, Friberg L, et al
    Prognostic usefulness of planar (123)I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF.
    J Nucl Cardiol. 2021;28:1490-1503.
    PubMed     Abstract available


  775. OTAKI Y, Manabe O, Miller RJH, Manrique A, et al
    Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with (15)O-water PET.
    J Nucl Cardiol. 2021;28:1477-1486.
    PubMed     Abstract available


  776. TADA T, Osuda K, Nakata T, Muranaka I, et al
    A novel approach to the selection of an appropriate pacing position for optimal cardiac resynchronization therapy using CT coronary venography and myocardial perfusion imaging: FIVE STaR method (fusion image using CT coronary venography and perfusion
    J Nucl Cardiol. 2021;28:1438-1445.
    PubMed     Abstract available


  777. NICHOLS KJ, Gecelter R, Van Tosh A
    Balancing risks and rewards in assessing pediatric heart disease.
    J Nucl Cardiol. 2021;28:1409-1412.
    PubMed    


  778. YOSHIDA R, Takagi K, Ishii H, Morishima I, et al
    Myocardial salvage after ST-segment-elevation myocardial infarction: comparison between prasugrel and clopidogrel in the presence or absence of high-residual platelet reactivity.
    J Nucl Cardiol. 2021;28:1422-1434.
    PubMed     Abstract available


  779. ALEXANDERSON-ROSAS E, Espinola-Zavaleta N, Garcia EV, Peix A, et al
    Diastolic dyssynchrony assessment by gated myocardial perfusion-SPECT in subjects who underwent cardiac resynchronization therapy.
    J Nucl Cardiol. 2021;28:1413-1421.
    PubMed     Abstract available


  780. PARTINGTON SL, Valente AM, Bruyere J Jr, Rosica D, et al
    Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease.
    J Nucl Cardiol. 2021;28:1395-1408.
    PubMed     Abstract available


  781. MARKENDORF S, Benz DC, Messerli M, Grossmann M, et al
    Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.
    J Nucl Cardiol. 2021;28:1364-1373.
    PubMed     Abstract available


  782. ARMSTRONG IS, Memmott MJ, Saint KJ, Saillant A, et al
    Assessment of motion correction in dynamic rubidium-82 cardiac PET with and without frame-by-frame adjustment of attenuation maps for calculation of myocardial blood flow.
    J Nucl Cardiol. 2021;28:1334-1346.
    PubMed     Abstract available


  783. LAWAL IO, Mokoala KG, Popoola GO, Lengana T, et al
    Impact of optimized PET imaging conditions on (18)F-FDG uptake quantification in patients with apparently normal aortas.
    J Nucl Cardiol. 2021;28:1349-1359.
    PubMed     Abstract available


  784. SILVA MENDES BI, Oliveira-Santos M, Vidigal Ferreira MJ
    Sodium fluoride in cardiovascular disorders: A systematic review.
    J Nucl Cardiol. 2021;28:1461-1473.
    PubMed     Abstract available


  785. SACHPEKIDIS C, Sachpekidis V, Kopp-Schneider A, Arsos G, et al
    Equilibrium radionuclide angiography: Intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function.
    J Nucl Cardiol. 2021;28:1304-1314.
    PubMed     Abstract available


  786. GIMELLI A, Liga R, Bertasi M, Kusch A, et al
    Head-to-head comparison of a CZT-based all-purpose SPECT camera and a dedicated CZT cardiac device for myocardial perfusion and functional analysis.
    J Nucl Cardiol. 2021;28:1323-1330.
    PubMed     Abstract available


    July 2021
  787. SHAO X, Chen Y, Chen Y, Zhang F, et al
    Feasibility and application of trimetazidine in (18)F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: A prospective, self-controlled study.
    J Nucl Cardiol. 2021 Jul 30. pii: 10.1007/s12350-021-02749.
    PubMed     Abstract available


  788. SCHATKA I, Bingel A, Schau F, Bluemel S, et al
    An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis.
    J Nucl Cardiol. 2021 Jul 30. pii: 10.1007/s12350-021-02715.
    PubMed     Abstract available


  789. LIU E, Huang J, Dong H, Chen Z, et al
    Diagnostic challenges in primary cardiac lymphoma, the opportunity of (18)F-FDG PET/CT integrated with contrast-enhanced CT.
    J Nucl Cardiol. 2021 Jul 27. pii: 10.1007/s12350-021-02723.
    PubMed     Abstract available


  790. SPINELLI L
    Left ventricular strain analysis by positron emission tomography: Beyond myocardial perfusion.
    J Nucl Cardiol. 2021 Jul 27. pii: 10.1007/s12350-021-02747.
    PubMed    


  791. VAN DER HEIDEN K, Barrett HE, Meester EJ, van Gaalen K, et al
    SPECT/CT imaging of inflammation and calcification in human carotid atherosclerosis to identify the plaque at risk of rupture.
    J Nucl Cardiol. 2021 Jul 27. pii: 10.1007/s12350-021-02745.
    PubMed     Abstract available


  792. JABER WA, Wang TKM, Cremer PC
    PET/CT for endocarditis in the ACC/AHA 2020 valve guidelines: Ready for prime time?
    J Nucl Cardiol. 2021 Jul 22. pii: 10.1007/s12350-021-02748.
    PubMed    


  793. NG ACT, van Rosendael AR, Bax JJ
    Automated artificial intelligence quantification of aortic atherosclerotic calcifications by 18F-sodium fluoride PET/CT.
    J Nucl Cardiol. 2021 Jul 21. pii: 10.1007/s12350-021-02700.
    PubMed    


  794. HOILUND-CARLSEN PF, Gerke O
    Sources of error with cardiovascular PET/CT and PET/MRI and questions to be answered to achieve clinical usefulness.
    J Nucl Cardiol. 2021 Jul 21. pii: 10.1007/s12350-021-02750.
    PubMed    


  795. SORENSEN J, Nordstrom J, Baron T, Morner S, et al
    Diagnosis of left ventricular hypertrophy using non-ECG-gated (15)O-water PET.
    J Nucl Cardiol. 2021 Jul 20. pii: 10.1007/s12350-021-02734.
    PubMed     Abstract available


  796. LIU J, Yang Y, Wernick MN, Pretorius PH, et al
    Improving detection accuracy of perfusion defect in standard dose SPECT-myocardial perfusion imaging by deep-learning denoising.
    J Nucl Cardiol. 2021 Jul 19. pii: 10.1007/s12350-021-02676.
    PubMed     Abstract available


  797. LEHNER S, Graner FP, Fischer M, Ilhan H, et al
    The assessment of left ventricular mechanical dyssynchrony from gated (99m)Tc-tetrofosmin SPECT and gated (18)F-FDG PET by QGS: a comparative study.
    J Nucl Cardiol. 2021 Jul 19. pii: 10.1007/s12350-021-02737.
    PubMed     Abstract available


  798. LIU FS, Wang SY, Shiau YC, Wu YW, et al
    Integration of quantitative absolute myocardial blood flow estimates from dynamic CZT-SPECT improves the detection of coronary artery disease.
    J Nucl Cardiol. 2021 Jul 8. pii: 10.1007/s12350-021-02713.
    PubMed     Abstract available


  799. EISENBERG E, Miller RJH, Hu LH, Rios R, et al
    Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02698.
    PubMed     Abstract available


  800. BORGES-ROSA J, Oliveira-Santos M, Silva R, Mendes J, et al
    [(18)F]FDG PET-CT in the diagnosis of bacterial pericarditis.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02706.
    PubMed    


  801. YUAN T, Wang X
    (68)Ga-FAPI PET/MRI in Coronary Heart Disease.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02667.
    PubMed    


  802. AHMED AI, Abebe AT, Han Y, Alnabelsi T, et al
    The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02681.
    PubMed     Abstract available


  803. UTRERA-COSTERO A, Bernal-Vergara JC, Olivan-Sasot P, Yepes-Agudelo AM, et al
    The value of (18)F-FDG PET/CT in two cases of Primary Pericardial Mesothelioma.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02690.
    PubMed    


  804. GUPTA K, Dixit P, Ananthasubramaniam K
    Cardiac PET in aortic stenosis: Potential role in risk refinement?
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02714.
    PubMed    


  805. NAGHSHTABRIZI B, Alvandi M, Shaghaghi Z, Hadei SK, et al
    Transient ischemic dilation or transient RV visualization in patients with normal SPECT stress myocardial perfusion imaging: Correlation with CT coronary artery calcium scoring and coronary angiography.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02704.
    PubMed     Abstract available


  806. NORIKANE T, Yamamoto Y, Takami Y, Mitamura K, et al
    Whole-body PET angiography on semiconductor PET/CT.
    J Nucl Cardiol. 2021 Jul 6. pii: 10.1007/s12350-021-02708.
    PubMed    


    June 2021
  807. FANG W, Hsu B
    Myocardial blood flow quantitation with the SPECT technique: Is it ready to be a substitute for PET myocardial blood flow quantitation?
    J Nucl Cardiol. 2021 Jun 27. pii: 10.1007/s12350-021-02697.
    PubMed    


  808. ZERAHN B, Haarmark C
    Cardiac CZT-SPECT: More than left ventricular imaging.
    J Nucl Cardiol. 2021 Jun 24. pii: 10.1007/s12350-021-02701.
    PubMed    


  809. THOMAS M, Spertus JA, Kennedy KF, Thompson RC, et al
    Reasons for discordance between positron emission tomography (PET) myocardial perfusion imaging (MPI) results and subsequent management.
    J Nucl Cardiol. 2021 Jun 24. pii: 10.1007/s12350-021-02695.
    PubMed     Abstract available


  810. PRIMUS CP, Clay TA, McCue MS, Wong K, et al
    (18)F-FDG PET/CT improves diagnostic certainty in native and prosthetic valve Infective Endocarditis over the modified Duke Criteria.
    J Nucl Cardiol. 2021 Jun 24. pii: 10.1007/s12350-021-02689.
    PubMed     Abstract available


  811. KAWAKUBO M, Nagao M, Yamamoto A, Nakao R, et al
    (13)N-ammonia positron emission tomography-derived endocardial strain for the assessment of ischemia using feature-tracking in high-resolution cine imaging.
    J Nucl Cardiol. 2021 Jun 11. pii: 10.1007/s12350-021-02677.
    PubMed     Abstract available


  812. ALJAROUDI WA, Hage FG
    Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.
    J Nucl Cardiol. 2021 Jun 8. pii: 10.1007/s12350-021-02685.
    PubMed     Abstract available


  813. CHEN X, Zhou B, Shi L, Liu H, et al
    CT-free attenuation correction for dedicated cardiac SPECT using a 3D dual squeeze-and-excitation residual dense network.
    J Nucl Cardiol. 2021 Jun 3. pii: 10.1007/s12350-021-02672.
    PubMed     Abstract available


  814. KOOSHKI N, Grambow-Velilla J, Mahida B, Benali K, et al
    Diagnostic performance of White Blood Cell SPECT imaging against intra-operative findings in patients with a suspicion of prosthetic valve endocarditis.
    J Nucl Cardiol. 2021 Jun 3. pii: 10.1007/s12350-021-02674.
    PubMed     Abstract available



  815. CME INSTRUCTIONS: Prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging: A meta-analysis.
    J Nucl Cardiol. 2021;28:901-903.
    PubMed    


  816. AIKAWA T, Funayama N, Sunaga D, Kayanuma K, et al
    Reverse redistribution-like change on dipyridamole-stress (99m)Tc-tetrofosmin imaging in a patient with angiographically mild coronary artery stenosis.
    J Nucl Cardiol. 2021;28:1182-1185.
    PubMed    


  817. LEHENBAUER K
    Leading by example: Experiences and lessons learned from ASNC's Future Leaders of Nuclear Cardiology Symposium.
    J Nucl Cardiol. 2021;28:1175-1178.
    PubMed    


  818. SOMAN P, Jain SK
    Image-guided device therapy: An opportunity for personalized medicine.
    J Nucl Cardiol. 2021;28:1162-1164.
    PubMed    


  819. YOSHINAGA K
    Ventricular phase analysis moves on to the next phase: What technologists should keep in mind.
    J Nucl Cardiol. 2021;28:1172-1174.
    PubMed    


  820. KAN K, Phillips LM
    Predicting left ventricular dyssynchrony: Can nuclear cardiology bring us closer "In Sync"?
    J Nucl Cardiol. 2021;28:1151-1152.
    PubMed    


  821. BEKKI M, Tahara N, Tahara A, Maeda-Ogata S, et al
    Switching from clopidogrel to prasugrel resolves vascular inflammation in patients receiving long-term aspirin plus clopidogrel therapy after coronary stent implantation.
    J Nucl Cardiol. 2021;28:1191-1192.
    PubMed    


  822. LIU Q, Zhu Y
    Multimodality imaging for diagnosis in primary cardiac angiosarcoma.
    J Nucl Cardiol. 2021;28:1189-1190.
    PubMed    


  823. MAEDA D, Kanzaki Y, Sohmiya K, Hoshiga M, et al
    A case of primary cardiac lymphoma: Difficult to diagnose.
    J Nucl Cardiol. 2021;28:1186-1188.
    PubMed    


  824. SILLANMAKI S, Gimelli A, Ahmad S, Samir S, et al
    Mechanisms of left ventricular dyssynchrony: A multinational SPECT study of patients with bundle branch block.
    J Nucl Cardiol. 2021;28:1140-1150.
    PubMed     Abstract available


  825. DE SOUZA FILHO EM, Mesquita CT
    Phase analysis of gated myocardial perfusion SPECT and cardiac resynchronization therapy: The good, the bad, and the ugly.
    J Nucl Cardiol. 2021;28:1136-1139.
    PubMed    


  826. ALI O, Shenoy M, Alani A, Alani M, et al
    Are SPECT MPI measures of dyssynchrony dyssynchronous?
    J Nucl Cardiol. 2021;28:1128-1135.
    PubMed     Abstract available


  827. MALHOTRA S, Iskandrian AE
    Spotlight on left ventricular dyssynchrony: Part 3: Diagnostic value and therapeutic guidance.
    J Nucl Cardiol. 2021;28:1021-1022.
    PubMed    


  828. DANAD I, Knaapen P
    Myocardial blood flow imaging in patients with a left bundle branch block or ventricular-paced rhythm: "And therein, as the Bard would tell us, lies the rub".
    J Nucl Cardiol. 2021;28:989-991.
    PubMed    


  829. SHETTY M, Akintoye E
    Top ten takeaways from #ASNC2020: FITs' perspective.
    J Nucl Cardiol. 2021;28:1068-1071.
    PubMed    


  830. OSBORNE MT, Abohashem S, Zureigat H, Abbasi TA, et al
    Multimodality molecular imaging: Gaining insights into the mechanisms linking chronic stress to cardiovascular disease.
    J Nucl Cardiol. 2021;28:955-966.
    PubMed     Abstract available


  831. VIJ A, Malhotra S
    Left ventricular regional asynchrony: Earliest marker for ischemic cardiomyopathy?
    J Nucl Cardiol. 2021;28:1051-1054.
    PubMed    


  832. VAN TOSH A, Votaw JR, Cooke CD, Cao JJ, et al
    Early onset of left ventricular regional asynchrony in arteries with sub-clinical stenosis.
    J Nucl Cardiol. 2021;28:1040-1050.
    PubMed     Abstract available


  833. NUDI F, Nudi A, Biondi-Zoccai G, Schillaci O, et al
    Myocardial perfusion imaging with cadmium-zinc-telluride cameras: Harry Potter and the Radiation Hallows?
    J Nucl Cardiol. 2021;28:1000-1004.
    PubMed    


  834. SREENIVASAN J, Jain D
    Parameters of left ventricular systolic and diastolic dyssynchrony on radionuclide imaging to improve cardiac resynchronization therapy in heart failure patients with dilated cardiomyopathy.
    J Nucl Cardiol. 2021;28:1037-1039.
    PubMed    


  835. BAUMGARTEN R, Cerci RJ, de Nadai Costa A, Pereira-Neto CC, et al
    Radiation exposure after myocardial perfusion imaging with Cadmium-Zinc-Telluride camera versus conventional camera.
    J Nucl Cardiol. 2021;28:992-999.
    PubMed     Abstract available


  836. WANG C, Shi J, Ge J, Tang H, et al
    Left ventricular systolic and diastolic dyssynchrony to improve cardiac resynchronization therapy response in heart failure patients with dilated cardiomyopathy.
    J Nucl Cardiol. 2021;28:1023-1036.
    PubMed     Abstract available


  837. PERSIA-PAULINO YR, Cuevas-Perez J, Fernandez-Asensio R, Junco-Vicente A, et al
    Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
    J Nucl Cardiol. 2021;28:1117-1125.
    PubMed     Abstract available


  838. GREEN R, Cantoni V, Acampa W, Assante R, et al
    Prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging: A meta-analysis.
    J Nucl Cardiol. 2021;28:904-918.
    PubMed     Abstract available


  839. IMBERT L, Marie PY
    Low-dose gated bloodpool SPECT: Is it time to make the shift?
    J Nucl Cardiol. 2021;28:951-954.
    PubMed    


  840. NAKAJIMA K, Okuda K, Maruyama K
    Demystifying dyssynchrony for diagnosis and prognosis: Tips for measuring heterogeneous phase distribution.
    J Nucl Cardiol. 2021;28:1064-1067.
    PubMed    


  841. THOMAS GS, Taghavi A
    Regadenoson myocardial perfusion imaging predicts prognosis in patients with either left bundle branch block or a ventricular paced rhythm.
    J Nucl Cardiol. 2021;28:978-980.
    PubMed    


  842. LIU YH, Fazzone-Chettiar R, Sandoval V, Tsatkin V, et al
    New approach for quantification of left ventricular function from low-dose gated bloodpool SPECT: Validation and comparison with conventional methods in patients.
    J Nucl Cardiol. 2021;28:939-950.
    PubMed     Abstract available


  843. ZUBIN MASLOV P, Narula N, Narula J
    Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
    J Nucl Cardiol. 2021;28:1100-1104.
    PubMed    


  844. PEIX A, Padron K, Cabrera LO, Pardo L, et al
    Left ventricular mechanical dyssynchrony in patients with chest pain and normal epicardial coronary arteries.
    J Nucl Cardiol. 2021;28:1055-1063.
    PubMed     Abstract available


  845. BRAVO PE, Bajaj N, Padera RF, Morgan V, et al
    Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
    J Nucl Cardiol. 2021;28:1089-1099.
    PubMed     Abstract available


  846. LIGA R, Gimelli A
    MPI in the era of CZT cameras: Absolute numbers are still better than relative figures.
    J Nucl Cardiol. 2021;28:1085-1088.
    PubMed    


  847. NUDI F, Biondi-Zoccai G, Nudi A, Neri G, et al
    Comparative analysis between myocardial perfusion reserve and maximal ischemia score at single photon emission computed tomography with new-generation cadmium-zinc-telluride cameras.
    J Nucl Cardiol. 2021;28:1072-1084.
    PubMed     Abstract available


  848. ISKANDER F, Iskander M, Gomez J, Doukky R, et al
    Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    J Nucl Cardiol. 2021;28:967-977.
    PubMed     Abstract available


  849. PEIX A, Padron K
    Imagine, believe, and achieve.
    J Nucl Cardiol. 2021;28:831-834.
    PubMed    


  850. THOMPSON RC
    A letter to fellows-in-training around the world.
    J Nucl Cardiol. 2021;28:1197-1198.
    PubMed    


  851. CUOCOLO A, Nappi C, Acampa W, Petretta M, et al
    Nuclear cardiac imaging between implementation and globalization: The key role of integration.
    J Nucl Cardiol. 2021;28:793-795.
    PubMed    


  852. DEKEMP R, Juneau D, Wu KY, Wells G, et al
    On the roles of reproducibility, ethics, and statistical modeling in medical research.
    J Nucl Cardiol. 2021;28:855-858.
    PubMed    


  853. ISKANDRIAN A
    In appreciation of our 2020 reviewers.
    J Nucl Cardiol. 2021;28:791-792.
    PubMed    


  854. POITRASSON-RIVIERE A, Murthy VL
    Deriving myocardial blood flow reserve from perfusion datasets: Dream or reality?
    J Nucl Cardiol. 2021;28:851-854.
    PubMed    


  855. JAIN D
    Molecular imaging of tumor-specific markers and their expression in other organs.
    J Nucl Cardiol. 2021;28:822-824.
    PubMed    


  856. HENZLOVA MJ, Duvall WL
    Did we solve soft tissue (breast) attenuation?
    J Nucl Cardiol. 2021;28:898-900.
    PubMed    


  857. BENZ DC, Fuchs TA
    How equilibrium radionuclide angiography can quantify tricuspid regurgitation.
    J Nucl Cardiol. 2021;28:873-875.
    PubMed    


  858. ZAMPELLA E, Assante R, Gaudieri V, Nappi C, et al
    Myocardial perfusion reserve by using CZT: It's a long way to the top if you wanna standardize.
    J Nucl Cardiol. 2021;28:885-887.
    PubMed    


  859. MANNARINO T, Assante R, Ricciardi C, Zampella E, et al
    Head-to-head comparison of diagnostic accuracy of stress-only myocardial perfusion imaging with conventional and cadmium-zinc telluride single-photon emission computed tomography in women with suspected coronary artery disease.
    J Nucl Cardiol. 2021;28:888-897.
    PubMed     Abstract available


  860. DE SOUZA ACDAH, Goncalves BKD, Tedeschi AL, Lima RSL, et al
    Quantification of myocardial flow reserve using a gamma camera with solid-state cadmium-zinc-telluride detectors: Relation to angiographic coronary artery disease.
    J Nucl Cardiol. 2021;28:876-884.
    PubMed     Abstract available


  861. EYHARTS D, Lavie-Badie Y, Cazalbou S, Fournier P, et al
    Quantitative assessment of tricuspid regurgitation using right and left ventricular stroke volumes obtained from tomographic equilibrium radionuclide ventriculography.
    J Nucl Cardiol. 2021;28:864-872.
    PubMed     Abstract available


    May 2021
  862. ROBSON PM, Kaufman A, Pruzan A, Dweck MR, et al
    Scan-rescan measurement repeatability of (18)F-FDG PET/MR imaging of vascular inflammation.
    J Nucl Cardiol. 2021 May 27. pii: 10.1007/s12350-021-02627.
    PubMed     Abstract available


  863. CAMPISI R, Merani MF, Rodriguez MI
    Correction to: BMIPP SPECT in cardiac sarcoidosis: A marker of risk?
    J Nucl Cardiol. 2021 May 25. pii: 10.1007/s12350-021-02669.
    PubMed    


  864. QUTBI M, Soltanshahi M, FarokhiMoghadam F, Ramandi FL, et al
    Polarity status of trigger signal during ECG-gating affects parameters of LV function in gated myocardial perfusion SPECT.
    J Nucl Cardiol. 2021 May 25. pii: 10.1007/s12350-021-02675.
    PubMed     Abstract available


  865. GAZZILLI M, Albano D, Lucchini S, Peli A, et al
    New criteria for the diagnosis of infective endocarditis using 18F-FDG PET/CT imaging.
    J Nucl Cardiol. 2021 May 25. pii: 10.1007/s12350-021-02663.
    PubMed     Abstract available


  866. RAUBA J, Harland D, Ajam T, Port S, et al
    What is this image? 2021: Image 6 result : The curious case of the hidden liver: Polycystic liver disease as depicted on planar projection images of a Tc-99m Sestamibi SPECT MPI study.
    J Nucl Cardiol. 2021 May 19. pii: 10.1007/s12350-021-02636.
    PubMed    


  867. MANABE O, Tamaki N
    Potential roles of (123)I-BMIPP SPECT to assess cardiac sarcoidosis.
    J Nucl Cardiol. 2021 May 14. pii: 10.1007/s12350-021-02654.
    PubMed    


  868. APERT A, Canu M, Jankowski A, Riou L, et al
    Comparison of Cadmium Zinc Telluride ECG-gated SPECT equilibrium radionuclide angiocardiography to magnetic resonance imaging to measure right ventricular volumes and ejection fraction in patients with cardiomyopathy.
    J Nucl Cardiol. 2021 May 14. pii: 10.1007/s12350-021-02653.
    PubMed     Abstract available


  869. LIN K, Chen X, Xue Q, Yao S, et al
    Diffuse uptake of [(68)Ga]Ga-FAPI in the left heart in a patient with hypertensive heart disease by PET/CT.
    J Nucl Cardiol. 2021 May 14. pii: 10.1007/s12350-021-02646.
    PubMed    


  870. PIRI R, Edenbrandt L, Larsson M, Enqvist O, et al
    Aortic wall segmentation in (18)F-sodium fluoride PET/CT scans: Head-to-head comparison of artificial intelligence-based versus manual segmentation.
    J Nucl Cardiol. 2021 May 12. pii: 10.1007/s12350-021-02649.
    PubMed     Abstract available


  871. GANDHI R, Bell M, Bailey M, Tsoumpas C, et al
    Prospect of positron emission tomography for abdominal aortic aneurysm risk stratification.
    J Nucl Cardiol. 2021 May 11. pii: 10.1007/s12350-021-02616.
    PubMed     Abstract available


  872. TSHORI S, Livschitz S, Volodarsky I, Goland S, et al
    Transthyretin Cardiac Amyloidosis Scintigraphy Using Planar D-SPECT on Dedicated Cardiac CZT Camera.
    J Nucl Cardiol. 2021 May 11. pii: 10.1007/s12350-021-02651.
    PubMed     Abstract available


  873. BRUNKEN RC
    The abnormal right ventricle: Relevant on low risk SPECT perfusion images?
    J Nucl Cardiol. 2021 May 11. pii: 10.1007/s12350-021-02647.
    PubMed    


  874. CAO J, Yang Y
    (18)F-FDG PET/CT detected recurrent renal cell carcinoma presenting with cardiac metastasis.
    J Nucl Cardiol. 2021 May 11. pii: 10.1007/s12350-021-02652.
    PubMed    


  875. AIKAWA T, Ibe T, Manabe O, Oyama-Manabe N, et al
    Right ventricular involvement of cardiac sarcoidosis: A comprehensive evaluation using cardiovascular magnetic resonance imaging and positron emission tomography.
    J Nucl Cardiol. 2021 May 7. pii: 10.1007/s12350-021-02655.
    PubMed    


  876. DIXIT P, Ananthasubramaniam K
    No shortcuts with left bundle branch block and myocardial perfusion imaging: Lesson learnt with dobutamine cardiac PET.
    J Nucl Cardiol. 2021 May 6. pii: 10.1007/s12350-021-02640.
    PubMed    


  877. BANDYOPADHYAY D, Gerard P, Jain D
    Significance of (123)I-mIBG SPECT cardiac imaging in heart failure.
    J Nucl Cardiol. 2021 May 4. pii: 10.1007/s12350-021-02643.
    PubMed    


  878. SIEKKINEN R, Kirjavainen AK, Koskensalo K, Smith NAS, et al
    Assessment of a digital and an analog PET/CT system for accurate myocardial perfusion imaging with a flow phantom.
    J Nucl Cardiol. 2021 May 4. pii: 10.1007/s12350-021-02631.
    PubMed     Abstract available


  879. RAO Z, Wu J, Jiang G, Zhang C, et al
    Cardiac metastasis from esophageal carcinoma detected on (18)F-FDG PET/CT and (68)Ga-FAPI PET/CT scan.
    J Nucl Cardiol. 2021 May 4. pii: 10.1007/s12350-021-02645.
    PubMed    


    April 2021
  880. SAZONOVA SI, Syrkina AG, Mochula OV, Anashbaev ZZ, et al
    Subacute myocardial infarction detected by technetium-99m-labeled somatostatin analog scintigraphy.
    J Nucl Cardiol. 2021 Apr 30. pii: 10.1007/s12350-021-02644.
    PubMed     Abstract available


  881. ZAVADOVSKY KV, Mochula AV, Maltseva AN, Shipulin VV, et al
    The current status of CZT SPECT myocardial blood flow and reserve assessment: Tips and tricks.
    J Nucl Cardiol. 2021 Apr 30. pii: 10.1007/s12350-021-02620.
    PubMed     Abstract available


  882. ALJAROUDI W
    Gastric wall uptake and attenuation artifact in 99m-Tc sestamibi SPECT: Hold the proton pump inhibitors!
    J Nucl Cardiol. 2021 Apr 30. pii: 10.1007/s12350-021-02528.
    PubMed    


  883. MOTWANI M
    You might be correct, but it makes no difference: No impact of attenuation correction for SPECT MPI on downstream testing.
    J Nucl Cardiol. 2021 Apr 28. pii: 10.1007/s12350-021-02622.
    PubMed    


  884. YANG X, Hu Z, You Z, Chen Y, et al
    Mediastinal diffuse large B-cell lymphoma mimicking invasive thymoma on (68)Ga-FAPI PET/CT.
    J Nucl Cardiol. 2021 Apr 28. pii: 10.1007/s12350-021-02623.
    PubMed    


  885. CAMPISI R, Merani MF, Rodriguez MI
    BMIPP SPECT in cardiac sarcoidosis: A marker of risk?
    J Nucl Cardiol. 2021 Apr 26. pii: 10.1007/s12350-021-02626.
    PubMed    


  886. HUTT E, Jaber WA, Fares M
    Asymptomatic STEMI during PET stress testing: First report in a patient with heart transplant.
    J Nucl Cardiol. 2021 Apr 26. pii: 10.1007/s12350-021-02625.
    PubMed    


  887. MURAO M, Norikane T, Chujo K, Takami Y, et al
    Clinical significance of PET angiography in Takayasu arteritis.
    J Nucl Cardiol. 2021 Apr 22. pii: 10.1007/s12350-021-02619.
    PubMed    


  888. CHUJO K, Norikane T, Murao M, Takami Y, et al
    Incidental (18)F-FDG myocardial uptake revealed as physiological lesion by (18)F-FLT PET/CT.
    J Nucl Cardiol. 2021 Apr 22. pii: 10.1007/s12350-021-02618.
    PubMed    


  889. BONNEFOY PB, Janvier L, Arede C, Drouet C, et al
    Reduced acquisition time for thallium myocardial perfusion imaging with large field cadmium-zinc-telluride SPECT/CT cameras: An equivalence study.
    J Nucl Cardiol. 2021 Apr 22. pii: 10.1007/s12350-021-02611.
    PubMed     Abstract available


  890. SANTARELLI MF, Genovesi D, Scipioni M, Positano V, et al
    Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images.
    J Nucl Cardiol. 2021 Apr 16. pii: 10.1007/s12350-021-02608.
    PubMed     Abstract available


  891. VALZANIA C, Mei R, Biffi M
    Three-dimensional left ventricular mechanical dyssynchrony assessed by myocardial perfusion gated-SPECT: Is there a role in cardiac resynchronization therapy?
    J Nucl Cardiol. 2021 Apr 16. pii: 10.1007/s12350-021-02614.
    PubMed    


  892. AHMADI R, Qutbi M
    Profound gating error and flattened time-volume curve from inefficient triggering from improper setting of ECG leads in myocardial perfusion SPECT.
    J Nucl Cardiol. 2021 Apr 13. pii: 10.1007/s12350-021-02615.
    PubMed    


  893. MORENO-BALLESTEROS A, Lojo-Ramirez JA, Jimenez-Hoyuela-Garcia JM
    18F-FDG PET/CT focal cardiac uptake: An unsuspected Chiari's network.
    J Nucl Cardiol. 2021 Apr 13. pii: 10.1007/s12350-021-02605.
    PubMed    


  894. JOSE A, Zhou C, Baker R, Walker J, et al
    Predictive value of incidental right ventricular abnormalities identified on SPECT for mortality and pulmonary hypertension.
    J Nucl Cardiol. 2021 Apr 13. pii: 10.1007/s12350-021-02612.
    PubMed     Abstract available


  895. AYERS MP, Peruri AV, Bourque JM
    Transforming ATTR cardiac amyloidosis into a chronic disease: The enormous potential of quantitative SPECT to improve diagnosis, prognosis, and monitoring of disease progression.
    J Nucl Cardiol. 2021 Apr 13. pii: 10.1007/s12350-021-02587.
    PubMed    


  896. LIU Y, Tao Y, Wang F, Huang Z, et al
    Mediastinum-type lung cancer on 68Ga-FAPI PET/CT with cardiac insufficiency as the first symptom.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02601.
    PubMed    


  897. PROMTEANGTRONG C, Jantarato A, Kunawudhi A, Kiatkittikul P, et al
    Clinical impact of quantitative [(15)O] H2O PET/CT myocardial perfusion imaging on decision-making regarding invasive management of coronary artery disease.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02604.
    PubMed     Abstract available


  898. BORGES-ROSA J, Oliveira-Santos M, Silva R, da Silva NP, et al
    Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[(18)F]F PET-CT.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02600.
    PubMed     Abstract available


  899. TANG H, Bober RR, Zhao C, Zhang C, et al
    3D fusion between fluoroscopy angiograms and SPECT myocardial perfusion images to guide percutaneous coronary intervention.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02574.
    PubMed     Abstract available


  900. TEKLU M, Mehta NN
    FDG-PET in ischemic strokes of unknown origin: Have we found the needle in the haystack?
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02598.
    PubMed    


  901. YAGHOOBI N, Mahdavi M, Maghsudi M, Malek H, et al
    Right ventricular ischemia by myocardial perfusion imaging in a 6-year-old child with pulmonary hypertension after ventricular septal defect repair.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02590.
    PubMed    


  902. PORT S
    Robert H. Jones, MD (Born 1940).
    J Nucl Cardiol. 2021;28:404-406.
    PubMed    


  903. DI CARLI MF
    Changing epidemiology of CAD: Why should we pay attention?
    J Nucl Cardiol. 2021;28:386-388.
    PubMed    


  904. GERBER J, Miller EJ
    Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake.
    J Nucl Cardiol. 2021;28:503-506.
    PubMed    


  905. HAIDER A, Bengs S, Diggelmann F, Epprecht G, et al
    Age- and sex-dependent changes of resting amygdalar activity in individuals free of clinical cardiovascular disease.
    J Nucl Cardiol. 2021;28:427-432.
    PubMed     Abstract available


  906. FLETCHER AJ, Dweck MR
    Detecting native and bioprosthetic aortic valve disease using (18)F-sodium fluoride: Clinical implications.
    J Nucl Cardiol. 2021;28:481-491.
    PubMed     Abstract available


  907. MONDAL P, Aljizeeri A, Small G, Malhotra S, et al
    Coronary artery disease in patients with human immunodeficiency virus infection.
    J Nucl Cardiol. 2021;28:510-530.
    PubMed     Abstract available


  908. AL-MEHISEN R, Alnemri K, Al-Mohaissen M
    Cardiac imaging of a patient with unusual presentation of granulomatosis with polyangiitis: A case report and review of the literature.
    J Nucl Cardiol. 2021;28:441-455.
    PubMed     Abstract available


  909. MEREDITH D, Cremer PC, Harb SC, Xu B, et al
    Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease.
    J Nucl Cardiol. 2021;28:536-542.
    PubMed     Abstract available


  910. LEE JC, Wijesekera VA
    Utilising combined MPI and CACS results.
    J Nucl Cardiol. 2021;28:744.
    PubMed    


  911. SHETTY M
    A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.
    J Nucl Cardiol. 2021;28:604-609.
    PubMed    


  912. DILSIZIAN V
    Interpretation and clinical management of patients with "Fixed" myocardial perfusion defects : A call for quantifying endocardial-to-epicardial distribution of blood flow.
    J Nucl Cardiol. 2021;28:723-728.
    PubMed    


  913. ISKANDRIAN AE
    Fixed perfusion defects revisited.
    J Nucl Cardiol. 2021;28:729.
    PubMed    


  914. WEHBE RM, Kansal P, Holly TA
    Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.
    J Nucl Cardiol. 2021;28:653-660.
    PubMed     Abstract available


  915. ALBASSAM O, Redwood T, Bowers N, Iwanochko R, et al
    Acute inflammatory pericarditis secondary to cardiac sarcoidosis evaluated by 18F-fluorodeoxyglucose PET/CT imaging.
    J Nucl Cardiol. 2021;28:763-767.
    PubMed    


  916. ALKORDY T, Wang S, Price M, Stodilka R, et al
    Evaluation of an incidental solid renal mass during cardiac Tc-99m MIBI SPECT/CT imaging.
    J Nucl Cardiol. 2021;28:760-762.
    PubMed    


  917. SIA CH, Ho JSY, Kong WKF, Wong RCC, et al
    Apical hypertrophic cardiomyopathy complicated by apical aneurysm.
    J Nucl Cardiol. 2021;28:756-759.
    PubMed    


  918. MINAMIMOTO R, Hotta M, Hiroe M, Awaya T, et al
    Proliferation imaging with (11)C-4DST PET/CT for the evaluation of cardiac sarcoidosis, compared with FDG-PET/CT given a long fasting preparation protocol.
    J Nucl Cardiol. 2021;28:752-755.
    PubMed    


  919. PARIHAR AS, Singh H, Bhansali A, Karthikeyan, et al
    Hepato-cardiac juxtaposition secondary to right hemi-diaphragmatic eventration on (99m)Tc-Sestamibi myocardial perfusion scintigraphy.
    J Nucl Cardiol. 2021;28:750-751.
    PubMed     Abstract available


  920. HUSSAIN M, Collier P, Jaber W
    Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough.
    J Nucl Cardiol. 2021;28:747-749.
    PubMed    


  921. MASSALHA S, Slart RHJA
    Anderson-Fabry disease: Worthy to in-SPECT the nerves?
    J Nucl Cardiol. 2021;28:650-652.
    PubMed    


  922. NICHOLS KJ, Van Tosh A
    Putting gated SPECT and PET left ventricular function computations in perspective.
    J Nucl Cardiol. 2021;28:575-578.
    PubMed    


  923. WAN N, Travin MI
    Cardiac PET assessment of myocardial microvascular flow may help identify subclinical left ventricular dysfunction and increased risk from aortic stenosis.
    J Nucl Cardiol. 2021;28:589-593.
    PubMed    


  924. CHRISTOPOULOS G, Jouni H, Acharya GA, Blauwet LA, et al
    Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    J Nucl Cardiol. 2021;28:661-671.
    PubMed     Abstract available


  925. ZHANG X, Qian Z, Tang H, Hua W, et al
    A new method to recommend left ventricular lead positions for improved CRT volumetric response and long-term prognosis.
    J Nucl Cardiol. 2021;28:672-684.
    PubMed     Abstract available


  926. CANTONI V, Green R, Acampa W, Zampella E, et al
    Diagnostic performance of myocardial perfusion imaging with conventional and CZT single-photon emission computed tomography in detecting coronary artery disease: A meta-analysis.
    J Nucl Cardiol. 2021;28:698-715.
    PubMed     Abstract available


  927. SPINELLI L, Imbriaco M, Giugliano G, Nappi C, et al
    Focal reduction in left ventricular (123)I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease.
    J Nucl Cardiol. 2021;28:641-649.
    PubMed     Abstract available


  928. SCHENONE AL, Jaber WA
    The neuro-hematopoietic-inflammatory arterial axis: The missing link between PTSD and cardiovascular disease?
    J Nucl Cardiol. 2021;28:695-697.
    PubMed    


  929. PRETORIUS PH, Ramon AJ, King MA, Konik A, et al
    Retrospective fractional dose reduction in Tc-99m cardiac perfusion SPECT/CT patients: A human and model observer study.
    J Nucl Cardiol. 2021;28:624-637.
    PubMed     Abstract available


  930. TOCZEK J, Hillmer AT, Han J, Liu C, et al
    FDG PET imaging of vascular inflammation in post-traumatic stress disorder: A pilot case-control study.
    J Nucl Cardiol. 2021;28:688-694.
    PubMed     Abstract available


  931. GUPTA K, Bajaj NS, Hage FG, Bhambhvani P, et al
    Myocardial perfusion artifacts in left bundle branch block: A diagnostic challenge.
    J Nucl Cardiol. 2021;28:543-545.
    PubMed    


  932. YAO Y, Wang DW, Fang W, Tian YQ, et al
    Evaluation of left ventricular volumes and ejection fraction by (99m)Tc-MIBI gated SPECT and (18)F-FDG gated PET in patients with prior myocardial infarction.
    J Nucl Cardiol. 2021;28:560-574.
    PubMed     Abstract available


  933. GIMELLI A, Pugliese NR, Bertasi M, Airo E, et al
    Cardio-pulmonary involvement in pulmonary arterial hypertension: A perfusion and innervation scintigraphic evaluation.
    J Nucl Cardiol. 2021;28:546-556.
    PubMed     Abstract available


  934. VAN TOSH A, Nichols KJ
    Prolonged left ventricular dysfunction following pharmacologic stress myocardial perfusion imaging: Should we be less stunned than in the past?
    J Nucl Cardiol. 2021;28:718-722.
    PubMed    


    February 2021
  935. VEERANNA V, Freeman AM
    The magic of improved crystal technology coupled with better resolution: Novel imaging findings may promise improved disease detection.
    J Nucl Cardiol. 2021;28:328-330.
    PubMed    


  936. SCHELBERT HR
    On the Relativity of Dipyridamole and Dobutamine Flows.
    J Nucl Cardiol. 2021;28:46-49.
    PubMed    


  937. MALHOTRA S, Doukky R
    Challenges in prediction of right ventricular failure among recipients of a left ventricular assist device.
    J Nucl Cardiol. 2021;28:309-310.
    PubMed    


  938. BULLOCK-PALMER RP
    Diagnosing cardiac amyloidosis: A wealth of new possibilities with nuclear cardiac imaging.
    J Nucl Cardiol. 2021;28:219-224.
    PubMed    


  939. SHARIR T, Hollander I, Kovalski G
    Can phase analysis of gated myocardial perfusion single-photon emission computed tomography predict adverse outcome in cardiac sarcoidosis?
    J Nucl Cardiol. 2021;28:137-139.
    PubMed    


  940. NAKAJIMA K, Yoneyama H, Slomka P
    Beware the pitfalls of beauty: High-quality myocardial images with resolution recovery.
    J Nucl Cardiol. 2021;28:245-248.
    PubMed    


  941. ROMERO-FARINA G, Aguade-Bruix S
    Perspective and future direction of intraventricular mechanical dyssynchrony assessment.
    J Nucl Cardiol. 2021;28:65-71.
    PubMed    


  942. ISKANDRIAN AE
    The 2020 trials and tribulations.
    J Nucl Cardiol. 2021;28:15-17.
    PubMed    


  943. ZHOU Y, He Z, Liao S, Liu Y, et al
    Prognostic value of integrative analysis of electrical and mechanical dyssynchrony in patients with acute heart failure.
    J Nucl Cardiol. 2021;28:140-149.
    PubMed     Abstract available


  944. SLOMKA PJ, Moody JB, Miller RJH, Renaud JM, et al
    Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.
    J Nucl Cardiol. 2021;28:115-127.
    PubMed     Abstract available


  945. ASIF T, Gomez J, Singh V, Doukky R, et al
    Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    J Nucl Cardiol. 2021;28:104-111.
    PubMed     Abstract available


  946. VADI SK, Sood A, Panda P, Debi U, et al
    Reversible perfusion pattern in hypertrophied papillary muscles evident on myocardial perfusion imaging with CZT-based cardiac-specific camera.
    J Nucl Cardiol. 2021;28:320-327.
    PubMed    


  947. HASNIE UA, Barrios J, Iskandrian AE, Hage FG, et al
    Cases from a Busy Nuclear Cardiology Laboratory.
    J Nucl Cardiol. 2021;28:153-161.
    PubMed    


  948. GECELTER R, Van Tosh A, Nichols K
    Normal variant left ventricular lateral wall 18FDG uptake in cardiac sarcoid evaluations.
    J Nucl Cardiol. 2021;28:375-376.
    PubMed    


  949. SHETTY S, Sistla P, Christodoulidis G
    The eye cannot see what the mind does not know.
    J Nucl Cardiol. 2021;28:371-374.
    PubMed    


  950. KONISHI T, Norikane T, Yamamoto Y, Fujimoto K, et al
    The potential relationship between (18)F-FDG uptake and wall shear stress in a patient with carotid artery disease.
    J Nucl Cardiol. 2021;28:367-370.
    PubMed    


  951. CHEN CC, Shen TY, Peterson CB, Hung GU, et al
    Comparison of ejection fraction calculation between CT and SPECT at high heart rate: A dynamic cardiac phantom study.
    J Nucl Cardiol. 2021;28:311-316.
    PubMed     Abstract available


  952. PRECIADO-ANAYA A, Preciado-Gutierrez OU, Balderrabano-Saucedo N, Hu D, et al
    Rings and ovoid heart: OCIR. A new cardiomyopathy? Family genetic findings and multimodality imaging analysis. A rare cardiac phenotype and review of the literature.
    J Nucl Cardiol. 2021;28:359-366.
    PubMed    


  953. MIURA S, Naya M, Manabe O, Ando A, et al
    Effects of ligation of a coronary artery fistula on coronary blood flow.
    J Nucl Cardiol. 2021;28:354-358.
    PubMed    


  954. PATEL VN, Tam MC, Palardy M, Konerman MC, et al
    Assessing the utility of pre-operative first pass radionuclide angiography to predict right ventricular failure post left ventricular assist device implantation.
    J Nucl Cardiol. 2021;28:303-308.
    PubMed     Abstract available


  955. PIEPER J, Patel VN, Escolero S, Nelson JR, et al
    Initial clinical experience of N13-ammonia myocardial perfusion PET/CT using a compact superconducting production system.
    J Nucl Cardiol. 2021;28:295-299.
    PubMed     Abstract available


  956. EL-DALATI S, Murthy VL, Owczarczyk AB, Fagan C, et al
    Correlating cardiac F-18 FDG PET/CT results with intra-operative findings in infectious endocarditis.
    J Nucl Cardiol. 2021;28:289-294.
    PubMed     Abstract available


  957. HEINDL B, Iskandrian AE, Hage FG
    Severe myocardial ischemia in a patient with diabetes mellitus and left bundle branch block.
    J Nucl Cardiol. 2021;28:278-288.
    PubMed     Abstract available


  958. SHIMIZU M, Iiya M, Fujii H, Kimura S, et al
    Left ventricular end-systolic contractile entropy can predict cardiac prognosis in patients with complete left bundle branch block.
    J Nucl Cardiol. 2021;28:162-171.
    PubMed     Abstract available


  959. BENZ DC, Ferro P, Safa N, Messerli M, et al
    Role of quantitative myocardial blood flow and (13)N-ammonia washout for viability assessment in ischemic cardiomyopathy.
    J Nucl Cardiol. 2021;28:263-273.
    PubMed     Abstract available


  960. ZAVADOVSKY KV, Mochula AV, Boshchenko AA, Vrublevsky AV, et al
    Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy.
    J Nucl Cardiol. 2021;28:249-259.
    PubMed     Abstract available


  961. TSUBOI K, Nagaki A, Shibutani T, Onoguchi M, et al
    Optimal choice of OSEM and SD reconstruction algorithms in CZT SPECT for hypertrophic cardiomyopathy patients.
    J Nucl Cardiol. 2021;28:236-244.
    PubMed     Abstract available


  962. CUDDY-WALSH SG, Clackdoyle DC, Renaud JM, Wells RG, et al
    Patient-specific SPECT imaging protocols to standardize image noise.
    J Nucl Cardiol. 2021;28:225-233.
    PubMed     Abstract available


  963. MARTINEAU P, Finnerty V, Giraldeau G, Authier S, et al
    Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.
    J Nucl Cardiol. 2021;28:209-218.
    PubMed     Abstract available


  964. KOYANAGAWA K, Naya M, Aikawa T, Manabe O, et al
    Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.
    J Nucl Cardiol. 2021;28:128-136.
    PubMed     Abstract available


  965. TUOMINEN H, Haarala A, Tikkakoski A, Kahonen M, et al
    FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
    J Nucl Cardiol. 2021;28:199-205.
    PubMed     Abstract available


  966. GALLINI C, Tutino F, Martone R, Ciaccio A, et al
    Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.
    J Nucl Cardiol. 2021;28:90-99.
    PubMed     Abstract available


  967. PEIX A, Karthikeyan G, Massardo T, Kalaivani M, et al
    Value of intraventricular dyssynchrony assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients undergoing cardiac resynchronization therapy (VISION-CRT).
    J Nucl Cardiol. 2021;28:55-64.
    PubMed     Abstract available


  968. GIMELLI A, Menichetti F, Soldati E, Liga R, et al
    Predictors of ventricular ablation's success: Viability, innervation, or mismatch?
    J Nucl Cardiol. 2021;28:175-183.
    PubMed     Abstract available


  969. YAMADA Y, Nakano S, Gatate Y, Okano N, et al
    Feasibility of simultaneous (99m)Tc-tetrofosmin and (123)I-BMIPP dual-tracer imaging with cadmium-zinc-telluride detectors in patients undergoing primary coronary intervention for acute myocardial infarction.
    J Nucl Cardiol. 2021;28:187-195.
    PubMed     Abstract available


    January 2021
  970. XING HQ, Gong JN, Chen BX, Guo XJ, et al
    Comparison of (68)Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardial fibrosis in a patient with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2021 Jan 20. pii: 10.1007/s12350-020-02517.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.